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The microbiological aetiology of vaginal discharge was studied in 208 women 
attending various outpatient clinics at King Edward VIII Hospital. 
Specimens from the lower genital tract were collected for microscopy and 
culture. Vaginal wet smear examination, amine liberation test and vaginal pH 
estimation were performed and assessed for their reliability for the rapid 
diagnosis of vaginal infections. 
Vaginal and endo-cervical infections were present in 163 (78,4%) women. Q. 
vaginalis (65,4%), I. vaginalis (37,9%), genital yeasts (37,0%), ~. hominis 
(59,6%), g. urealyticum (48,1%), anaerobic bacteria (32,6%), ~. gonorrhoeae 
(11,1%), f. trachomatis (22,1%) and Herpes simplex virus (0,9%) were 
detected. Of the 104 women in · whom vaginal infections were detected, 
bacterial vaginosis was present as the sole infection in 32 (22,2%), I. 
vaginalis in 35 (24,3%) and C. albicans in 23 (15,9%). Bacterial vaginosis 
occurred concurrently with I. vaginalis and f. albicans in 24 (16,5%) and 11 
(7,5%) women respectively; whilst I. vaginalis and f. albicans occurred 
concurrently in 14 (9,7%) women. In 6 (4,1%) women all three infections were 
present. No vaginal or endo-cervical pathogens were detected in 45 (21,6%) 
women. 
Women with bacterial vaginosis were found to be significantly colonised with 
§. vaginalis, M, hominis, anaerobic bacteria and curved Gram-negative 
bacilli (p < 0,05). 
i i 
Vaginal wet smear microscopy detected I.. vaginalis in 29% and "clue" cells 
in 41,3% of smears. The presence of "clue" cells (91,8%) and a positive 
amine test (76,7%) was significantly associated with bacterial vaginosis. 
Although a raised vaginal pH was also significantly associated with 
bacterial vaginosis, this test was less specific (65,2%) than "clue" cells 
(85,9%) and the amine test (95,5%). The vaginal Gram stain, as performed in 
this study, was found to be unreliable for the detection of "clue" cells. 
§. vaginalis biotypes 1 and 5 were significantly associated with bacterial 
vaginosis, however the serotyping scheme did not distinguish between strains 
isolated from women with and without bacterial vaginosis. The antimicrobial 
susceptibility pattern of 93 strains of §. vaginalis was not typical of 
either Gram-positive or Gram-negative bacteria. 
Serological tests revealed reactive syphilis serology in 47 (22,6%) and the 
presence of hepatitis B surface antigen in 16 (7,7%) women. Antibody to 
human immunodeficiency virus was detected in 4 (1,9%) women attending the 
colposcopy clinic. 
This study clearly demonstrates the high prevalence of vaginal and/or 
endo-cervical infections in women locally, the majority of whom were 
asymptomatic. The high frequency of concurrent infections is of concern and 
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Vaginal infections in adult women are amongst the commonest problems 
encountered in clinical practice. 
In premenopausal women, a vaginal discharge of infectious origin may 
be either due to a cervicitis, vaginitis or a combination of both 
conditi ons. The major causes of cervi citi s are sexually transmitted 
pathogens namely Neisseria gonorrhoeae, Chlamydia trachomatis and 
Herpes simplex virus. A cervical infection represents a reservoir for 
sexual or perinatal transmission and can lead to complications such as 
irritation and promotion of cervical neoplasia, salpingitis and 
endometritis in non-pregnant women, and chorio-amnioniti s, premature 
rupture of membranes, and ascendi ng infections in pregnancy and the 
puerperium. 
In women presenting with a vaginal discharge, where a uterine cause 
and vaginal lesions have been excluded, the two established and 
recognised causative agents are Candida albicans and Trichomonas 
vaginal is. A further syndrome in women who present with an abnormal 
discharge, but in which these agents have not been implicated, is 
recognised. This has been variously termed - non-specific vaginitis 
(NSV), Gardnerella-associated vaginitis (GAV) and bacterial vaginosis 
(BV). These vaginal conditions are generally devoid of serious 
complications, however, they are common and do account for significant 
morbidity. 
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The diagnosis, aetiology, pathogenesis, epidemiology and management of 
bacterial vaginosis has not been fully elucidated. 
Gardnerella vaginal is, a Gram-variable bacillus, first described by 
Leopold in 1953 (Leopold, 1953), has been implicated as the predomi-
nant aetiological agent of bacterial vaginosis (Gardner and Dukes, 
1955; Vontver and Eschenbach, 1981). Its aetiological role has been 
described as one of synergism with a number of micro-organisms found 
in vaginal secretions. Recent studies have shown an association with 
Mycoplasma hominis (Holmes, 1984), non-sporeforming anaerobes (Pheifer 
et ~, 1978; Spiegel et ~, 1980; Taylor et ~, 1982) and anaerobic 
curved Gram-negative rods (Hjelm et ~, 1981; Skarin and Mardh, 1982) 
which have been named Mobiluncus species (Spiegel and Roberts, 1984). 
Thi s associ ati on has been e 1 uci dated by gas 1 iqui d chromatography 
(GLC) of vaginal secretions from women with bacterial vaginosis. 
Characteristically the lactate is reduced whilst succinate is in-
creased (Spiegel et ~, 1980). The concentration of amines such as 
putrescine and cadaverine are also increased (Chen et ~, 1979). 
Studi es performed in Europe and North Ameri ca have shown prevalence 
figures of 40% to 50% for bacterial vaginosis, 20,5% for candidiasis 
and 9,8% for trichomoniasis (Fleury, 1981). This compares with preva-
lence figures of 31% for candidiasis and 47% for trichomoniasis 
reported in local studies (Hoosen et ~, 1981). Numerous studies on 
the aetiology of vaginal discharges have been performed in South 
Africa. Fehler et al (1984 ) reported on the prevalence of G. 
3 
vaginal is, but did not assess its association with bacterial 
vaginosis. Pochee et ~ (1986) have reported a 61% prevalence of 
bacterial vaginosis; however they made no attempt to culture the 
presumed aetiological agents in their study. 
The aim of this study was to: 
a Determine the prevalence of .§.. vaginalis, I. vaginalis and f.. 
albicans in pregnant and non-pregnant women presenting at King 
Edward VIII Hospital, Durban. 
b Attempt to confirm the role of G. vaginalis and anaerobic bacte-
ria in bacterial vaginosis. 
c Evaluate rapid bedside techniques such as wet smear microscopy, 
amine test and pH determination for the diagnosis of bacterial 
vaginosis. 
d Evaluate culture media - both transport and isolation media in 
order to determine the efficacy of transport media for the 
recovery and isolation of G. vaginalis as compared to direct 
plating method. 
e Characterise G. vaginalis isolates by various techniques 
including biotyping. 
f Evaluate the in vitro activity of various antimicrobial agents 
against.§.. vaginal is. 
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2.0 LITERATURE REVIEW 
2.1 COMMENSAL VAGINAL FLORA 
The normal flora are micro-organisms which coexist with humans and do 
not cause di sease under normal ci rcumstances. Typi ca lly these flora 
colonise the skin, mucous membranes or those sites in contact with the 
environment. Some of these micro-organisms are usually fa i rly permanent 
residents while others may commonly but not invariably be present 
transiently. Terms used synonomously with "normal f l ora" include 
"commensal flora" and "endogenous flora". The normal flora are usually 
well adapted to survive under the physiological and nutritional 
condi ti ons found in specifi c body sites; however the norma 1 flora of 
the vagina are influenced by many factors and are usually altered 
because of hormonal cyclical changes. 
Benefits provided to the host by the normal flora include the provision 
of competition and prevention of colonisation by pathogenic bacteria. 
The recognition of this has given rise to the widely accepted concept 
of "colonisation resistance". 
Although human normal flora are regarded primarily as being of benefit 
to the host, they are not entirely without pathogenic potential as they 
may, under certain circumstances, be associated with localised 
i nfecti ons and may occas iona lly spread to other body sites, 
particularly those which are normally sterile, to cause significant 
infections (Hill et ~, 1984). In the case of the normal vaginal flora, 
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these playa significant role in defence against infection by genital 
pathogens (Cohen et ~, 1984a). In the late 1800's, Doderlein described 
the prominence of facultative Gram-positive rods as part of the normal 
vaginal flora (Doderlein, 1894 - cited by Paavonen, 1983). These were 
called Doderlein bacilli, which comprised a heterogenous species of 
acidophilic Gram-positive bacilli, synonomous with lactobacilli. 
Traditionally, the vaginal flora were assessed by vaginal smears based 
on the presence of Doderlein bacilli and/or their replacement by mixed 
predominantly coccal type flora (Leppaluoto, 1971). The association of 
lactobacilli with a normal clinical examination in pre-menopausal women 
led to the concept that only lactobacilli were normal in endogenous 
flora and the presence of other organisms represented an aberration. 
With the advent of improved bacteriologic culture techniques for 
isolation and differentiation of bacteria, particularly obligate 
anaerobic bacteria and with the application of such sensitive 
techniques, numerous species have been detected either in frequent or 
small numbers. Apart from the lactobacilli which were the species most 
commonly isolated from the healthly vagina (Bartlett et ~, 1977; 
Masfari et~, 1986; Levison et ~, 1979), the vagina was also shown to 
be colonised by anaerobic bacteria (Bartlett et ~, 1977; Larsen, 
1980). Anaerobic Gram-positive cocci and Bacteroides species are the 
main anaerobic organisms in the vagina and cervix. These may also be 
present in high concentrations (Bartlett and Polk, 1984). The most 
prevalent bacteria of the vaginal flora of healthy women are shown in 
Table I. 
TABLE I CLASSIFICATION OF BACTERIA FOUND IN HUMAN VAGINA 
(Huggins and Preti, 1981) 
Aerobic Anaerobic 
Gram-pos Hi ve Streptococcus Streptococcus 
cocci Staphylococcus Peptostreptococcus 
Micrococcus Peptococcus 
Gram-positive Lactobacillus Lactobacillus 





Gram-negative Neisseria Vei 11 one 11 a 
cocci Acidaminococcus 
Gram-negative Escherichia Bacteroides 












Lactobacill i are generally the predominant aerobic organisms isolated 
followed by diptheroids and Staphylococcus epidermidis. Organisms such 
as Staphylococcus aureus, Lancefield Group B streptococci, Escherichia 
coli and Bacteroides are not frequently isolated from the vagina 
despite their association with upper genital tract infection (Paavonen, 
1983) . 
Of relevance to this study is the occurrence of §.. vaginalis. Some 
workers, McCormack et ~ (1977), Levison et ~ (1978); Sautter and 
Brown (1980) and Masfari et ~ (1986), reported a high frequency of §.. 
vaginalis varying from 5% to 50%. Their findings differed from the 
results of the study of Bartlett et ~ (1977) in that none of the 
latter's subjects harboured this organism (Table II). These differences 
may reflect the sensitivity of isolation procedures used by various 
researchers. Bacteroides spp, Peptococci and Peptostreptococci are the 
predominant anaerobes isolated (Larsen and Galask, 1980). The presence 
of all other organisms isolated in small numbers reflects the 
increasing sensitivity of isolation procedures. 
The vaginal internal environment shows considerable variation depending 
inter alia on age, hormonal status and sexual activity. Throughout the 
menstrual cycle the total number of anaerobic bacteria appears to be 
fairly constant. However, there is generally a 100-fold decrease in the 
concentration of aerobic bacteria shortly prior to menstruation. There 
is a great variation of specific bacteria when multiple samples are 
obtained from the same individual. This has been shown by Bartlett et 
TABLE II MOST PREVALENT BACTERIA OF THE VAGINAL FLORA 
OF HEALTHY NON-PREGNANT PRE-MENOPAUSAL WOMEN 
Bartlett et al 1977 --n=22 
Facultative anaerobic bacteria 







Sautter and Brown 1980 
n=7 






Unidentified O2 catalase neg 




Masfari et al 1986 
n=22- -






















~ (1977), whose analysis of specimens obtained sequentially throughout 
the menstrual cycle showed considerable cyclical variation in terms of 
the variety and numbers of organisms present. These cyclical hormonal 
changes regulating the menstrual cycle influence the composition of the 
vaginal flora. Bartlett and Polk (1984) have suggested that the vaginal 
flora be regarded as a dynamic ecosystem. 
2.2 NORMAL VAGINAL SECRETIONS 
The human vagina is lined by stratified squamous epithelium with no 
glands. The vaginal secretions normally are a mixture of secretions 
originating predominantly from the cervical mucus and transudates 
through the vaginal epithelium, with contribution from secretions of 
the Bartholins and Skenes· glands, endometrial and tubal fluids; 
leucocytes and exfoliating epithelial cells. These cells may be 
superficial, intermediate or parabasal cells in origin, depending on 
the level and phase of stimulation by ovarian hormones. The mean amount 
of vaginal secretions produced by menarchal women is between 1 to 3 
grams per 24 hours (Paavonen, 1983). These are usually white, of curdy, 
floccu~ar consistency and importantly the odour is not disagreeable. 
The characteristics of normal vaginal secretions are listed in 
Table III. The characteristics and the amount of vaginal secretions are 
i nfl uenced by oestrogen concentration and sexual stimul ati on and may 
change during the normal menstrual cycle. Such increases are regarded 
as physiological and may also occur during pathology. 
TABLE III CHARACTERISTICS OF NORMAL VAGINAL SECRETIONS 
(Paavonen, 1983) 
Amount Minimal or variable 
Colour Whitish, mucoid 
Consistency Floccular, curdy 
Presence during examination Pooled 
pH Approximately 4,5 
10 
Wet mount observations Rare leucocytes, variable 
number of mononuc l ear cells, 
large Gram-positive rods, 
vaginal epithelia l cells 
with distinct borders 
Organic acid content 
Diamines* 
* Putrescine and cadaverine 
2.3 HOST DEFENCE MECHANISMS 
Predominantly lactate 
Absent 
Mechanisms which control the microflora of the vagina are poorly 
understood, however a large number of factors regulate the composition 
and dynamics of this microbial ecosystem. 
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The vagina harbours a complex microflora, but only a few micro-
organisms are considered to be able to produce vaginal infections. 
Majority of these infections are exogenous infections and predisposing 
factors include: trauma, sexual activity and/or iatrogenic disruption 
of the mi cro-envi ronment (Cohen et ~, 1984a), most of them bei ng 
sexually transmitted. 
Generally in the body, the skin and mucous membrane form the first line 
of defence against invasive pathogens and the vaginal mucosa is no 
exception in this regard. Intact vaginal mucosa of women of 
reproductive age comprises a significant barrier to infection, unless 
breached. 
Microbial interaction, regulated by hormonal influence of oestrogen and 
non-specific factors such as mucosal secretions containing mucus 
(Elstein, 1978), lysozyme (Root and Cohen, 1981), lactoferrin (Arnold 
et ~, 1980), zinc and fibronectin (Cohen et ~, 1984a) provide 
non-specific protection while specifically secretory IgA concentrations 
increase in response to specific pathogens to afford protection (Fubara 
and Freter, 1973). 
2.3.1 Non-specific mechanisms 
2.3.1.1 Microbial interaction 
The predominant species found in the vaginal flora of the majority of 
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women of reproductive age are lactobacilli. The detailed knowledge of 
the factors influencing their presence and numbers is not available, 
but there is good evidence that they are influenced by the level of 
hormones particularly oestrogens. Furthermore lactobacill i and/or their 
products are believed to regulate the growth and surv ival of other 
vaginal organisms. 
The glycogen content of vaginal epithelial cells is under honnonal 
influence (Cruickshank and Shannan, 1934). Lactobacilli in the vagina 
break down glycogen to glucose and lactic acid resulting i n a reduction 
of vaginal pH and thus promote an acid local environment (Hill et ~, 
1985). Other micro-organisms are inhibited at the low pH usually 
observed and this is regarded as the main reason for the beneficial 
antibacterial effect which lactobacilli exert in the vagina. Thus the 
numbers of lactobacill i and the resultant acid formation are largely 
dependent on the amount of glycogen in vaginal epithelial cells, 
thereby explaining the significant effect of oestrogens on the 
microbial ecology. 
The presence and amount of glycogen and therefore the 1 actobaci 11 i 
population vary at different stages of life, affecting the pH at these 
different stages (Table IV). Other antimicrobial factors have been 
attributed to lactocins produced by lactobacilli and compounds such as 
hydrogen peroxide (H202) and lactic acid are also responsible for the 
antibacterial activity against other organisms in the vagina (Mardh and 
So 1 tesz, 1983). 
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TABLE IV VAGINAL FLUID pH, GLYCOGEN CONTENT, OESTROGEN AND 













Vaginal Glycogen° Ovarian Lactobacilli 
* pH content activity 
oestrogen° 
7,5 + + + 
( generally 
7,0 - absent) 
4,5 + + + 
4,0 + + + 
3,8 + + + 
6,0 +/- +/- +/-
Adapted from Cohen, 1969; Cohen et ~, 1984 
Adapted from Cruickshank and Sharman, 1934 
Menstrual cycle and sexual activity may affect results 
Present 
Absent 
+/- Decreased amounts 
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Eschenbach et ~ (1989) emphasized the importance of H202-producing 
lactobacilli in the vagina and suggested that these organisms 
contribute to the control of the microflora and may prevent the 
development of bacterial vaginosis (to be described later) in some 
women. The H202 produced by lactobacilli species may therefore 
represent another non-specific defence mechanism of the normal vaginal 
epithel ium. 
2.3.1.2 Vaginal mucus 
Mucus, a glycoprotein is secreted by goblet-shaped epithelial cells. It 
passes through intracellular channels, provides lubrication for the 
epithelium and serves as a protective barrier against the adjacent 
environment (Elstein, 1978). 
Bacteria usually adhere to the mucosa by specialised cell surface 
structures (adhesins) which promote adherence to specific cell 
receptors. These adhesins are usually the fimbriae (Cohen et !l, 
1984b). Mucus plays an important role in i nterferi ng with bacteri a 1 
adherence and subsequent colonisation, by binding to bacterial surfaces 
prior to potential attachment to specific cell receptors. 
The chemical composition of mucus also supports the growth of 
lactobacilli therefore helping to maintain a pH of less than 4,5. 
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2.3.1.3 Antimicrobial secretions 
Both lysozyme (Root and Cohen, 1981) and lactoferrin (Arnold et ~, 
1980) have been identified in vaginal mucus and are capable of 
affecting microbial survival. 
Lysozyme, an enzyme is capable of hydrolysing the beta 1-4 
peptidoglycan linkage of micro-organisms in which this site is 
available, thereby allowing osmostic lysis. Not all organisms are 
susceptible to lysozyme and therefore would develop some sensitivity to 
this enzyme (Cohen et !l, 1984a). 
Lactoferrin is an iron binding glycoprotein. Most bacteria require iron 
for growth, and the presence of lactoferrin binding the iron is capable 
of retarding the growth of certain micro-organisms, however iron in 
excess of the binding capacity of lactoferrin will result in the 
presence of free iron thereby neutral ising the inhibiting action 
(Arnold et ~, 1980). 
The presence of zinc in the secretions may play an important role at 
mucosal surfaces for bacterial survival. Zinc inhibits the growth of a 
variety of pathogens especially that of f. trachomatis, Herpes simplex 
virus and T. vaginalis (Cohen et !l, 1985). Fibronectin, a 
glycoprotein, is found in a soluble form in plasma. It plays an 
important role in the attachment of some pathogenic bacteria to host 
tissues, but may also interfere with the attachment of others (Cohen et 
~, 1984a). Soluble fibronectin could be found in vaginal fluid during 
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menses and following leakage of plasma from damaged vaginal tissues. 
Its presence may enhance the invasiveness of certain pathogens by 
facilitating adherence to specific cells. 
2.3.1.4 Phagocytic cells 
Polymorphonuclear neutrophils and monocytes migrate to tissues in 
response to microbial invasion and most probably play an important 
defensive role at mucosal surfaces. The phagocytic cells are usually 
attracted directly by bacterial products or by the generation of 
complement components. Once attracted the bacteria will attach to 
phagocytic cells through ligand receptor interactions and opsonize with 
immunoglobulin and complement. Once opsonized the killing of the 
pathogen is enhanced by the neutrophil oxidative metabolism, depending 
on the redox state of the organism (Root and Cohen, 1981). 
2.3.2 Specific immune mechanisms 
The role of specific immune mechanism against pathogens in the vagina 
is still unclear. 
2.3.2.1 Antibodies 
Antibodies arise from stimulation by specific organisms and are 
produced locally by plasma cells in the cervical submucosal tissue. IgA 
antibodies are produced preferentially to IgG and IgM antibodies 
(McNabb and Tomasi, 1981). Secretory IgA appears to be more important 
( 
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than IgG and IgM in its role of preventing adherence and of promoting 
killing (Fubara and Freter, 1973). The antibodies found on mucosal 
surfaces may interfere di rectly with the attachment of bacteri a or 
neutralise viruses which could activate the complement cascade 
resulting in the killing of the susceptible pathogen, or may enhance 
opsonization and killing (intracellular lysis) of the pathogen by 
phagocytic cells (Root and Cohen, 1981). 
2.3.2.2 Cell mediated immunity 
The role of lymphocyte - monocyte interaction at the vaginal mucosal 
surface is generally non-protective especially against recurrent 
infections (Cohen et !l, 1984b). 
2.4 ALTERATION OF VAGINAL FLORA 
As already mentioned the vaginal ecosystem appears complex. Factors 
such as normal vaginal flora with the presence of lactobacilli 
regulated by hormones and the host's defence mechanisms all regulate 
the composition and dynamics of the microbial ecosystem to produce and 
maintain a healthy vagina. 
Multiple factors influence the composition of the vaginal microflora. 
Some of these are the bacterial flora themselves, especially the 
presence of lactobacilli, hormonal and host defence mechanisms. A 
multiplicity of other largely host factors have also been shown to be 
capable of influencing the microbial habitat, these include sexual 
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activity, trauma, antibiotic therapy, hormonal status and iatrogenic 
factors. Any alteration of vaginal flora may resolve spontaneously and 
therefore be transient or may result in symptoms. The latter may 
require therapy if symptoms persist and if the aetiological agent is a 
micro-organism. 
2.5 CLINICAL PRESENTATIONS 
A variety of conditions which can cause vaginal discharge in normal 
healthy women may be due to an excessive sloughing off of epithel ial 
cells or excessive mucoid secretions from healthy endocervical glands 
or due to atrophic vaginitis, desquamative inflammatory vaginitis, 
vaginitis emphysematosa, vaginal fistulae and vaginal ulcers. Although 
often diagnosed these conditions are much less common than infections. 
The patients may complain of a mild to profuse grey-white discharge 
with the absence of irritation and odour. These conditions are usually 
managed with topical oestrogen or hydrocortisone cream depending on the 
condition and primarily of reassurance to the patient (Fleury, 1981). 
Any condition that increases the amount of cervical secretion or 
desquamation of vaginal epithelium may give rise to a primary vaginal 
discharge. This may be physiological or pathological. If pathological, 
the causative organism is able to penetrate through epithelial defi-
ciences. When this happens, patients usually present with a combination 
of symptoms such as increased vaginal di scharge, vul vo-vagi nal 
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irritation including dyspareunia or dysuria and may be accompanied with 
vaginal odour. 
Signs and symptoms are often non-specific to permit an accurate clini-
cal diagnosis since concurrent infections of the cervix and vagina may 
occur at the same time. 
!!. gonorrhoeae and f. trachomatis colonize the columnar epithelium, 
causing a purulent cervical discharge, however they are not the major 
causes of vaginitis of reproductive age. I. vaginalis and C. albicans 
are the major causes of vaginitis with vaginal irritation or 
inflammation respectively. In addition, another cause of vaginal 
discharge is a milder, unpleasant syndrome termed bacterial vaginosis. 
2.5.1 Candidiasis 
Candida species may be a common commensal of healthy people and can be 
recovered from the mouth and intestinal tract. In women with 
predisposing factors such as pregnancy, diabetes, long term antibiotic 
usages, mal ignancies and chemotherapy there may be excessive glycogen 
or glucose in vaginal tissues. This may give the yeast an advantage 
over normal vaginal bacteria, resulting in vulvovaginal candidiasis. In 
males Candida species has been responsible for balanitis, thus the 
organism could be sexually transmitted which may also result in 
recurrent disease. 
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Candidiasis is the term given to candida vaginitis and is caused by 
candida species. Wilkinson in 1849 reported the first case of vaginal 
discharge in a patient with associated yeast-like organisms (Wilkinson, 
1849). In an analysis of data for 1980 and 1981, Young has shown that 
f. albicans was the most commonly found yeast in cases of vaginal dis-
charge and infection, followed by Torulopsis glabrata and the other 
species occurring rarely (Young, 1982). Candida species has been 
isolated from healthy vaginas ranging from 5% to 15% in non-pregnant 
women to 31% in asymptomatic pregnant females (Young, 1982). 
Patients presenting with candidiasis usually complain of pruritis due 
to intense irritation. The discharge present is characterised as milky-
white with white pseudomembranes on the vaginal mucosa. There may be 
associated dysuria, dyspareunia and the lesions may extend to the labia 
and perineum causing severe excoriation. There is strong evidence that 
the organism is sexually transmitted (Miles et ~, 1977) but a 
persistent reservoir in the oral cavity and gastrointestinal tract is 
important for recurrences (Sobel, 1984). 
Vaginal candidiasis can be diagnosed clinically by its cottage cheese 
appearance with reddened vaginal walls or the discharge examined 
microscopically in wet smear preparations either in saline or potassium 
hydroxide or by Gram stain for the presence of yeast and pseudohyphae. 
The secretions can be cultured onto media for the isolation and identi-




Donne, in 1836 visualised motile micro-organisms in the purulent frothy 
1 eucorrhea of women presenting with vaginal di scharge and vagi niti s 
(cited by Ross, 1982). 
Initially the organism T. vaginalis received little attention but is 
now firmly established as being sexually transmitted (McLellan et ~, 
1981). This is due to the fact that only a trophozoite form is present 
and no cystic form (Rein and Muller, 1984) thus being sensitive to 
light, drying and changes in temperature. 
I. vaginalis is highly site specific (Rein, 1985) limiting its site of 
infection to the vagina in the female, therefore no reservoir such as 
the mouth or rectum can be found (Robinson et ~, 1963). The incidence 
among females in developed communities ranges from 1,4% among single 
women (Willcox, 1960) to 44,2% in women attending a sexually 
transmitted diseases clinic. It is generally considered to be more 
common in pregnant women ranging from 4% detected in developed 
communities (Willcox, 1960) to 49% detected in developing (Hoosen et 
~, 1981). 
Clinically a patient infected with I. vaginalis may vary from an 
asymptomatic carrier to one presenting with symptoms which may range 
from being mild to severe. The symptomatic patient may present with an 
excessive vaginal discharge which is due to an acute inflammation. The 
discharge is often offensive, being pale green and frothy and may also 
be accompanied with additional symptoms such as vulval irritation, 
22 
dysuria and frequency of micturition and occasionally dyspareunia. In 
severe forms the vaginal walls may be diffusely reddened throughout 
with punctate pink spots - the so-called "strawberry vagina" (Ross, 
1982). These features are clinically diagnostic of I. vaginalis and may 
not requi re confi rmati on. In mil der conditi ons and concurrent i nfec-
tions a diagnosis is made by the demonstration of the organism from 
vaginal secretions in normal saline wet smear preparations. Microscopi-
cally the organisms are slightly larger than polymorphonuclear 
neutrophils and characterised by their jerking motility. The organism 
can be detected by phase contrast microscopy, and by stained smears 
such as Papanicolaou, Giemsa and acridine orange, as well as by culture 
in various media, including modified Diamond's medium. The sensitivity 
of culture is far superior to staining techniques and the latter have 
no added advantage over the normal wet smear preparations. 
2.5.3 
Newer techniques for identifying trichomonads are the immunofluorescent 
antibody test using monoclonal antibodies (Krieger et ~, 1988) and 
ELISA test and also detecting serum antibodies by these techniques. 
These are still experimental and seem unlikely that they may be used 
routinely. 
Bacterial vaginosis 
In 1954 and 1955 Gardner and Dukes first described the clinical entity 
of a mild, but generally unpleasant vaginal syndrome with a lack of an 
inflammatory response, naming this clinical condition as non-specific 
vaginitis. 
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Subsequently, there has been some controversy regarding the definition 
of this clinical condition (van der Meijden, 1984). It has been 
described as a vaginosis, because of the absence of an inflammatory 
response. Furthermore, it has been microbiologically associated with §. 
vaginalis (Gardner and Dukes, 1955) and non-sporeforming anaerobes 
(Pheifer et ~, 1978; Taylor et ~, 1982) which led to the condition 
being described as Haemophilus vaginalis vaginitis, Gardnerella 
(vaginalis)-associated vaginosis, non-specific vaginosis, non-specific 
discharge, anaerobic vaginosis and bacterial vaginosis. Thus the 
original description of non-specific vaginitis is no longer acceptable, 
since this condition is associated with the presence of specific 
micro-organisms and since an inflammatory response cannot be 
identified, therefore it should not be termed a "vaginitis". 
Over the years bacteri a 1 vagi nos i s has been the mos t wi de ly accepted 
definition, since it describes the bacterial association together with 
the lack of evidence of an inflammatory response. It also denotes "a 
replacement of lactobacilli of the vagina by characteristic groups of 
bacteria accompanied by changed properties of the vaginal fluid" 
(Westrom et~, 1984). 
The clinical description of bacterial vaginosis as described by Gardner 
and Dukes (1955) has remained the most accurate and has been confirmed 
by many workers (Ray and Maughan, 1956; Brewer et ~, 1957; Pheifer et 
~, 1978; Spiegel et ~, 1980; Eschenbach et ~, 1988). Typically 
patients present with a moderate increase in vaginal discharge which is 
often offensive, greyish, homogeneous with decreased acidity. The 
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discharge contains few inflammatory cells and any other recognised 
vaginal pathogens, such as T. vaginalis and Candida species, may be 
absent. 
Of relevance to this syndrome is the increased offensive discharge. The 
offensive odour is more prominent during menstruation and after sexual 
intercourse · (Vontver and Eschenbach, 1981). The assessment of normal 
vaginal secretions can be subjective and also depends on the ability of 
a patient to tolerate an increased discharge, which may be variable. If 
this condition were to be left untreated it could be distressing to the 
patient. Vaginal or vulval irritation could occur and dysuria and 
dyspareunia could be associated. 
Normal vaginal secretions are usually curdy, often odourless, whitish 
and without any frothiness. However, unlike normal secretions, the 
vaginal discharge in bacterial vaginosis can be scanty to profuse, but 
usually moderate, homogeneous in nature and appears to adhere to the 
vaginal wall in a thin film. The colour is often greyish. The discharge 
in bacterial vaginosis has been reported to be frothy by some authors 
(Gardner and Dukes, 1955), a criterion often considered to be 
characteristic of trichomonal vaginitis. 
The smell of the discharge is characteristic in that it is often 
unpleasant with a prominent "fishy" odour. This odour has been 
a ttri buted to the presence · of vola til e ami nes such as putresci ne, 
cadaverine (Chen et ~, 1979) and trimethylamine (Brand and Galask, 
1986) . 
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The pH of normal vaginal secretions is acidic. However, in bacterial 
vaginosis the pH is greater than 4,5 and often 5,0 to 5,5. This shift 
in vaginal pH is often accompanied by a reduction or replacement of 
vaginal lactobacilli. 
Microscopic examination of vaginal discharge from women with signs and 
symptoms of bacterial vaginosis characteristically revea l s a striking 
absence of polymorphs and lactobacilli and a predominance of vaginal 
epithelial cells which have a granular appearance. The latter 
appearance is the result of bacteria adhering to the cells. These cells 
are characteristic and often provide the most valuable clue to the 
presence of this condition. These have been designated "clue" cells to 
emphasize their diagnostic significance (Gardner and Dukes, 1955). 
Microscopic examination of the Gram stained smears confirms the 
presence of epithelial cells with large numbers of adherent pleomorphic 
Gram- negative or variable bacilli. 
This clinical condition of bacterial vaginosis is distinct from 
candidal vaginitis, but shares some similarities with trichomonal 
vaginitis, particularly the presence of offensive and frothy discharge. 
2.6 DIAGNOSIS OF BACTERIAL VAGINOSIS 
2.6.1 Signs and symptoms 
The diagnosis of. bacterial vaginosis was often based only on the 
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symptoms (Frampton and Lee, 1964) or on the observation of an abnormal 
vaginal discharge (Akerlund and Mardh, 1974). The ability of the 
patient or clinician to assess the presence and amount of discharge is 
subjective. This depends on the personal hygiene of the patient and the 
ability to tolerate an increased discharge. A study by Gardner (1980) 
had shown that a minority of women with infection complained of vaginal 
discharge and unpleasant odour. However, on specific enquiry, the 
majority admitted to symptoms. These patients were unaware of the 
significance of their symptoms and accepted these as normal, however, 
after appropriate therapy, improvement was noted. 
The assessment of the appearance and amount of discharge by the 
examining clinician has also been subjective. The ability of two 
clinicians to assess the same patients has shown marked differences 
(Taylor et al, 1982) even in the assessment of the odour (Clay, 1982). 
2.6.2 Clinical diagnosis of bacterial vaginosis 
The existence of bacterial vaginosis as a clinical entity appears 
beyond doubt. However, there are no adequate clinical definitions of 
the syndrome and in addition, there have been no definite criteria for 
the diagnosis. McCormack et ~ (1977) suggested that well defined 
criteria were needed to be established for the uniform and reliable 
diagnosis of bacterial vaginosis. 
Spiegel et ~ (1980) used specific criteria to define their patients 
with bacterial vaginosis. These were based firstly on the absence of 
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recognised pathogens such as I. vaginalis and/or yeasts on wet smear 
examination, and secondly on the presence of any two of the following: 
a) homogeneous vaginal secretions; b) pH of the discharge being greater 
than 4,5; c) presence of "clue" cells on wet smear examination; 
d) release of 'fishy' odour on addition of 10% potassium hydroxide 
(KOH). G.vaginalis was isolated from 100% of patients fulfilling these 
criteria. 
Amsel et ~ (1983) confirmed that symptoms alone were not a reliable 
indication of the presence of bacterial vaginosis. They found that 50% 
of their patients with bacterial vaginosis were asymptomatic and 12% 
were aware of symptoms but did not complain about these. In view of 
this, they also strongly recommended the use of such specific 
diagnostic criteria. By combining and selecting the criteria advocated 
by Spiegel et ~ (1980) they showed improved diagnostic specificity 
(Amsel et~, 1983). 
These criteria would be useful for the rapid and reliable diagnosis of 
bacterial vaginosis, in clinic settings, however, assistance from the 
laboratory may be necessary. 
2.6.3 Direct microscopy 
Direct microscopic examination is often used in the diagnosis of 
bacterial infections. Using this, Gardner and Dukes (1955) utilized 
wet smear preparations and described the characteristic "clue" cells 
(Plate 1). These cells were also seen on Gram stained smears together 
PLATE 1 
IIClue ll cells as seen on vaginal wet smear microscopic 
preparation (x40 objective) 
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, ' PLATE 2 : 
"Clue" cells as seen on Gram stained smear with the 
presence of gardnerella morphotype predominant in 
bacterial vaginosis (x50 objective) 
PLATE 3 : 
Gram stained smear showing the presence of lactobacillus 




Therefore, thi s study showed that any mi croscopi c changes present in 
the vaginal flora could result in the isolation of small numbers of 
§. vaginalis. These would not necessarily produce any significant 
changes and 'could be classified as normal. The technique used by 
Spiegel et ~ (1983) gave a 90% correlation with a clinical diagnosis 
of bacterial vaginosis using the specific criteria as described by 
Amsel et ~ (1983). Krohn et ~ (1989) reported that the predictive 
value for a diagnosis of bacterial vaginosis was as high as 76% for the 
Gram stain. 
Direct immunofluorescence has been used to detect adherent 
Gram-negative bacteria, §. vaginalis in vaginal specimens (Hansen et 
~, 1989). This technique was positive for G. vaginalis in 21% of 
specimens compared to only 12,5% of cultures (Hansen et ~, 1987). 
2.6.4 pH determination 
The pH of the discharge in bacterial vaginosis is greater than 4,5, 
usually between 5,0 and 5,5. Gardner and Dukes (1955) found that 91% of 
patients with bacterial vaginosis had a pH greater than 5,0 compared to 
92% of women with normal discharge who had a pH between 4,0 and 4,7. 
Elevated pH of vaginal fluid was found to be the most sensitive but 
least specific of the clinical criteria which can be used for diagnosis 
(Eschenbach et ~, 1988). This could usually be due to presence of 
concurrent infections with T. vaginal is. 
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2.6.5 Amine test 
The offensive "fishyll odour in bacterial vaginosis is due to the 
presence of cadaverine, putrescine (Chen et ~, 1979) and/or 
trimethylamine (Brand and Galask, 1986). The addition of 10% potassium 
hydroxide to fresh vaginal discharges enhances the smell. The potassium 
hydroxide converts the non-volatile salts into highly volatile and 
unpleasant smelling bases. This happens rapidly, therefore the test 
must be II read" immediately (Pheifer et ~, 1978). False positives may 
occur in the presence of semen and menstrual fluid. 
2.6.6 
Pheifer et ~ (1978) reported t~at 36(67%) of 54 women with an abnormal 
discharge and none of the 43 women with a normal discharge had positive 
amine test with 10% KOH. Amsel et ~ (1983) found 76% of women with 
bacterial vaginosis to have positive tests. 
Culture of organisms 
The isolation of G. vaginalis from vaginal fluid has been considered as 
the cornerstone of diagnosis. The use of improved culture techniques 
and selective media (Goldberg, 1976; Totten et ~, 1982; Ison et ~, 
1982) has increased the sensitivity with which G. vaginalis may be 
isolated. 
Spiegel et al (1980) have shown that quantitative estimation of the 
numbers of G. vaginalis present in the vagina had shown differences 
between women with and without bacterial vaginosis. Thus the presence 
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of small numbers of ~. vaginalis in women without characteristic signs 
could be encountered (Amsel et ~, 1983) and care should be taken in 
interpreting a positive culture result. Other organisms such as 
non-sporeforming anaerobes (Taylor et ~, 1982), anaerobic curved rods 
(Hjelm et ~, 1981) and mycoplasmas (Pheifer et ~, 1978) have all been 
2.6.7 
associated with bacterial vaginosis. 
The isolation and identification of these organisms is difficult and 
usually time-consuming, and the fact that normal women may also harbour 
these organisms makes screening for them unrealistic. 
Gas liquid chromatography 
The problems encountered in the diagnosis of bacterial vaginosis 
resulted in the search for alternative reliable procedures. 
The bi ochemi ca 1 changes occurri ng in bacteri a 1 vagi nos i s were fi rst 
noted by Spiegel et ~ (1980) who utilized gas liquid chromatography to 
analyse the short chain fatty acids present in vaginal fluids. In 
normal vaginal fluid lactobacilli are predominant and produce large 
amounts of the non-volatile lactate, whereas in patients with bacterial 
vaginosis the predominant organisms are ~. vaginalis and anaerobes 
which are acetate and succinate producers. This results in a reduced 
lactate and increased succinate peak (Fig 1). A succinate to lactate 
ratio of ~ 0,4 has a predictive value of 90% for a positive G. 
vaginalis culture (Spiegel et ~, 1980; Ison et ~, 1982). 
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Normal secretions Bacterial vaginosis 
FIGURE 1 : 
Gas liquid chromatographic analysis of vaginal 
secretions: 
a Normal secretions showing a lactate peak; 
b Bacterial vaginosis showing a reduced lactate 
peak and increased succinate peak 
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If volatile fatty acids such as acetate, butyrate and propionate are 
also detected this too may be a useful indicator of bacterial vaginosis 
and would slightly increase the sensitivity of the test (Jokipii et ~, 
1986). 
This test has been useful, however false positives do occur in 
trichomonas vaginitis. Significantly little data are available on 
concurrent or mi xed infections. Other di sadvantages are the need for 
specialised equipment and the requirement of a large sample of vaginal 
fluid. 
2.6.8 High-voltage electrophoresis 
Chen et ~ (1979) have analysed vaginal washings using high-voltage 
electrophoresis to detect the presence of the diamines, putrescine and 
cadaverine in women with bacterial vaginosis. 
2.6.9 Thin layer chromatography 
A more sensitive technique, requiring a smaller sample was also 
advocated by Chen et ~ (1982). The thin-layer chromatography of 
dansylated vaginal washings detects the diamines. The subsequent 
fl uorescence of the dansyl di ami nes is compa red wi th tha t of dansyl 
alanine. A positive test detecting the presence of diamines was 
obtained in 88% of women with bacterial vaginosis and a negative test 
in 90% of women without bacterial vaginosis. 
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The high-voltage electrophoresis and thin layer chromatography are 
methods which require expertise and are time-consuming, and may have 
limited value in a diagnostic laboratory. 
2.7 AETIOLOGY OF BACTERIAL VAGINOSIS 
I. vaginalis and f. albicans are readily recognised aetiological agents 
of vaginitis and vaginal discharge, however, the aetiology of bacterial 
vaginosis is still poorly understood. 
2.7.1 Role of Gardnerella vaginalis 
Bacterial vaginosis is the term used to reflect a complex alteration of 
vaginal bacterial flora with the presence of increased discharge, 
without an apparent inflammatory response. G. vaginalis has been 
closely associated with bacterial vaginosis, but whether this 
represents a true infection is still unclear. Gardner and Dukes (1955) 
originally associated bacterial vaginosis with H. vaginalis i§. 
vaginalis) although Curtis (1914) initially described a similar 
organism from leucorrhoeal vaginal discharges and Leopold (1953) 
isolated a similar organism from urines and urethra of men and uterine 
cervix of women. 
As the potential role of §. vaginalis increased many workers reported 
the isolation of §. vaginalis from the vagina of women both with and 
without any vaginal symptoms or discharge. The rate of isolation varied 
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from 13% to 92% for symptomatic patients and from 0% to 70,5% for 
asymptomatic patients (Table V). 
There was general agreement among workers that the organism most 
prevalent in bacterial vaginosis was §. vaginalis. Some however 
disagreed. Heltai (1959), Frampton and Lee (1962) and Levison (1979), 
were able to routinely isolate §. vaginalis from patients without any 
specific signs and symptoms. In addition, McCormack et ~ (1977) found 
29% of asymptomatic sexually inexperienced females to harbour the 
organism. These authors considered the organism to be part of the 
endogenous vaginal flora. It was soon recognised that differences in 
isolation rates between different studies were at least in part due to 
the lack of well-defined diagnostic criteria. Spiegel et ~ (1980) and 
Amsel et ~ (1983) suggested the diagnosis of bacterial vaginosis 
should be standardised. Specific guidelines and diagnostic criteria for 
standard clinical use were proposed. The use of more specific criteria 
greatly reduced the degree of variation between studies (Table VI). 
Subsequent studies applying these criteria, confirmed the highly 
significant association of G. vaginalis with bacterial vaginosis with 
8/12 studies reporting 80% or more patients with §. vaginalis and 4/12 
studies reporting between 30% to 80%. However Amsel et ~ (1983) 
supported the conclusions of McCormack et ~ (1977) that §. vaginalis 
was a common component of the vaginal flora since 40% of women without 
bacterial vaginosis diagnosed by their criteria were also colonised as 
compared to 29% of sexually inexperienced women reported in the study 




2.7.2 Role of anaerobic bacteria 
Until 1978, §. vaginalis was the only agent considered in the aetiology 
of bacterial vaginosis. Pheifer et al (1978) described the isolation of 
a vari ety of non-sporeformi ng anaerobes from patients with bacterial 
vaginosis. The total number of anaerobic bacteria was significantly 
higher in patients with bacterial vaginosis than in healthy controls. 
Their findings were subsequently confirmed by other workers (Spiegel et 
~, 1980; Taylor et ~, 1982; Blackwell et ~, 1983). The anaerobic 
organisms most frequently isolated were ~. melaninogenicus, ~. bivius, 
B. corrodens (ureolyticus), B. asaccharolyticus, B. disiens and 
anaerobic cocci (Pheifer et ~, 1978; Spiegel et ~, 1980; Taylor et 
~, 1982; Blackwell et ~, 1983). The anaerobic bacterial count numbers 
usually equalled those of §. vaginal is. It was therefore suggested that 
the syndrome of bacterial vaginosis reflected a mixed infection by §. 
vaginalis plus anaerobic bacteria which are present in a symbiotic 
rel ati onshi'p. 
More recently anaerobic bacteria, namely the so-called anaerobic curved 
rods (ACR) (Plate 4) have been associated with bacterial vaginosis by 
some workers (Hjelm et ~, 1981; Sprott et ~, 1982; Phillips and 
Taylor, 1982; Skarin and Mardh, 1982). The presence of ACR was first 
noted by Curti sin 1913 and 1914, who suggested that they may pl ay a 
role in leucorrhoeal discharges. However, on most occasions he obtained 
very poor growth or failed to grow these organisms to allow proper 
identification. He nevertheless concluded that lithe anaerobic flora, 
PLATE 4 : 
Gram stained smear showing the presence of small Gram-




notably its bacilli were of paramount importance and that it could play 
a role in leucorrhoeal discharges" (Curtis, 1913, 1914). 
Since Hjelm et ~IS (1981) rediscovery of the possible role of ACR's 
several other workers have performed studies supporting the association 
of ACR's with bacterial vaginosis. Isolation rates ranged from 8,6% to 
100% in these studies (Table VII). It is however noteworthy that some 
workers failed to isolate ACR's or found only a low positivity rate in 
patients with clinical bacterial vaginosis. 
ACR have been characterised and two distinct forms have been identified 
(Table VIII). They have been found to be genetically and biochemically 
distinct from any other ACR's and therefore the genus Mobiluncus has 
been proposed (Spiegel and Roberts, 1984). 
2.7.3 Role of Mycoplasma hominis 
The role of M. hominis in bacterial vaginosis was investigated by 
Pheifer et ~, (1978). Although ~. hominis was isolated from 10 of the 
18 patients with bacterial vaginosis and from only one of 18 controls 
(Pheifer et ~, 1978), ~. hominis persisted in the vaginas of patients 
who responded to therapy for bacterial vaginosis. However, the 
isolation rate of M. hominis was not affected in patients who responded 
to therapy for bacterial vaginosis. It was therefore concluded that M. 
hominis could not playa significant role in the aetiology of bacterial 
vaginosis. 
TABLE VII PREVALENCE OF ANAEROBIC GRAM-NEGATIVE CURVED 
RODS IN BACTERIAL VAGINOSIS 
Reference Symptomatic 
% 
Hjelm et ~, 1981 30,0 
Skarin, 1981 8,6 
Phillips and Taylor, 1982 11,0 
Sprott et ~, 1983 22,5 
Thomason et ~, 1984 100 
Pattman, 1985 21,6 







TABLE VIII ~DIFFERENTIAL CHARACTERISTICS OF ANAEROBIC GRAM-NEGATIVE 
CURVED RODS (MOBILUNCUS SPECIES) 
Characteristics 
Length of cells (urn) 
Flagella 
Gram reaction 
Growth stimulated by 
arginine 
Hippurate hydrolysed 
Acid from glycogen 
Acid from melibiose 
Acid from trehalose 
Nitrate reduced 
CAMP reaction 


















from Spiegel and 















* adapted from Carlone et ~, 1986 
+ = positive 
- - negative 
+(-) usually positive 













The aetiology of bacterial vaginosis remains complex in that anaerobic 
flora may co-exist with §. vaginalis to cause the vaginosis. Whether 
they represent distinct clinical entities is still uncertain. 
2.8 PATHOGENESIS OF BACTERIAL VAGINOSIS 
There seems little doubt that §. vaginalis is present in most cases of 
bacterial vaginosis. Non-sporeforming anaerobes and Mobiluncus species 
have some role in the pathogenesis. The presence of a single species 
aetiology is doubtful and two types of organisms may be present and act 
synergistically to produce signs and symptoms. In bacterial vaginosis 
there is no true inflammation, no outpouring of pus. Since §. vaginalis 
is a surface parasite, it rarely provokes signs and symptoms on its 
own, and the histology of the vaginal biopsy shows no penetration of 
the epithelium (Gardner and Dukes, 1955). 
Transmission of infection to volunteers was demonstrated by Gardner and 
Dukes (1955) who inoculated 15 healthy women vaginally with vaginal 
secretions of patients with bacterial vaginosis. Eleven of the 15 women 
developed clinical signs and symptoms within 10 days and §. vaginalis 
was isolated from all 11. A further 13 women were inoculated with pure 
cultures of §. vaginalis. Only 3 of the 13 patients became colonised by 
the organism and only one developed clinical signs and symptoms of 
bacterial vaginosis. 
On the basis of these findings Gardner and Dukes believed that they had 
satisfactorily fulfilled Kochis postulates which require the organism 
to be observed in disease, isolated and grown in pure culture, give 
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rise to disease when inoculated into a susceptible host and be 
recovered from the diseased host. Kochis postulates were not entirely 
fulfilled since vaginal secretions were used and Kochis postulates are 
aimed at a single pathogen. Since G. vaginalis was the only organism 
isolated from the secretions, it may reflect the isolation media used 
were not sensitive enough to detect other vaginal flora which are 
usually present in vaginal secretions. Thus, the authors may have 
transmitted a mi xed infection with more than one pathogen, whi ch may 
also be part of the normal flora and also exist in a symbiotic 
relationship. Therefore it would be difficult to fulfil Kochis 
postulates. 
Criswell et ~ (1969) showed the capacity of §.. vaginalis to induce 
infection in volunteer subjects. Five of the 9 patients given 
approximately 2x1010 colony forming units of a 12 hour culture became 
co 1 oni sed with G. vagi na 1 is and had c 1 i ni ca 1 evi dence of bacteri a 1 
vaginosis and only 2 of the 20 women given a 24 hour culture of the 
same i nocul urn produced the same symptoms. The differences in these 
results may be due to the age of the inoculum when grown in a biphasic 
medium. This appeared to be an important factor, since optimal 
viability was obtained in 12 hours when the organisms were in a 
logarithmic phase of growth. Viability decreased after 24 hours when 
the organisms were in a stationary phase (Criswell et ~, 1969). 
Although the minimum infecting dose of ~. vaginalis is yet unknown it 
seems that a high infective dose was necessary to produce infection. It 
is not clear whether reservoirs providing such high infective doses 
exist in nature. At present available evidence thus suggests that §.. 
vaginalis infection is transmissible, but this is not yet conclusive. 
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In bacterial vaginosis, the odour of vaginal discharge is offensive, 
with a characteristic smell; this is considered to be due to the 
presence of diamines such as putrescine and cadaverine, (Chen et ~, 
1979). Since g. vaginalis is known to produce acetic acid (Moss and 
Dunkelberg, 1969) but not produce these amines, other vaginal anaerobic 
bacteria can. It would therefore seem that mixed infections may be 
synergistic in rendering the environment alkaline, whilst presence of 
putrescine may be a growth factor for the survival of g. vaginalis 
(Chen et ~, 1979). 
In bacterial vaginosis the presence of so-called "clue" cells is often 
characteristic. "Clue" cells are vaginal squamous epithelial cells 
studded with organisms seen during wet smear microscopy. g. vaginalis 
does not have adhesins but may be coated with protein and carbohydrate 
which act as adhesins (Peeters and Piot, 1985) and in vitro it has the 
ability to adhere to epithelial cells more so than lactobacilli (Mardh 
and Westrom, 1976). Regarding pathogenesis, it is unclear whether G. 
vaginalis adheres to epithelial cells and causes shedding or whether 
adherence occurs on exfoliated cells. Chen et ~ (1979) have suggested 
that amines such as cadaverine and phenethylamine present in vaginal 
washings are skin irritants and these may contribute to the exfoliation 
of epithelial cells. With regard to pathogenesis, the ability of G. 
vaginalis to adhere to epithelial cells is unclear. 
A possible relationship between g. vaginalis and anaerobic bacteria 
exists in the pathogenesis of bacterial vaginosis resulting in an 
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increased production of amines, raising vaginal pH at a level ideal for 
the growth of G. vaginalis (Piot and Vanderheyden, 1982). 
To further elucidate the pathogenesis of bacterial vaginosis, the 
grivet monkey, whose genital tract shows close morphological and 
physiological similarities to that of the human vagina, was used as an 
experimental model for vaginosis (Mardh et ~, 1984). The vaginas were 
inoculated with ACR's alone or in combination with §. vaginalis. The 
results of the monkey challenged with §. vaginalis alone were invalid 
due to a technical error, however, the monkey challenged with §. 
vaginalis and a long variant of anaerobic curved rod produced within 6 
days distinct signs and symptoms of bacterial vaginosis. The vaginal 
discharge was thin, grey, translucent and did not show an increase in 
leucocytes. In addition, the vaginal mucosa appeared normal without any 
macroscopic signs of inflammation (Mardh et ~, 1984). 
The vaginas of three different primate species were challenged with §. 
vaginalis (Johnson et ~, 1984). Ten pig-tailed macaques became 
colonised between 11 to 39 days whereas four tamarins and three 
chimpanzees failed to become colonised. However, specific signs 
associated with bacterial vaginosis, that is, "clue" cells, raised 
vaginal pH, increased levels of volatile fatty acids were not detected. 
The failure to produce disease with specific signs and symptoms may 
have been due to the different physiology and microbial flora of the 
primate genital tract and/or the need for the presence of other 
anaerobic organisms to act synergistically to produce disease. 
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It remains unclear what initially causes the imbalance of normal 
vaginal flora, resulting in an overgrowth of organisms in bacterial 
vaginosis, thereby allowing them to act as pathogens. It may be a 
transient change in the physiological state of the patient or due to 
the male sexual partner, providing a passive reservoir for reinfection 
(Ison and Easmon, 1985). 
2.9 EPIDEMIOLOGY OF BACTERIAL VAGINOSIS 
Bacterial vaginosis has been considered to be a sexually associated 
rather than a sexually transmitted condition (Easmon, 1986). Sufficient 
data have been provi ded for thi s. The acqui si tion of the organi sm G. 
vagi na 1 i s after the onset of sexua 1 intercourse has been shown by 
Gardner and Dukes (1955, 1959) who described 2 and 6 of their patients 
who acquired G. vaginalis after marriage. Lee and Schmale (1973) 
recovered G. vagi na 1 is from 21 of 154 young women who acqui red the 
organism after release from a correctional school for the weekend. 
§. vaginalis has further been associated with sexual activity since it 
has been found more frequently in women with a history of marital 
instability (Josey et ~, 1976), promiscuity (Gardner et ~, 1957), 
pregnancy (McCormack et ~, 1977), abortion (Amsel et ~, 1983), in 
those with multiple sexual partners, those receiving oral 
contraceptives (McCormack et ~, 1977) and in patients using 
intrauterine contraceptive devices (Amsel, 1983). 
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§. vaginalis has rarely been found to be present in the vagina before 
puberty (Kummel, 1963, cited by Taylor-Robinson, 1985). Its absence in 
such females provides additional evidence that its presence may be 
associated with sexual activity. However, this has been disputed by 
McCormack (1977) who found 29% of asymptomatic sexually inexperienced 
women to be colonised. Likewise Amsel et ~ (1983) found 4/18 sexually 
inexperienced women to be colonised with §. vaginalis; none of these 
subjects fulfilled their diagnostic criteria for bacterial vaginosis. 
There is overwhelming evidence that §. vaginalis is often present in 
association with recognised sexually transmitted pathogens. In 
particular it has been found together with r. vaginalis (Ray and 
Maughan, 1956; Brewer et ~, 1957; Josey et ~, 1976; McCormack et ~, 
1977; Taylor et ~, 1982; Blackwell and Barlow, 1982; Amsel et ~, 
1983) and N. gonorrhoeae (Levison et ~, 1977; Blackwell and Barlow, 
1982) and occasionally with Candida species (Ray and Maughan, 1956; 
Josey et ~, 1976). All these studi es provi de s i gni fi cant evi dence 
associating §. vaginalis with sexual activity, however, if bacterial 
vaginosis is to be considered a sexually transmitted infection, the 
presence of a male reservoir needs to be established. 
Leopold (1953) was the first to show that §. vaginalis could be 
isolated more frequently from the urine of men whose wives had vaginal 
cultures positive for G. vaginalis than from randomly selected men. 
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Gardner and Dukes (1955) showed a prevalence of 96% in the urethras of 
male sexual partners of women harbouring §. vaginal is. High prevalences 
of colonisation in males have been confirmed (Table IX). 
In addition Ison et al (1985) found G. vaginalis in 38% of semen - - -
samples from unselected men attending an infertility clinic. Although 
the minimum infecting dose of §. vaginalis is not yet known, it has 
been suggested that semen could act as a vehicle for the sexual 
transmission of G. vaginalis (Easmon, 1986). 
Colonisation of the male urethra by §. vaginalis usually results in an 
asymptomati c carri er state (Gardner, 1980; Tayl or-Robi nson, 1985) and 
the existence of this established male reservoir could explain the 
recurrent infections experi enced by some female pati ents. Successful 
therapy with sulphonamide creams (Pheifer et ~, 1978 and Blackwell et 
~,1983) and metronidazole has prevented recurrences of colonisation 
in women with §. vaginalis infections. Recurrence after successful 
therapy further supports the concept of reinfection from the male 
partner. Pheifer et ~ (1978) found that reinfection rates in women 
after successful therapy were lower when thei r sexual partner used 
barrier contraceptives or when they refrained from sexual intercourse. 
The lower incidence associated with barrier methods was confirmed by 
Bramley (1981). These findings all suggest that effective therapy of 
both female patients and their male partners should diminish the 
frequency of recurrences. 
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TABLE IX OCCURRENCE OF GARDNERELLA VAGINALIS IN MALES 
Reference Sexual contacts of Unselected men 
§. vaginalis +ve 
women 
Specimen Total No +ve Total No +ve tested (%) tested (%) 
Leopo 1 d, 1953 Urine 9 4(44,5) 965 54(5,5) 
Josephson and 
Thomason, 1986 Urine NT NT 14,178 322(3,2) 
Gardner and 
Dukes, 1955 Urethra 47 45(96) 2 0(0) 
Gardner and 
Dukes, 1959 Urethra 101 91(90) 38 1(3) 
Pheifer et ~, 
1978 Urethra 34 27(79) 3 0(0) 
Blackwell et 
~, 1982 Urethra NA NA(30) NT NT 
Kinghorn et 
~, 1982 Urethra NT NT 194 14(7,2) 
Dawson et ~, 
1982 Urethra NT NT 430 49(11,4) 
Holst et ~, 
1985 Urethra 19 0(0) 309 14(4,2) 
Ison and Easmon, 
1985 Semen NT NT 58 22(38) 
Abdennader et 
~, 1990 Urethra 40 14(35) 44 5( 11) 
NT = Not tested 
NA = Not variable 
2.10 
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~. vaginalis has also been reported by some workers to be more 
prevalent in certain population groups. In particular it has been 
isolated more frequently in women of the non-white population (Lewis 
and O'Brien, 1969; Gardner et ~, 1957; Dunkelberg, 1962; McCormack et 
~, 1977). 
Other potential factors have been studied. Variables such as age, 
marital status, menstrual history and personal hygiene have not been 
shown to have a s i gnifi cant i nfl uence on the prevalence of vagi na 1 
colonisation by ~. vaginal is. 
Numerous studies have been done to determine the prevalence of ~. 
vaginalis in women of different population groups and female patients 
attending various clinics. Not unexpectedly considerable variations in 
the prevalence of ~. vaginalis culture positivity have been found. This 
wide variation is not surprising since these include patients with 
bacterial vaginosis or vaginal discharge due to other causes or those 
with no apparent or abnormal vaginal disease. These studies are 
summarised in Table X and it is clear that G. vaginalis may be commonly 
found in a significant proportion of women. 
GARDNERELLA VAGINALIS 
2.10.1 Taxonomy 
Since it was first recognised, the taxonomy of ~. vaginalis has 
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TABLE X SUMMARY OF STUDIES ON THE PREVALENCE OF GARDNERELLA VAGINALIS IN VARIOUS CLINIC POPULATIONS 
Reference Clinic Type of Race No. of subjects No. (%) with vaginal culture 
patient investigated positive for ~. vagina1is 
No % 
Gardner and Dukes, 1955 Private 0, G White 1181 141 12,0 
Ray and Maughan, 1956 Clinic NK NK 447 68 15,2 
Gardner et a1, 1957 Private NK White 2251 274 12,2 --
Oe1aha et a1, 1964 Private G, P, PP NK 121 27 22,3 --
Lewis and O'Brien, 1969 Clinic NK ' NK 475 137 28,8 
:Ounke1berg, 1970 Clinic STO White/Negro 200 62 31 ,0 
Bramley et a1, 1981 Clinic FP NK 522 27 5,0 --
Osborne et a1, 1982 Clinic G NK 383 67 17,5 --
Ratnam and Fitzgerald, 1983 Clinic G, FP, STO NK 1585 417 26,3 
Mirza et a1, 1983 Clinic STO NK 100 75 75,0 --
Kelsey et a1, 1987 Private FP NK 173 13 7,7 --
Lefevre et a1, 1988 Clinic NK NK 392 147 37,5 --
*Feh1er et a1, 1984 Clinic STO Urban Black 205 96 47,0 -- Clinic FPC Urban Black 101 . 56 55,0 
*Petersen et a1, 1986 Clinic STO Rural Black 50 30 60,0 -- Clinic Non G Rural Black 50 27 54.0 
* Southern African studies 
0 Obstetric 
G = Gynaeco1ogy 
P = Pregnant 
PP = Post-partum 
STO Sexually transmitted disease 
FP = Family p 1 anni ng 
NK = Not known 
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presented problems. In part this has been due to its variable staining 
by Grams' method. In addition, as described in section 2.10.4 
(Identification), workers initially did not apply uniform criteria for 
its identification. Leopold (1953) first reported the isolation of 
small Gram-negative rod-shaped bacteria from patients with prostatitis 
and cervicitis, however, no attempt was made to classify the organism. 
Two years later, in 1955, Gardner and Dukes (Gardner and Dukes, 1955) 
described a similar fastidious organism from vaginal secretions which 
was implicated in bacterial vaginosis. They proposed the name 
Haemophilus vaginalis based on colonial morphology, growth in 
thioglycollate broth and characteristic biochemical profile (Table XI). 
This organism was initially isolated on blood containing media, which 
led to its inclusion into the genus Haemophilus. 
Although Edmunds (1960a) described the organism as a small 
Gram-negative non-sporing bacillus resembling H. influenzae, he 
suggested that microscopically " .•• it has a tendency to grouping in 
parallel rows and to show some angling, with two bacilli meeting at an 
acute angle at their ends, rather like diptheroid bacilli and there is 
associated with this a tendency to Gram positivity in occasional 
bacilli. These tendencies are much increased by growth in fluid media 
or in media containing fermentable carbohydrates". This description 
would be appropriate for corynebacteria, however he justified the use 
of the generic name Haemophilus since the organism appeared to require 
X factor (haemin) although it did not require V factor (nicotinamide 
adenine nucleotide) (Edmunds, 1960b). 
TABLE XI GARDNERELLA VAGINALIS AS DESCRIBED 
BY GARDNER AND DUKES IN 1955. 
Gram-negative, pleomorphic rod 
Non-motile 
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Growth on sheep blood agar after 24-48 hours at 37°C; forming 
minute pinpoint colourless, transparent colonies O,05-0,2mm in 
diameter. 
Growth in thioglycollate broth microaerophilic with small 
puff-ball appearance 
Oxidase-negative 
Acid produced from: glucose, maltose, arabinose, rhamnose, 
laevulose, xylose 
No action on: lactose, sucrose, mannitol, trehalose, glycerol, 
raffinose, salacin or dulcitol 
Sensitive to bacitracin, tetracycline 
Resistant to penicillin, polymyxin and streptomycin 
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Lapage (1961) was the first to demonstrate that neither X factor nor V 
factor were essential for its growth, invalidating its placement in the 
genus Haemophilus, since no organism can be placed in the genus 
Haemophilus unless it requires X and/or V factors or any other 
definable coenzyme-like substance (Zinneman, 1967). However, these 
factors were stimulatory (Dukes and Gardner, 1961). This bacterium, he 
concluded did not belong to the genus Haemophilus (Lapage, 1961). 
Zinneman and Turner (1963) proposed the name Corynebacterium vaginale 
on morphological grounds since it was a Gram-positive rod, showing club 
formation, polar granules and characteristic chinese letter arrangement 
resembling that seen with corynebacteria. Dunkelberg et ~ (1969), 
endorsed its placement in the genus Corynebacterium on these grounds. 
However, unl ike other corynebacteri a the organi sm was catalase 
negative. Further, doubts on its classification as Corynebacterium were 
the conflicting reports on its cell wall structure. 
Certain features associated with Gram-positive organisms were 
demonstrated: electron microscopy showed it to form a cell wall with 
septa (Reyn et ~, 1966) and Jones and Weitzman (1971) showed it to 
contain citrate synthase. The cell wall of H. vaginalis 594 1§. 
vaginalis NCTC 10287) contained 6-deoxytalose but not arabinose which 
is normally present in corynebacteria (Vickerstaff and Cole, 1969). In 
comparative studies performed with Escherichia coli, this strain 594 
was found to possess a multi-layered cell wall containing 11 to 14 
amino acids, a low mucopeptide content and no techoic acid - all 
features considered to be consistent with Gram-negative organisms, 
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whilst diaminopimelic acid was not demonstrated (Criswell et ~, 1971). 
Although an outer membrane was not readily apparent (Costerton et ~, 
1974) these results indicated that this organism had properties closer 
to those of Gram-negative organisms. Further support was by Greenwood 
and Pickett (1980) who showed the presence of a 
"lipopolysaccharide-like" fraction associated with the cell wall of G. 
vaginal is. 
In contrast, the presence of simple amino acid profiles including 
lysine was reported by Harper and Davis (1982), who also did not find 
diaminopimelic acid (Criswell et ~, 1971; Harper and Davis, 1982) 
which is usually found in Gram-negative cell walls and in a few Gram-
positive species. Subsequent electron micrscopy studies confirmed the 
presence of a very thin cell wall, absence of an outer membrane or any 
other lamellae structure (Sadhu et ~, 1989). These results were in 
agreement with those of Reyn et ~ (1966). 
In contrast to Greenwood and Pickett's (1980) work, Sadhu et ~ (1989) 
failed to demonstrate 2-keto-3 deoxy-D-mannose-2-octonoic acid, heptose 
and hydroxy fatty acids which are specific for the lipopolysaccharide 
(LPS) of Gram-negative baccili. Thus the results confirm Q. vaginalis 
cell walls to be that of Gram-positive organisms, however, they are 
unusually thin in most cells. 
Overall these results favour §. vaginalis to have cell walls more 
closely to resemble that of Gram-positive bacteria, however the walls 
appear to be unusually thin. Clearly this organism does not belong to 
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the genus Haemophilus or Corynebacterium. Attempts were made to place 
it in genera such as Lactobacillus, Butyribacterium and 
Propionibacterium, however placement in the latter three did not apply 
as §. vaginalis produces acetic acid as the principal end product (Moss 
and Dunkelberg, 1969) rather than lactic, butyric or propionic acid 
produced by these three genera respectively. Further, the guanine plus 
cytosine content of the DNA of §. vaginalis (42 mol %) distinguishes it 
from true Corynebacterium spp (51 mol %) and Propionibacterium spp 
(53 mol %). 
Numerical taxonomic analysis performed on numerous clinical isolates of 
§. vaginalis showed that all strains form one tight cluster with a 95% 
similarity. These could not be split into species or biovars (Greenwood 
and Pickett, 1980; Piot et,!l, 1980). The same researchers performed 
the DNA homology studies which showed little homology between §. 
vaginalis strains and related species. On the basis of these findings 
Greenwood and Pickett (1979, 1980) recommended the creati on of a new 
genus to accormnodate this clearly different bacterium. They proposed 
the name Gardnerella in honour of Doctor H L Gardner. Only one species 
has been identified so far and the genus cannot be assigned to any 
family because of its unusual cell wall characteristics. The accepted 
name is now Gardnerella vaginalis and its features are detailed in 
Table XII. 
TABLE XII CHARACTERISTICS OF GARDNERELLA VAGINALIS STRAIN 594 
OF GARDNER AND DUKES =ATCC 14018 = NCTC 10287 
(Greenwood and Pickett, 1980) 




Temperature requi rements : optimum 35°C to 37°C; growth occurs 
within range of 25°C to 42°C 
pH requirements: optimum 6,0 to 6,5; No growth at pH 4,0 
Haemolysis 
Beta-haemolysis on human and rabbit blood agar 
No haemolysis on sheep blood agar 
Fastidious in its growth requirements, does not require X or V 
factor 
Fermentati ve; acetic acid is major end product 
Antigenic structure : seven serological groups 
Pathogeni city: 
Major role in "non-specific" bacterial vaginitis 
Source : isolated from human genital/urinary tract. Worldwide 
distribtu i on 
DNA base composition 43+/- 1 mol % G+C 
61 
2.10.2 Antigenic structure/determinants 
Although the morphological, cultural and biochemical characteristics of 
§. vaginalis has been studied in considerable detail, reports on its 
antigenic structure are somewhat scarce. Various workers have 
investigated the antigenic structure of G. vaginalis. One object of 
such studies is the recognition of specific antigenic determinants so 
that there cou ld be a possibil ity of investigating serovars based on 
antigenic differences. 
Edmunds (1962) utilized whole cell suspensions as antigen to produce a 
panel of 13 antisera raised in rabbits. These were used to develop a 
serogroupi ng scheme based on serogroup antigen s. Since G. vagi na 1 is 
organisms do not often produce smooth suspensions they are 
unsatisfactory for use in agglutination tests. By utilizing the 
precipitation test, these antisera grouped 36 of the 50 strains of G. 
vaginalis studied, placing them in one of 7 main serological groups. 
Three of the 50 strains were non-groupable with these 13 antisera and 
11 strains gave indefinite reactions. Edmunds was unable to show 
significant correlation between different antigenic groups and the 
clinical origin or biochemical properties of the strains. The antigens 
used were not further characterised. 
Vice and Smaron (1973) and Svarva and Maeland (1982) also raised 
antisera in rabbits using whole cell suspensions. These were used 
exclusively in an indirect fluorescent antibody method for the 
identification of G. vaginal is. Vice and Smaron (1973), used 6 
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reference strains to prepare antisera. The strain ATCC 14018 (§. 
vaginalis NCTC 10287) grown diphasically produced the most satisfactory 
anti sera. After absorpti on with L. aci dophil us the anti sera reacted 
with 6 reference strains and 10 clinical strains of §. vaginalis, and 
no cross-reacti ons were demonstrated with strains of C. diphtheria, C. 
xerosis and L. aCidophilus. 
The findings of Svarva and Maeland (1982) were similar to those of Vice 
and Sma ron (1973), but they observed reduced reactivity with one of the 
206 clinical isolates of §. vaginalis studied and confirmed lack of 
cross-reacti vity of the anti -Gardnerell a sera with bacteri a of other 
species . 
Using an Ouchterlony immunodiffusion test Sma ron and Vice (1974) 
studied the antigenic relationship between isolates of G. vaginalis. 
The antiserum was raised in rabbits against strain 594 of §. vaginalis. 
On the basis of the precipitin bands obtained, they showed that all 
strains of G. vaginalis examined, had a common antigenic determinant. 
However, the pattern of precipitin bands varied between strains and 
when stra i ns were under different culture conditions. A distinct band 
of reaction (identity) was obtained with 12 of the 15 strains tested 
and this appeared to reflect one antigen of high molecular weight. 
There was no antigenic relationship between §. vaginalis and C. 
diphtheria, f. cervicis, f. xerosis and L. acidophilus. 
Broth cultures of §. vaginalis have been found to contain three 
extracellular soluble antigens, which have been designated (i), (0) and 
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(m). These antigens are heat stable, resist protease but are 
susceptible to periodate treatment and thus may be polysaccharide or 
glycoprotein in nature (Smaron and Vice, 1977). Absorption studies 
suggested that these antigens may be cell wall antigens situated at or 
near the surface of the organism. 
To identify the antigenic components of G. vaginal is, sensitive 
techniques such as sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SOS-PAGE) and Western blotting have been used 
(Boustouller et ~, 1986). Although inter-strain variation in 
immunogenic polypeptide profiles was demonstrated, a common antigen of 
molecular mass 41 kilo daltons (kOa) was found in all 23 strains 
tested. Both proteins and lipopolysaccharides can be separated by 
SOS-PAGE, and to determine the nature of the species-specific antigen, 
the §. vagina l is extract was treated with proteinase K prior to 
electrophoresis. Since bands developed only from the untreated 
material, it was concluded that the antigen was protein in nature. 
However, the authors were unable to determine whether the antigens were 
situated on the bacterial cell surface or not, since homogenised 
suspensions were used. 
Identification of this large molecular weight protein antigen, which 
appears to be common to all §. vaginalis strains could open the way for 
raising species specific monoclonal antibodies for diagnostic 
application. 
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Other workers have attempted to develop a serotyping system for §. 
vaginalis based on other antigens. Ison et ~ (1987) raised antisera 
which were directed against different immunodominant proteins ranging 
from 40 kDa to 90 kDa in size. These antisera were used to develop a 
serotyping scheme for G. vaginal is. 
2.10.3 Isolation 
§. vaginalis is fastidious in its growth requirements and therefore 
cannot be easily cultivated in vitro. Leopold (1953) first isolated the 
organism on medium containing rabbits blood (Casman's) after 48 hours 
incubation. The colonies were generally minute with definite 
haemolysis. Thereafter, Gardner and Dukes (1955) also isolated the 
organism on medium containing sheep blood. 
Dunkelberg and McVeigh (1969) demonstrated the growth requirements of 
§. vaginalis to include five of the B-vitamins (riboflavin, thiamine, 
niacin, folic acid and biotin), purines, pyrimidines, inorganic salts, 
trace metals and some amino acids. These substances were usually 
present together with a fermentable carbohydrate in the dextrose starch 
agar which they used as an isolation medium. 
The growth of the organism is enhanced when cultures are incubated in 
an atmosphere with increased carbon dioxide and also when incubated 
anaerobi ca lly. 
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In view of the fastidious nature of the organism, a variety of culture 
media have been developed and tested. Blood containing media (Leopold, 
1953; Gardner and Dukes, 1955; Edmunds 1960a), chocolate agar (Pheifer 
et !l, 1978), dextrose starch agar (Dunkelberg and McVeigh, 1969), 
peptone starch dextrose agar (PSD) (Dunkelberg et !l, 1970) and human 
blood agar (Edmunds, 1960a; Greenwood et !l, 1977; Totten et !l, 1982; 
Ison et !l, 1982) will all support the growth of §. vaginalis. The 
cultural characteristics of G. vaginalis on these are detailed in Table 
XII I. 
These various media all have some advantages and disadvantages. On PSD 
agar, §. vagina.lis produces characteristic colonies but the use of a 
dissecting microscope is necessary for their detection. Chocolate agar 
supports its growth, however, the colonies may be difficult to 
differentiate from those of other vaginal flora. 
The acidity of the medium is also important, §. vaginalis grows at an 
optimal pH of 6 to 6,5 (Edmunds, 1960a) and the choice of peptone in 
providing the vitamins, purines and pyrimidines is critical. Since the 
organism utilises these to produce acetic acid (Moss and Dunkelberg, 
1969) which may lower the pH to less than 4,5 which is inimical to G. 
vaginalis, subculture is necessary every 48 hours. The organism does 
not grow on MacConkey, Thayer-Martin and tellurite containing agar 
(Taylor-Robinson, 1985). 
Since §. vaginalis grows poorly and is usually difficult to isolate in 
the presence of other vaginal flora, attempts have been made to produce 
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media with both selective and indicator properties. A modification of 
the PSD agar was made by replacing soluble starch with corn starch and 
bromocresol purple as a pH indicator (Smith, 1975). Only organisms such 
as §. vaginalis which utilise starch will grow well on this medium and 
produce a yellow colour. A modification of this medium took advantage 
of the ability of §. vaginalis to hydrolyse starch resulting in a zone 
of cleari ng around each colony (Mickelson et ~, 1977). 
The original success of Casman's agar (Casman, 1947), and media 
containing sheep blood prompted the investigation of other blood 
containing med ia for the isolation of §. vaginalis. Greenwood et al 
(1977) developed their so-called vaginalis agar which contained 1% 
proteose peptone and 5% whole human blood. This medium supported the 
growth of G. vaginal is, colonies of which produced unique 
beta-haemolys i sand coul d thus easi ly be recogni sed. Furthermore, the 
use of a dissecting microscope was not necessary. 
The inclusion of selective agents such as colistin, nalidixic acid 
(Goldberg and Washington, 1976) and amphotericin B (Spiegel et ~, 
1980) to suppress the growth of other vaginal organisms was introduced 
almost at the same time as the re-introduction of media containing 
blood (Goldberg and Washington, 1976). Since human blood was found to 
be more sensitive, Totten et al (1982) modified Columbia 
colistin-nalidixic acid (CNA) agar by overlaying this base with agar 
containing 5% human blood agar plus amphotericin B to create bilayer 
plates. The advantage of this medium is that the beta-haemolysis is 
more distinct and the high degree of selectivity enables small numbers 
of G. vaginalis to be detected. 
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Ison et ~ (1982) investigated the selective ability of human blood 
agar containing amphotericin B and nalidixic acid with either 
gentamicin or with colistin. The medium containing gentamicin was more 
effective than colistin in suppressing other vaginal organisms whilst 
the production of beta-haemolysis was not affected. In addition they 
confirmed the differential beta-haemolysis phenomenon, namely that~. 
vaginalis produces diffuse beta-haemolysis on human blood agar (Plate 
5) and not on horse blood agar (Plate 6). This differentiation is a 
useful aid in the rapid identification of the organism. 
As most sexually transmitted pathogens are fastidious in nature and do 
not survive delay in transport prior to culture, specimens are often 
cultured directly onto appropriate media immediately after collection 
or otherwise sent to the laboratory in suitable transport media. 
The ideal transport medium should maintain viability of the organism(s) 
in transit and allow the recovery of the maximum number of organisms, 
even if they are present in small numbers. Difco proteose peptone, 1,5% 
in distilled water (Dunkelberg et ~, 1970), Stuart transport media 
(Akerlund and Mardh, 1974; Jolly, 1983), heart infusion broth 
supplemented with 1% proteose peptone No 3 (Bailey et ~, 1979) and 
Amies' medium (Josey et ~, 1976; Ison et ~, 1982), have proved 
satisfactory as transport media for specimens for the recovery of ~. 
vaginalis. In a subsequent study by Bailey et ~ (1979) it was found 
PLATE 5 : 
Production of diffuse beta-haemolysis on human blood 
agar by Gardnerella vaginalis 
PLATE 6 : 




that isolation rates of §. vaginalis were not significantly affected 
when specimens were inoculated directly onto media or inoculated after 
some delay. They demonstrated a delay of up to 6 hours appeared to have 
little effect on the viability of the organisms. However, it is 
possible that longer delays may be associated with lower yields. 
2.10.4 Identification 
Ideally identification schemes are based on colonial morphology, Gram 
stain reaction , biochemical tests and may include susceptibility to 
certain drugs and dyes. Since §. vaginalis is the organism primarily 
implicated in bacterial vaginosis, it is necessary to differentiate and 
distinguish it from other catalase negative, small Gram-variable rods, 
which commonly occur in vaginal specimens from women with and without 
vaginitis. 
The identification of G. vaginalis has been complicated by its 
previously confused taxonomy and the variety of identification schemes 
used in the past. Detailed schemes for identification have since aided 
resolution of its taxonomic position (Section 2.10.1), but these 
schemes are not ideally suited to routine diagnostic clinical 
laboratory use, because of their time-consuming nature (Greenwood and 
Pickett, 1979, Piot et ~, 1980, 1982b; Taylor and Phillips, 1983). 
The identification scheme described by Dunkelberg et ~ (1970b) was 
based on the recognition of typical colonial morphology after 48 hours 
incubation on peptone starch dextrose agar (PSD) using a dissecting 
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microscope. The organism was confirmed by a negative catalase reaction, 
inhibition of growth by hydrogen peroxide and fermentation of the 
carbohydrates glucose, maltose and starch. This method was also 
successfully used by Lee and Schmale (1973) and Akerlund and Mardh 
(1974). 
Carbohydrate fermentation has been used extensively in identification 
protocols. However, these have been difficult to perform and require 
some degree of experti see Furthermore, they are time-consumi ng and 
reproducibility has been reported to be poor (Edmunds, 1962; Dunkelberg 
et ~, 1970; Pi ot et ~, 1980). 
The incubation time required to detect acid production is usually 
between 48 to 72 hours. Greenwood et al (1977) used a buffered 
substrate for carbohydrate fermentation; this gave rapid results in 
approximately 3 hours. The fermentation of sucrose, xylose and mannose 
(Taylor and Phillips, 1983) has been found to be extremely variable. 
Since the majority of strains of G. vaginalis ferment starch and 
maltose consistently (Dunkelberg et ~, 1977; Bailey et ~, 1979), it 
may seem ideal to include these in identification protocols. However, 
the value of these carbohydrates is limited as they are also fermented 
by other similar vaginal organisms (Piot, 1982b; Taylor and Phillips, 
1983). A negative mannitol reaction has also been used as a useful 
negative control (Piot et ~, 1982b). Overall there is a general view 
that carbohydrate fermentation tests are difficult to perform, poorly 
reproducible and are of little discriminating value. Thus their routine 
application in the diagnostic setting is limited. 
72 
Ideally, tests which give a rapid and reliable presumptive 
identification, should be selected for use in clinical diagnostic 
laboratories. 
The Gram stain could be used but is of limited value because G. 
vaginalis has the structural and biochemical characteristics of a Gram-
negative bacterium, yet appears as both Gram-negative and Gram-positive 
bacilli in young cultures (Plate 7). Thus, it could readily be mistaken 
for unclassified vaginal coryneform organisms. 
A speci fi c i ndi rect fl uorescent anti body test has been used for the 
identification of §. vaginalis (Redmond and Kotcher, 1963; Vice and 
Smaron, 1973; Svarva and Maeland, 1982). The antiserum raised in 
rabbits against reference strain ATCC 14018 gave good fluorescence with 
all except one strain of G. vaginalis tested. The antisera also 
discriminated well between G. vaginalis and other vaginal organisms 
including lactobacilli. The use of this test would be ideal for the 
rapid identification of G. vaginalis since the method used had 
excellent sensitivity and specificity, however the antiserum was not 
commercially available. 
Other identification protocols which included fermentation of starch, 
raffinose and hippurate hydrolysis together with diffuse beta-
haemolysis were proposed. Using a combination of these the majority of 
PLATE 7 : 
Gram stained smear of a 24-hour culture of Gardnerella 
vaginal is, showing typical pleomorphic Gram-variable rods 
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the strains of ~. vaginalis were identified within one hour (Yong and 
Thompson, 1982; Jolly, 1983) and were differentiated from other G. 
vaginalis-like organisms which gave different patterns. Based on the 
above tests, a standardised commercially available system has been used 
by Lien and Hillier (1989). This system may be useful for the 
identification of G. vaginalis in laboratories where human blood 
bilayer plates are not available. 
Inhibition tests have also been used in diagnostic laboratories. Park 
et al (1968) rel ied on growth inhibition by al pha-haemolytic 
streptococci or pneumococci in addition to colonial morphology and Gram 
stain reaction. All 30 strains tested were reliably identified. Reimer 
and Reller (1985) found that previously identified strains of G. 
vaginalis were inhibited by some strains of alpha-haemolytic 
streptococci and by paper discs containing sodium polyanethole 
sulfonate (SPS). Most strains of G. vaginalis are inhibited in disc 
diffusion tests by high concentrations of metronidazole (50ug), 
trimethoprim (5mg) and bile (10%), but resistant to sulphonamides (1mg) 
(Piot et ~, 1982b). These tests have been found to discriminate well 
and are simple to perform, but require at least 24 hours incubation. 
Taylor and Phi 11 ips (1983) have recommended the use of seven tests 
which are easy to perform and interpret. These are beta-haemolysis on 
human blood agar, sensitivity to trimethoprim (5mg) and metronidazole 
(128ug), resistance to a low concentration of metronidazole (32ug), 
growth in the presence of 2% sodium chloride, growth on nutrient agar 
and the production of lactic acid from glucose. 
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A criteri on whi ch has been found most useful, is the producti on of 
diffuse beta-haemolysis on human blood agar on primary isolation. Thus, 
this feature has been proposed for the rapid presumptive identification 
(Smith et ~, 1979; Totten et ~, 1982) of ~. vaginal is. However, other 
oganisms such as lactobacilli and streptococci also produce beta-
haemolysis (Smith et ~, 1979; Piot et ~, 1980; Taylor and Phillips, 
1983) reducing the reliability of this criterion. 
It has been shown that the use of beta-haemolysis together with 
colonial morphology, negative catalase test and typical Gram stain 
reaction can correctly identify 90% to 97% of G. vaginalis strains 
(Piot et ~, 1982b). Ison et ~ (1982) have used horse blood agar 
together with human blood agar and have shown that ~. vaginalis 
produces diffuse beta-haemolysis on human blood agar and not on horse 
blood agar. Demonstration of differential haemolysis can aid in the 
rapid presumptive identification on primary isolation. 
Research laboratories may require to perform additional tests to obtain 
optimal discrimination. The use of alpha and beta-glucosidase together 
with hippurate and starch hydrolysis have been found to give a high 
discriminative value of up to 99% (Piot et ~, 1982b). 
To date there has been no consensus as to which tests may be most 
appropriate for the identification of G. vaginalis. Minimal criteria 
for the identification of ~. vaginalis from specimens of genital tract 
have been suggested by Taylor-Robinson et ~ (1984b). They are of the 
opinion that occurrence of beta-haemolysis, typical colonial morphology 
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with a Gram-negative to variable staining reaction (Plate 7) would 
strongly suggest that the organism was §.. vaginalis. However, if the 
isolate was from a site other than the genital tract, a larger number 
of tests would need to be employed; these could include the use of a 
test for catalase production and inhibition by metronidazole (50ug) 
(Table XIV). 
2.10.5 Biotyping 
Since §.. vaginalis has been isolated from vaginal fluid of women with 
and without bacterial vaginosis, it has necessitated the 
characterisation of strains. However, biochemical reactions used did 
not differentiate the strains, thus techniques such as biotyping were 
developed to enable this characterisation. 
The first simple and reproducible biotyping scheme was developed by 
Piot et ~ (1984). Their scheme was based on the reactions obtained for 
lipase, hippurate hydrolysis and beta-galactosidase activity (ONPG). 
Eight biotypes were identified (Table XV) (Piot et ~, 1984). The 
commonest biotypes were 1, 2 and 5 which included over 80% of G. 
vaginalis isolates tested (Piot et~, 1984). 
Thi s scheme was further developed by Benito et ~ (1986) wi th the 
addition of fermentation reactions of arabinose, galactose and xylose 
(Benito et ~, 1986). This scheme identified 17 biotypes with four in 
Group I, five in Group II, four in Group III, and four in Group IV 
(Table XVI). 
TABLE XIV: MINIMAL CRITERIA FOR THE IDENTIFICATION OF 
GARDNERELLA VAGINALIS 
(Taylor-Robinson et ~, 1984b) 
Minimum 
Diffuse beta-haemolysis on human blood bilayer 
agar media with Tween 80 
Typical colonial morphology 
Gram-negative to variable reaction 
Additional 
Catalase negative 
Any zone of inhibition with metronidazole (50ug) 
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TABLE XV BIOTYPES OF GARDNERELLA VAGINALIS 
(Piot et ~, 1984) 
BIOCHEMICAL TESTS 
Biotype Hippurate Lipase Beta-galactosidase 
1 + + + 
2 + + 
3 + 
4 + + 
5 + 
6 + + 
7 
8 + 
+ = Positive reaction 
= Negative reaction 
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(ONPG) 
TABLE XVI BIOTYPES OF GARDNERELLA VAGINALIS 
(Benito et a1, 1986) 
BIOCHEMICAL TESTS 
Biotype Hippurate ONPG Lipase 
GROUP I 
1a + + + 
1b + + + 
Ic + + + 
1d + + + 
GROUP II 
IIa + + 
IIa1 + 
IIb + + 
IIc + + 
IId + + 
GROUP III 
IlIa + + 
II Ib + + 
II Ic + + 






+ = Pos i tive reaction 
- - Negative reaction 
























A comparison of the biotypes as defined by Benito et ~ (1986) showed 
that strains identified as Group I corresponded to the biotype I of 
Piot; those of Group II to biotype 2; Group IIa to biotype 5, Group III 
to biotype 4 and those of Group IV to biotype 3. However, Benito et ~ 
(1986) found no combinations corresponding to biotypes 6 and 8. 
The results of these two studies did not sh~w any predominance of a 
particular biotype amongst strains of §. vaginalis isolated from women 
with bacterial vaginosis or amongst those from asymptomatic women. 
However, the isolation of the identical biotypes from sex partners when 
both were sampled within 24 hours, suggested that G. vaginalis may be 
sexually transmitted. 
Geographically the biotypes were similarly distributed, that is, those 
isolated from women in Seattle (USA), Nairobi (Africa) and Antwerp 
(Belgium) (Piot et ~, 1984). In contrast, geographical differences 
were found using the scheme of Benito et al (1986). 
Thus, to date application of these biotyping schemes has not enabled 
workers to distinguish any differences between G. vaginalis strains 
isolated from symptomatic and asymptomatic women. 
2.10.6 Antimicrobial susceptibility 
In order to identify those antimicrobial agents which may potentially 
be effective for the treatment of Gardnerella-associated infections, 
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several workers have determined the in vitro susceptibility of G. 
vaginalis to a variety of antimicrobial agents. 
Gardner and Dukes (1955) determined the susceptibility of §. vaginalis 
by the disc diffusion method and found the organism to be sensitive to 
bacitracin and tetracycline, usually resistant to chloramphenicol and 
resistant to penicillin, polymyxin and streptomycin. In contrast, other 
workers have reported the organism to be sensitive to penicillin 
(Frampton and Lee, 1964; Akerlund and Mardh, 1974, Levison et !.!.' 
1979) • 
Frampton and Lee (1964) examined 18 clinical isolates of §. vaginalis 
using the disc diffusion method and found all strains sensitive to 
penicillin, erythromycin and tetracycline. They demonstrated resistance 
to polymyxin and colistin. Akerlund and Mardh (1974) reported 10 
strains of G. vaginalis to be sensitive to penicillin, tetracycline, 
chloramphenicol, streptomycin but resistant to sulphonamides. 
McCarthy et !.!. (1979) determined the minimum inhibitory concentration 
(MIC) of several agents for strains of §. vaginalis including type 
strain 594. All strains were sensitive to ampicillin and penicillin 
with MICs of less than 0,06mg/t and less than 0,124mg/t respectively. 
All were resistant to sulphadiazine at a concentration of 128 mg/t and 
also resistant to colistin and nalidixic acid. The resistance of the 
organi sm to a 11 these agents except trimethoprim and vancomyci n has 
been used for the development of a selective medium for the isolation 
of G. vaginalis from clinical specimens. 
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The metronidazole susceptibility of eight clinical isolates and two 
reference strains (ATCC 14018, ATCC 14019) were determined by the tube 
dilution method both aerobically and anaerobically by Pheifer et ~, 
(1978). MIC fo r the two reference strains were 3mg/t (ATCC 14018) and 
6mg/t (ATCC 14019) and for the eight clinical isolates, these ranged 
from 2 to 12mg/t. An additional 12 strains were tested by the agar 
dilution method and these isolates showed a gradual reduction of growth 
at 0,5mg/t and with complete inhibition by 4 to 8mg/t anaerobically. 
Although §. vaginalis has been shown to be only variably sensitive to 
metronidazole, its hydroxymetabolite, being the major metabolite in the 
body was investigated to determine its relative antibacterial activity 
(Ralph 1983). 
Ralph (1983) found §. vaginalis to have a metronidazole MIC of 4mg/t 
whilst for the hydroxymetabolite this was only 1mg/t. Easmon et ~ 
(1982) reported similar results although the MICs obtained in their 
study were slightly higher. These results were confirmed by the studies 
of Jones et ~ (1985), however, the median MIC of metronidazole for §. 
vaginalis was 32mg/t and of the hydroxymetabolite was 4mg/t and three 
stra i ns were resistant to both agents with MICs of 128mg/.e. Clearly 
the hydroxymetabolite seems more active than the parent compound on a 
weight to weight basis. However, it remains unclear as to why 
metronidazole therapy is so successful clinically in bacterial 
vaginosis even t hough §. vaginalis, the organism implicated in its 
aetiology usually exhibits reduced sensitivity to this agent. Other 
nitroimidazoles tested include tinidazole with MIC 90 (MIC at which 90% 
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of isolates are inhibited) of 16mg/t and 32mg/t, showing similar 
activity to metronidazole (Shanker and Munro, 1982; Piot, 1984). 
The fluoroquinolones have generally demonstrated lower activity against 
G. vaginalis than against many other bacteria; the MIC 90 for 
ciprofloxacin, A56619 and A56620 against G. vaginalis being 4, 8 and 
4mg/t respectively. The MIC90 for the same agents against N. 
gonorrhoeae was 0,008, 0,03 and 0,015mg/t respectively, which is 
considerably lower. These agents may playa role in the treatment of 
bacterial vaginosis just as metronidazole which is moderately active 
against §. vaginalis in vitro, is useful in the treatment of bacterial 
vaginosis (Tjiam et ~, 1986). 
2.10.7 Extra-vaginal infections caused by Gardnerella vaginalis 
§. vaginalis has been found to be a common inhabitant of the normal 
vagina and associated with bacterial vaginosis. The potential of the 
organism to cause invasive disease is uncertain, although it has been 
isolated from sites other than the vagina. 
The organism was first reported from the urine of men by Leopold 
(1953). It has also been found in the male urethra (Dawson et !l, 1982; 
Ki nghorn et !l, 1982; Chowdury, 1986) and semen (I son and Easmon, 
1985). Although the presence of the organism in the male genital tract 
is primarily associated with asymptomatic carriage (Gardner, 1980; 
Dawson et !l, 1982), it has been implicated in urinary tract infection 
(Abercrombie et ~, 1978), non-gonoccocal urethritis (Chowdury, 1986) 
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and bacteraemia in a man following prostatectomy (Patrick and Garnett, 
1978). It has also been associated with balanoposthitis (Kinghorn et 
~, 1982; Burdge et ~, 1986) and bacteraemia secondary to a pulmonary 
abscess (Legrand et al, 1989). 
§.. vaginalis has been found more frequently in the urinary tract of 
women than men (Josephson and Thomason, 1986). The isolation of the 
organism from the bladder of women was first described by McFadyen and 
Eykyn (1968) who found an incidence of 16% - (159 of 1000) suprapubic 
aspirates of healthy pregnant women; similarly McDowall et ~ (1981) 
reported an incidence of 18% in mid-stream urine specimens. The 
isolation rate was higher (58%) in pregnant women who had underlying 
renal disease. The presence of the organism in patients' urine was not 
associated with a pyuria and in spite of not receiving treatment, they 
remained asymptomatic. 
Fairley and Birch (1983) observed squamous epithelial cells with 
adherent bacteria resembling "clue" cells in the bladder aspirates of 
persons whose urine was culture positive for §.. vaginal is. They 
suggested that "clue" cells from the vaginal mucosa may provide an 
effective vehicle of spread from the vagina to the urinary tract. 
G. vaginalis has frequently been found in association with U. 
urealyticum in the urine of pregnant women (Savige et ~, 1983) and in 
renal transplant patients (Birch et ~, 1981) and it is possible that 
these two organisms may interact in the urinary tract, enabling G. 
vaginalis to be a potential pathogen. 
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Edmunds (1959 ) reported an association between isolation of G. 
vaginalis from high vaginal swabs and the presence of puerperal pyrexia 
and leucorrhoea. Q. vaginalis has also been isolated from endometrial 
samples from women with post-partum or post-caesarean section 
infections and septic abortions (Regamy and Schoenknecht, 1973). 
Eschenbach et ~ (1984) showed that organisms associated with bacterial 
vaginosis, that is Q. vaginalis and/or anaerobes were isolated from 61 
of 100 women wi th post-partum endometritis, with Q. vaginalis being the 
mos t cormnon i so 1 ate from both the blood and endometri urn. Bac teri a 1 
vaginosis was also associated more often in women giving birth 
prematurely (49%) than at full term (24%). 
Most patients presenting with bacteraemia with Q. vaginalis have been 
obstetric patients (Vontver and Eschenbach, 1981). It appears that the 
organism may be an opportunistic pathogen spreading to the blood stream 
following trauma to the tissues of the genital tract (Venkataramani and 
Rathbun, 1976; Reimer and Reller, 1984). It is unclear whether a 
positive blood culture represents a true infection or a transient 
bacteraemia, since other organisms occurring in the lower genital tract 
were also isolated from the blood culture (Reimer and Reller, 1984), 
suggesting tha t bacteraemia reflects the spread of vaginal flora into 
areas of tissue damage with subsequent spread to the blood stream. 
Furthermore, the studies have also reported that despite initial 
presentation with high fever and abdominal pain, the patients recovered 
without appropriate antibiotic therapy and complications such as 
meningitis or endocarditis were not encountered. 
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.§.. vaginalis has been isolated from cord blood of neonates, (Platt, 
1971; Monif and Baer, 1974). None of these infants appeared to be 
clinically infected. Platt (1971) found .§.. vaginalis in the blood of 
one child who subsequently died and from the scalp lesions of another 
who survived. 
From reports available, it would appear that patients at greater risk 
of developing urinary tract infections are women, those with chronic 
renal disease and especially pregnant women, as the vagina, which may 
be colonised with .§.. vaginalis lies in close proximity to the urinary 
tract. Although .§.. vaginalis was found to be non-invasive (Gardner and 
Dukes, 1955) the organism could spread from the vagina to other body 
sites including the bloodstream. Invasion of the blood stream usually 
occurred during or after parturition, thus the infection is a result of 
opportunistic spread of .§.. vaginalis, dependent on the underlying 
predisposing conditions of the host. 
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3.0 PATIENTS AND METHODS 
3.1 STUDY PERIOD 
The clinical portion of this study was carried out between November 
1987 and March 1988. During this period all clinical assessments were 
performed and specimens collected. 
3.2 PATIENTS 
A total of 208 women attending four different out-patient cl inics at 
King Edward VI I I Hospital (KEH) Durban, were investigated. 
KEH is a 2 000 bed hospital situated in central Durban. The hospital 
has a number of out-patient clinics and serves a large, predominantly 
Black urban and peri-urban resident population and also serves as a 
referral centre for the Natal-KwaZulu region. 
The study group comprised: 
55 women presenting to the family planning clinic (FPC) for advice 
on contraception; 
52 pregnant women presenting to the ante-natal cl inic (ANC) for 
their first ante-natal consultation; 
51 women presenting to the sexually transmitted diseases (STD) 
clinic, either as patients with vaginal symptoms such as vaginal 
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discharge and/or vaginal irritation or itching or as contacts of 
patients with known sexually transmitted diseases; 
50 patient s attending the colposcopy clinic (CC). These patients 
were referred from the hospital family planning clinic or from 
periphera l family planning clinics for follow-up of abnormal 
uterine cervical cytology, suggestive of cervical intra-epithelial 
neoplasia (CIN). 
Patients were excluded from the study if they were menstruating or if 
they had taken any antimicrobial agent(s), or received any local 
therapy for vaginitis within the previous month, or had douched on the 
day of the examination. 
Patients were informed of the purpose of the study and the need for 
non-invasive procedures including a vaginal examination. Only patients 
giving (verbal ) consent were included in the study. 
A confidentia l questionnaire was administered to each woman by 
interview. Information elicited included the following: patient's age, 
marital status, pregnancies, contraception used, number of sexual 
partners and current genital symptoms. 
3.3 CLINICAL METHODS 
Each patient was examined by the attending doctor. Examination included 
a general examination and a comprehensive gynaecological examination. 
During the latter, the patient was placed in the lithotomy position and 
89 
an unlubricated sterile speculum passed into the vagina. The amount, 
type and consistency of vaginal secretions were assessed and clinical 
specimens collected. Clinical data were recorded on a standard form. 
In the case of patients attending the colposcopy clinic, a colposcopic 
exami nati on was performed and cervi ca 1 bi ops i es were performed 
routinely as part of a diagnostic examination. Pregnant women were 
subjected to routine ante-natal examination. 
3.4 SPECIMEN COLLECTION 
3.4.1 
Specimens were coll ected from the vagina, endo-cervix, urethra and 
rectum. Venous blood was collected aseptically from a peripheral vein. 
Specimens were processed in the order described (Table XVII). The 
formulations for all media used are detailed in Appendix A. 
Vaginal specimens 
A sterile polypropylene disposable pipette (Sterilin, Polychem, South 
Africa) was used to collect vaginal discharge and secretions from the 
lateral and posterior fornices. The vaginal pH was measured directly 
from the pipette using narrow range pH paper. The remaining discharge 
was mixed into 1,5mi of sterile physiological saline and a drop was 
placed on a glass slide for wet smear microscopic examination. For the 
culture of r. vaginalis O,5mi of the saline mixture was inoculated into 
modified Diamond's medium. The remaining saline mixture was stored at 
-20°C and subsequently examined by gas liquid chromatography for 
volatile and non-volatile organic acids. 
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* TABLE XVII PROCESSING OF SPECIMENS 
Nature/site Microscopic Additional tests 
of specimen Examination 
Wet Gram Pap If for pH KoH GLC 
smear stain stain Ct 
Vagina +a + + + + + 






GC HSV GV MH AN Yeast Trich Coli- Syph Hep B HIV 
UU forms 
Vagina - - + + + + + 
Endo-cervix + + - + -
Urethra + - + 
Rectum + - - - - + 
MSU - + + + 
Blood - - - + + + 
* See text section 3.4 
+ Specimen tested 
Specimen not tested 
a Vaginal wet smear microscpy 
b Direct urine microscopy 
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For each patient, further vaginal specimens were obtained by means of 
sterile cotton-tipped swabs and immediately (at the clinic) used for 
the fo 11 owi ng: 
i the preparation of a smear for Gram staining; 
ii mixing with O,25me of 10% potassium hydroxide (KOH) for the 
detection of the characteristic IIfishyll odour; 
iii inoculation onto selective human blood agar (SHBA) and horse 
blood agar (BA) for the isolation of ~ vaginalis; 
iv inoculation onto pre-reduced Wilkins-Chalgren anaerobic agar 
(Oxo id, UK) supplemented with horse blood for the isolation 
of anaerobic bacteria; 
v inoculation onto Sabourauds dextrose agar (Difco, USA) for 
the i solation of yeasts; 
vi inoculation of Shepard's A7 agar and U9 broth for isolation 
of genital mycoplasmas. 
vii one swab specimen was placed into Stuart transport medium 
(Oxo id, UK) and another into modified Cary-Blair transport 
medium. This was to determine the efficacy of transport media 
for the recovery and isolation of §. vaginalis as compared to 
the direct plating method (iii above). 
A wooden spatula was used to collect material from the vaginal wall and 
a smear made on a glass slide. This was immediately fixed using 





Endo-cervical specimens were collected after wiping the ecto-cervix 
with sterile cotton wool swabs to clear any adherent vaginal 
secretions. Three sterile cotton-tipped and one sterile dacron-tipped 
(plastic shaft) swabs were sequentially inserted into the endo-cervical 
canal and rotated firmly to obtain cervical cells and exudate. Of the 
cotton-tipped swabs: 
i one was inoculated onto modified New York City Medium (MNYC) for 
the isolation of N. gonorrhoeae. The same swab was also used for 
the preparation of a smear for Gram staining; 
ii one was inoculated onto Shepard·s A7 agar for genital mycoplasmas; 
iii one was placed in virus transport medium (VTM) for culture of 
Herpes simplex virus. 
The dacron-tipped swab was rolled onto an unmasked area of a MicroTrak 
glass slide. The material was air-dried, fixed in acetone and stored at 
-70°C for subsequent direct immunofluorescent (IF) staining for antigen 
detection for f. trachomatis (Microtrak, Syva, USA). 
An Ayre· s spatul a was used to prepare a cervi ca 1 smear for 
Papanicolaou·s staining. 
3.4.3 Urethral specimens 
The urethral meatus was first wiped clean with a sterile cotton wool 
swab after which the para-urethral glands were gently massaged and then 
3.4.4 
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two endo-urethral specimens were obtained using calcium alginate-tipped 
swabs (Calgiswab Type 1, Inolex, USA). 
i one was inoculated onto MNYC medium and SHBA . 
ii one was used for preparation of a smear for direct IF staining for 
C. trachomatis (as in dacron-tipped endo-cervical swab). 
Rectal specimens 
A rectal mucosal swab was obtained by inserting a cotton-tipped swab 
into the anus for approximately 3cms and sweeping the tip peripherally 
against the mucosa. This was plated out onto MNYC and Sabourauds 
dextrose agar for the detection of N. gonorrhoeae and yeasts 
respectively. 
3.4.5 Mid-stream urine specimen 
Each patient was supervised and requested to pass a mid-stream urine 
specimen into a sterile container. This was held on ice and transported 
to the laboratory within 2 hours for further processing. 
3.4.6 Serological specimens 
Serum was separated aseptically from the clotted blood specimens and 
kept at -20°C prior to the performance of serological tests for 
syphilis, and the detection of hepatitis B surface antigen and antibody 
to human immunodeficiency virus (HIV). 
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3.4.7 Transport of specimens 
All inoculated plates were immediately placed into candle extinction 
jars and transported to the laboratory within 2 hours, where the plates 
were streaked out and then incubated appropriately (see separate 
sections). The VTM were held at 4°C on ice and transported to the 
laboratory where they were held at -70°C until they could be inoculated 
onto cell mono layers. 
3.5 MICROBIOLOGICAL METHODS 
Microscopic examination of the vaginal wet smears, estimation of 
vaginal pH and the amine 1 iberation tests were conducted immediately 
after collection of specimens at the respective clinics. All further 
processing of specimens was done in the laboratory. 
3.5.1 Vaginal wet smear microscopic examination (direct microscopy) 
Wet smears (see section 3.4.1) were examined by light microscopy 
(Nikon) under low power magnification (X40 objective) within 10 minutes 
of specimen collection for the presence of epithelial cells, 
inflanmatory cells, "cl ue cells", motile trichomonads, yeasts and 
bacteria. The attachment of large numbers of bacteria to vaginal 
epithelial cells with obscure cellular and nuclear outlines were 
defined as "cl ue cells". 
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3.5.2 pH estimation 
The pH of the vaginal fluid was estimated by the application of a drop 
of vaginal secretion from the collecting pipette to a narrow range 
(4-6) pH paper (Whatman, BDH, England) and reading against the colour 
chart provided by the manufacturer. 
3.5.3 Amine liberation test 
A cotton-tipped swab containing vaginal secretions was added to O,25ml 
of 10% potassium hydroxide (KOH) (w/v) solution in a test tube. The 
production of a fishy odour was considered to be a positive reaction, 
indicative of the release of aromatic amines (Pheifer et ~, 1978). 
3.5.4 Stained smears 
3.5.4.1 Gram stain 
Vaginal smears were prepared by transferri ng vagi na 1 secreti ons to 
glass slides. The slides were air-dried, heat-fixed and Gram-stained. 
Smears were examined under oil immersion (XlOO objective) and quant-
itated for the presence of "clue" cells, Gram-variable bacilli, yeasts, 
lactobacilli, §. vaginalis-like organisms, Gram-negative curved rods 
(ACR) and other bacteria. 
Endo-cervical smears were Gram stained and examined for the presence of 
inflammatory cells and intra- and/or extracellular Gram-negative 
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diplococci suggestive of ~. gonorrhoeae. The presence of more than 10 
inflammatory cells per oil immersion field was considered to be 
indicative of cervicitis (Paavonen et ~, 1986). 
3.5.4.2 Papanicolaou (Pap) stained smears 
3.5.5 
Vaginal and cervical smears were prepared as described in 3.4.1 and 
3.4.2 and stained with the Pap stain. The smears were microscopically 
examined for the presence of "clue cells" with pleomorphic bacilli 
(suggestive of §. vaginalis), yeasts, T. vaginalis, koilocytes -
suggestive of human papilloma virus (HPV) infection and dysplasia. 
Examination of mid stream urine specimen 
Using a calibrated loop, lOut of un spun urine specimen was inoculated 
onto SHBA, HB agar and cystine lactose electrolyte deficient agar 
(CLEO). The centrifuged deposits were examined microscopically using a 
light microscope (Nikon) and X40 objective for the presence of 
inflammatory cells, red blood cells, epithelial cells, trichomonads and 
casts. 
3.5.6 Culture and identification of micro-organisms 
The formulations and methods for the preparation of media used appear 
in appendix A. 
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3.5.6.1 Gardnerella vaginalis 
§. vaginalis was isolated on SHBA (5% v/v) and BA (5% v/v) agar, 
incubated for 48 hours at 37°C in 6% CO2. 
The SHBA medium was used for primary isolation only. All suspicious 
colonies with characteristic diffuse beta-haemolysis on SHBA medium 
were sub-cultured onto human blood agar without antibiotics (HB). After 
single sub-culture all isolates were stored in sterile human group 0 
red cells at -70°C. Isolates were subsequently further identified in 
batches. 
Identification of §. vaginalis was made on the basis of colonial 
morphology, typical pleomorphic Gram-variable bacilli, negative oxidase 
and catalase tests and characteristic diffuse beta-haemolysis on human 
but not horse blood agar (Ison et~, 1982) (see section 2.10.3). 
The identity of all isolates was confirmed by the presence of 
alpha-glucosidase and absence of beta-glucosidase activity. A zone of 
inhibition around a 5ug trimethoprim (Oxoid) disc and a 50ug 
metronidazole (Mast) disc and no zone of inhibition to a 1mg 
sulphathiazole (Mast) disc were additional criteria used in the 
identification of G. vaginal is. 
3.5.6.2 Anaerobic bacteria 
Anaerobic bacteria were isolated on pre-reduced Wilkens-Chalgren 
anaerobic agar (Oxoid) supplemented with 5% (v/v) horse blood. 
98 
Vaginal specimens were inoculated onto a third of the plate and a 5ug 
metronidazole (Mast) disc was placed on the initial inoculum. The 
plates were streaked out for single colonies and transferred into a gas 
pak jar (Baltimore Biological Laboratories-BBL) containing moistened 
paper and incubated at 37°C for 5 days under anaerobic conditions 
provided by using Anaerocult A (Merck). 
Anaerobic bacteria were recognised by their inhibition by metronidazole 
(Phillips and Taylor, 1987) and inability to grow aerobically. 
3.5.6.3 Genital yeasts 
Yeasts were isolated on Sabouraud's dextrose medium which was incubated 
for 48 hrs at 37°C in air. All yeasts isolated were inoculated into 
fresh normal human serum and incubated at 37°C for 3 hours and observed 
for the production of pseudohyphae (germ tube test) (Cooper and 
Silva-Hutner, 1985). Isolates that produced pseudohyphae were identifed 
as C. albicans and all other isolates were identified by using the API 
20C auxanogram (API Systems SA, France). The numerical profile obtained 
for the unknown yeast was compared with those given by the analytical 
profile index (API + 2021). 
3.5.6.4 Genital mycoplasmas 
For the isolation of genital mycoplasmas swabs were inoculated onto A7 
agar plates (Shepard and Lunceford, 1976) and U9 broths (Shepard and 
Lunceford, 1970). The plates and broths were incubated in gas pak (BBL) 
jars microaerophically using BBL gas pak anaerobic systems at 37°C for 
99 
48 hours. After 48 hours incubation A7 agar plates were examined using 
a Nikon light microscope with XI0 objective for the presence of 
characteristic colonies of Ureaplasma urealyticum and Mycoplasma 
hominis. Colonies of U. urealyticum were identified as dark golden 
brown colonies of variable size. The dark brown colonies were due to 
the manganese reaction since ureaplasmas are urease positive. Colonies 
of ~. hominis were identified by their typical fried egg appearance, 
much larger than Q. urealyticum and failure to produce the manganese 
reaction. The U9 broth cultures were observed twice daily for up to 7 
days for a colour change, that is from orange to pink (due to 
alkalinity resulting from urea hydrolysis) with no turbidity, whereupon 
they were immediately sub-cultured onto A7 agar plates and incubated 
and examined as described above. 
3.5.6.5 Trichomonas vaginalis 
I. vaginalis was identified by screening the vaginal wet smear using 
X40 objective for motile trichomonads, exhibiting characteristic 
morphology and jerky movement. 
Culture was pe rformed in Diamond's medium (Diamond, 1957) modified by 
the addition of amikacin (lOOug/mt) ampicillin (Img/mt) and 
amphotericin B (5ug/mt). The inoculated broths were incubated at 37°C 
in 6% CO2 for up to 7 days. Wet smears were made daily from cultures 
and examined microscopically for the presence of T. vaginalis as 
described above. 
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3.5.6.6 Neisseria gonorrhoeae 
~. gonorrhoeae was isolated on MNYC which consisted of gonococcal agar 
base (Oxoid) with the addition of yeast autolysate supplement (Oxoid) 
and lincomycin, colistin, amphotericin B, trimethoprim (LCAT) 
antibiotic supplement (Oxoid). 
Swab specimens were inoculated directly onto the medium and incubated 
for 48 to 72 hours at 37°C in 6% CO2. 
~. gonorrhoeae was identified as an oxidase positive, Gram-negative 
coccus, producing typical results in carbohydrate utilisation tests, 
namely utilisation of glucose but not maltose, sucrose and lactose. 
All isolates were screened for penicillinase production using 
chromogenic cephalosporin as substrate (Nitrocefin-Glaxo, England) 
(O'Callaghan 1972). Whatman's filter paper No 1 (Whatman, England) was 
impregnated wi t h nitrocefin solution (0,05% w/v). Colonies were smeared 
onto the filter paper; a deep pink colour appearing within 2 minutes, 
being indicative of penicillinase production. A known positive ..lli. 
gonorrhoeae) and negative ..lli. gonorrhoeae) were i ncl uded as control 
organisms. 
3.5.6.7 Chlamydia trachomatis 
f· trachomatis was identified using a direct antigen detection test 
(MicroTrak, Syva, USA) . 
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Smears of urethral and endo-cervical exudate (section 3.4.2) were 
examined using the "MicroTrak" C. trachomatis direct fluorescent 
antibody reagent. The reagent contains monoclonal antibodies specific 
to the principle membrane protein of ~. trachomatis and Evans blue 
counterstain in a protein stabilised buffer solution. Tests were 
performed according to the manufacturer's instructions. A summary of 
the procedure is given below: 
The acetone-fixed smears were stained using 30ut of diluted monoclonal 
antibody which was spread over the smear. The slides were incubated at 
room temperature for 15 minutes in a moist chamber. At the end of the 
incubation the slides were gently rinsed in distilled water for 10 
seconds and air dried. A drop of mounting fluid was added and slides 
mounted with a coverslip and examined with a Nikon fluorescent 
microscope at a wavelength of 540nm. A positive diagnosis was made on 
the presence of one or more elementary bodies. Elementary bodies were 
identified as characteristically brightly staining with a distinctive 
disc shape and green colour. Elementary bodies were confirmed using 
x100 objective. Positive and negative control slides provided by the 
kit manufacturer were set up in parallel with the test slides. 
3.5.6.8 Culture for Herpes simplex virus 
The presence of Herpes simplex virus in endo-cervical specimens was 
detected by culture in monkey kidney cells. Inoculated monolayers were 
incubated at 37°C and observed daily for up to 14 days. Herpes simplex 
virus was identified by its characteristic cytopathic effects and its 
identity confirmed by staining with fluorescein isothiocyanate labelled 
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monoclonal antibody (MA Bioproducts, Maryland, USA) against Herpes 
simplex virus (Types 1 and 2). 
3.5.6.9 Culture of G. vaginalis from specimens in transport media 
Vaginal secretions, collected from the posterior fornix were inoculated 
into Stuart and modified Cary-Blair transport media (section 3.4.1). 
These were allowed to stand at room temperature overnight in the 
laboratory; thereafter they were plated onto SHBA and HB agar for the 
isolation of ~. vaginalis. For each set of specimens the growth 
obtained from swabs inoculated from the two transport media were graded 
and compared wi th one another and with the growth obtained on the 
directly inoculated media. 
3.6 GAS LIQUID CHROMATOGRAPHIC ANALYSIS OF VAGINAL SECRETIONS TO 
DETERMINE SUCCINATE : LACTATE RATIOS 
Previously preserved saline suspensions of vaginal secretions were 
prepared for gas liquid chromatography by the method adapted by Spiegel 
e t .!!., (I 980) . 
3.6.1 Extraction of non-volatile acids 
The sample (0,5m.e) was acidified with 0,1m.e of 50% aqueous sulphuric 
acid (v/v), mixed with 1m.e of methanol and incubated in a 55°C heating 
block for 30 minutes. Water (O,5m.e) was added and the non-volatile 
acids were extracted with 0,25m.e of chloroform. The solution was gently 
mixed and centri fuged for 5 minutes at 1000g to separate the chloroform 
3.6.2 
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layer from the aqueous layer. The chloroform layer was carefully 
removed for analysis. 
Extraction of volatile acids 
The sample (0,5mt) was acidified with O,lmt of 50% aqueous sulphuric 
acid (v/v) and 1mt ethyl ether added. The mixture was gently inverted 
repeatedly and centrifuged for 5 minutes at 1000g to separate the 
aqueous 1 ayer from the ethyl ether 1 ayer. The ethyl ether 1 ayer was 
carefully removed for analysis. 
3.6.3 Gas liquid chromatography 
Gas liquid chromatography was performed using Hewlett Packard - 5790A 
Series gas chromatograph. This was attached to a Hewlett Packard 
integrator 33908 for the recording of results. A 2 microlitre volume 
was injected onto a column. The following operating temperatures were 
employed: column temperature 170°C, detector temperature 250°C. Helium 
was the carrier gas at 50mt/minute. 
The ratio of the succinate peak to that of the lactate peak was then 
calculated by measuring the heights of the peaks in millimeters. A non 
volatile fatty acid standard included pyruvic, lactic, oxalacetic, 
oxalic, methyl malonic, malonic, fumaric, succinic acids (Supelco) and 
a volatile fatty acid standard included formic, acetic, propionic, 
isobutyric, bu tyric, isovaleric, valeric, isocaproic, caproic and 
heptanoic acids (Supelco). 
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3.7 ANTIMICROBIAL SUSCEPTIBILITY OF GARDNERELLA VAGINALIS 
Minimum inhibitory concentrations (MIC) were determined by the agar 
dilution method. 
3.7.1 Bacterial strains 
All previously confirmed vaginal isolates of §. vaginalis were tested 
for their in vitro susceptibility to antimicrobial agents. Isolates 
stored at -70°C were thawed and inoculated onto HB agar and incubated 
in air plus 6% CO2 for 48 hours. Three control strains were included 
with every test batch. These were reference cultures of Staphylococcus 
. 




The antimicrobial agents tested were as powders of stated potencies for 
laboratory use supplied by pharmaceutical companies. The antibiotics 
were dissolved in appropriate solvents to prepare stock solutions. 
These were then diluted in water to provide a final range of 
concentration from 128mg/L to 0,001 mg/L when tested. 
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HB agar was prepared as described in appendix A, but kept molten at 
SO°C. Freshly prepared, appropri ately dil uted antibioti c sol uti ons in 
smt amounts was added to 20mi of molten agar. This was mixed thoroughly 
and dispensed into 9cm sterile petri dishes. The agar medium was 
allowed to solidify at ambient temperature and dried at 37°C for 30 
minutes. All plates were kept at 4°C and used within 24 hours of 
preparation. Antibiotic free plates were used for growth control. 
Inoculum preparation 
Colonies of §. vaginalis from a 48 hour HB agar culture were suspended 
in Mueller Hinton broth (MHB) and the turbidity adjusted to match that 
of a O,S MacFa r land standard. A 1 in 10 dilution was then prepared in 
MHB for inoculation onto agar containing antibiotics. Inoculation of 
media was made within 30 minutes of adjusting the inoculum. 
Minimum inhibitory concentration (MIC) determination 
The diluted suspensions were applied to agar plates using a Cathra 
replicator (Rousseau and Harbec, 1987). The final inoculum applied to 
the testing media was approximately lOS colony forming units (CFU). 
Antibiotic free plates were inoculated at the beginning and end of each 
set of antibiotic plates to ensure viability of organisms and to check 
for potential contamination. 
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All plates were incubated at 37°C in air in 6% CO2 for 48 hours except 
those for metronidazole, tinidazole and 2-hydroxymetabolite of 
metronidazole were incubated anaerobically in gas pak jars (BBL) at 
37°C. After incubation plates were examined for growth. The growth on 
the antibiotic plates was compared to the growth on the antibiotic free 
plates. Very fine hazy growth or single colonies were considered to 
indicate no growth. 
The MIC of each antibiotic was defined as the lowest concentration of 
an antibiotic which inhibited growth of the organism (Plate 8). 
3.8 BIOTYPING OF GARDNERELLA VAGINALIS 
G. vaginalis isolates were biotyped according to the scheme described 
by Piot et al (1984). The biochemical tests used were hippurate 
hydrolysis, lipase and beta-galactosidase activity (appendix B). The 
pattern of results obtained from these tests was used to determine the 
biotype of each isolate. 
3.9 SEROTYPING OF GARDNERELLA VAGINALIS 
Whole cell antigen of §. vaginalis was trapped on nitrocellulose 
membrane. This was reacted with antibody directed against 
immunodominant protein and visualised using anti-rabbit immunoglobulin 
linked to alkaline phosphatase for the polyclonal antibody, and anti-
mouse immunoglobulin linked to phosphatase for the monoclonal antibody. 
PLATE 8 : 
Antibiotic containing agar plates to determine 




The technique used was a dot blotting enzyme-l inked assay which was 
convenient and enabled many strains to be tested against a variety of 
anti sera. 
3.9.1 Bacterial strains 
3.9.2 
All previously confirmed ~. vaginalis isolates were serotyped. 
Preparation of antigen 
~. vaginalis was grown on the HB agar for 48 hours in 6% CO2. 
Suspensions of bacteria were prepared in saline. The optical density 
(00) was calculated at a wavelength of 540nm on a spectrophotometer by 
using a 1 in 10 dilution of the original suspension. The 00 of the 
suspension was adjusted to 0,05. 
3.9.3 Control organisms 
Suspensions of control organisms were prepared and tested every time 




G. vaginalis 170(C) 
G. vaginalis NCTC 10915 
Lactobacillus acidophilus 
Control strains 1 and 2 were provided by Doctor Cathy Ison (St Mary's 





The antisera used were also kindly provided by Doctor Cathy Ison. These 
were spec i ally prepared for resea rch purposes by Cora 1 abs Research, 
United Kingdom. The antibodies raised to G. vaginalis were directed to 
proteins of differing molecular weights. One polyclonal and four 
monoclonal antisera were used as a panel for the serotyping scheme. 
Immune Dot Blot Technique 
A nitrocellulose membrane 0,45 urn (Anderman and Co., Ltd) measuring 
l2x8cm was soaked in sterile saline for 10 minutes. The membrane was 
blotted between paper to remove excess saline and placed in Bio Dot 
blotter (Bio-Rad Laboratories). 
A volume of lOOue of adjusted bacterial suspensions was added to each 
well of the 96 well Bio Dot apparatus. Duplicate dots were prepared for 
each test organism and controls for 5 antibodies resulting in 10 dots 
per organism. 
The Bio Dot was allowed to stand for 20 minutes thereafter the bacteria 
were concentrated onto the membrane by the application of a vacuum. The 
membrane was carefully removed from the Bio Dot and soaked in blocking 
buffer on an orbital shaker for 60 minutes at 37°C. The membranes were 
immersed in 20mi of the following serotyping antisera diluted in 
washing buffer with 0,05% (w/v) sodium azide. 
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antisera working dilution v/v 
Monoc 1 ona 1 1 1 : 10,000 
Monoclonal 2 1 : 20,000 
Monoclonal 3 1 : 5,000 
Monoclonal 5 1: 100 ,000 
Polyclonal C 1:200,000 
The membranes were incubated overnight at 37°C on an orbital shaker. 
Thereafter they were rinsed in saline and then in washing buffer for 
three 15 minute washes. 
3.9.6 
20me of anti-rabbit immunoglobulin linked to alkaline phosphatase 
(Oakopatts 0306) diluted 1:5000 (v/v) in washing buffer was added to 
membrane reacted with antibody C. 
20me of anti-mouse conjugate (Oakopatts 314) diluted 1:3000 (v/v) with 
washing buffer was added to each of the other membranes. Membranes were 
incubated again for 5 hours on a shaker at 37°C. 
The washing steps were repeated. The complexes of antigen and antibody 
were visualised by immersing each membrane in 20mt substrate for 
exactly 10 minutes while being shaken at room temperature. The reaction 
was halted by washing the membranes in distilled water. These were then 
blotted and air dried. 
Reading of Membranes 
The intensity of the colour obtained for the test dots were visually 
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compared and graded in comparison to those obtained for the immunizing 
strains (Plate 9). This aided to check the specificity of the antiserum 
and in the interpretation of results. 
The reaction obtained with that of the polyclonal antisera was compared 
with §. vaginalis 170 (C) strain and the reaction obtained with that of 
the monoclonal antisera was compared with §. vaginalis NCTC 10915 
strain. 
Lactobaci 11 us aci dophi 1 us was non-reacti ve and negati ve results were 
compared with this strain. 
The membranes were read macroscopi ca lly by three observers and scored 
as follows 
0 = no reaction (negative) 
1 = weak reaction 
2 = reaction more than that of 1 but less than that of the 
control strain 
3 = strong reaction of greater than or equa 1 to in intensity to 
that of the control strain. 
The duplicate results of each observer were summed and thereafter the 
scores from all three observers were summed. This could possibly give a 
result of any value from 0 to 18. A cut off pOint of 12 and over was 
considered positive. The value of 
typability and reproducibility. 
12 was found to gi ve acceptable 
1 2 3 4 5 6 1 2 3 4 
a • ~ 
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PLATE 9 : 
Nitrocellulose membrane showing varying intensities of 







3.10 SEROLOGICAL METHODS 
3.10.1 Syphil is 
The tests carried out for syphilis were the non-specific Rapid Plasma 
Reagin, (RPR) (Brewer Diagnositc Kits, BBl Microbiology Systems, 
Maryland, USA) both qualitative and quantitative. 
The specific tests were Treponema pallidum haemagglutination (TPHA) 
test (Fujirebio, Tokyo, Japan) and the indirect fluorescent treponemal 
antibody absorption (FTA-Abs) test using treponemal antigen, sorbent 
and fluorescein labelled anti-human immunoglobulin conjugate (Bio 
Merieux, France). Specific fluorescent treponemal antibodies for the 
IgG and IgM classes were also tested for. 
3.10.2 Hepatitis B surface antigen 
A radio immunoassay (Ausria-Abbott laboratories) was used to detect 
hepatitis B surface antigen (HBsAg) in serum specimens. 
3.10.3 Human immunodeficiency virus (HIV) 
Sera were tested for antibodies to HIV-l using Abbott recombinant 
HIVI/HIV-2 ELISA test (Abbott laboratories). All positive sera were 
confirmed by Western blotting (Diagnostic Biotechnology, Singapore). 
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3.11 ANALYSIS OF DATA 
Where required patient data were analysed using the Chi-square test 
with Yates' correction. The level of significance was set at 95% and 
recorded as p ~ 0,05. 
The sensitivity, specificity, predictive value of positive and negative 




of positive test 
Predictive value 
of negative test 
= No. of true positive tests x 100 
Total no. of women with 
bacterial vaginosis tested 
= No. of true negative tests x 100 
Total no. of women without 
bacterial vaginosis tested 
= No. of true positive tests x 100 
Total no. of positive tests 
= No. of true negative tests x 100 
Total no. of negative tests 
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4.0 RESULTS 
The subjects admitted to this study were recruited consecutively at the 
four clinics. Inclusion was made irrespective of the clinical diagnosis 
in individual patients. 
4.1 PATIENT DATA 
The patient data are presented in Table XVIII. All patients were Black 
between the ages of 16 to 52 years with . a mean age of 26,1 years. There 
were no significant differences in the mean ages of women attending the 
four different clinics, however, the mean age of the women attending 
the colposcopy clinic (CC) was 31,2 years. 
A high proportion, 130 (62,5%) women were unmarried whilst the 
remaining were married or paying lobola. Paying lobola was considered 
to be tantamount to marriage, because it traditionally signifies a 
commitment to one partner with a view to marriage and during this time 
sexual intercourse continues. There were more unmarried women in the 
sexually transmitted diseases (STD) clinic (68,8%) and colposcopy 
clinic (CC) (72,0%) groups compared to the ante-natal clinic (ANC) 
(51,9%) and family planning clinic (FPC) (58,2%) groups. The mean 
parity of the women was 2,1 with a range from 0 to 7. There were no 
significant differences in parity between the groups. 
The majority of the women in the STD group (66,7%) did not use any form 
of contraception compared to 24% of women from the CC group. Parenteral 
TABLE XVIII DATA OF PATIENTS ATTENDING VARIOUS CLINICS 
STD CC ANC FPC 
patients patients patients patients 
n=51 n=50 n=52 n=55 
Age in years 
mean 26,5 31,2 26,4 25,1 
range 18-44 18-52 16-37 16-38 
Marital status 
single 35 36 27 32 
(68,8) (72,0) (51,9) (58,2) 
paying lobola*/ 16 14 25 23 
married (31,2) (28,0) (48,1) (41,8) 
Parity 
mean 1,8 2,4 2,1 2,2 
range 0-7 0-7 0-6 0-7 
Contraception 
no contraception 34 12 NA ° (66,7) (24,0) (0) 
parenteral 15 22 40 
progesterone (29,4) (44,0) (72,7) 
oral contraceptive 2 14 11 





tubal ligation 1 
(2,0) 
No. of sexual partners 
(in the past year) 
mean 1,1 1,1 1,0 1,1 
range 1-2 1-2 1-2 1-2 
(total to date) 
mean 2,5 2,4 2,1 2,1 
range 1-10 1-10 1-7 1-10 




Signifies a commitment to marriage - see text 
Not applicable 



















progesterone was by far the most popular method of contraception. 
Significantly only one woman admitted to the use of condom (barrier 
method) .by the sexual partner. 
There were no differences in the mean number of sexual partners which 
was 1,1 for the past year and 2,3 overall. However, the total number of 
sexual partners per individual woman ranged from 1 to 10. 
CLINICAL CHARACTERISTICS 
4.2.1 Urinary symptoms on enquiry 
4.2.2 
Data relating to urinary symptoms are provided in Table XIX. A total of 
24,0% of women complained of burning on micturition. This was sometimes 
associated with frequency or urgency. 
Vaginal symptoms on enquiry 
Women attending the CC, ANC, FPC and approximately half of those 
attending the STD clinics did not present with a complaint of vaginal 
discharge, however, on specific questioning, 54,8% (Table XX) of women 
admitted to having vaginal discharge which ranged from mild (59,6%) to 
profuse (14,0% ). The colour of the discharge varied from white/grey to 
blood stained. In women who had vaginal discharge an offensive odour 
and pruritis vulvae were associated in only 37,5% and 30,3% 
respectively. 
TABLE XIX URINARY SYMPTOMS ON ENQUIRY 
Burning on 














No % No % 
9 18,0 9 17,3 
5 10,0 8 15,4 





No % No % 
12 21,8 50 24,0 
9 16,4 33 15,9 
4 7,3 13 6,3 
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TABLE XX VAGINAL SYMPTOMS ON ENQUIRY 
STD CC ANC FPC Total 
patients patients patients patients patients 
n=51 n=50 n=52 n=55 n=208 
No % No % No % No % No % 
Vaginal 





mil d 12 35,3 19 67,8 20 83,4 17 60,7 68 59,6 
moderate 14 41,2 8 28,6 2 8,3 6 21,4 30 26,4 
profuse 8 23,5 1 3,6 2 8,3 5 17,9 16 14,0 
Colour of 
discharge* 
white/grey 20 58,8 15 53,6 16 66,7 10 35,7 61 53,5 
yellow 9 26,5 11 39,3 5 20,8 16 57,1 41 36,0 
green 3 8,8 0 0 2 8,3 2 7,2 7 6,1 
blood-stained 2 5,9 2 7,1 1 4,2 0 0 5 4,4 
Odour 28 54,9 17 34,0 14 26,9" 19 34,5 78 37,5 
Pruriti s 28 54,9 15 30,0 9 17,3 11 20,0 63 " 30,3 





The presence of a vaginal discharge was ascertained by the examining 
clinician who reported whether it was present around the introitus with 
pooling in the vaginal fornices. Using these criteria a discharge was 
diagnosed in 95,1% of all women (Table XXI). The graded quantity of the 
discharge ranged from mild in 61,6% of women to profuse in 10,1% of 
women. 
PREVALENCE OF MICRO-ORGANISMS 
4.3.1 Vaginal micro-organisms 
On the basis of positive cultures from vaginal specimens, §. vaginalis 
was isolated from 136/208 (65,4%) women (Table XXII). There were no 
significant differences in isolation among the four groups. The overall 
prevalence of I.. vaginalis was 37,9%; the highest being ANC group 
(51,9%) followed by the STD group (47,0%), CC group (28,0%) and FPC 
group (25,5%). The prevalence of yeasts (37,0%) in the vagina was 
significantly lower than §. vaginal is, with the highest prevalence in 
the ANC group (55,8%). ~. hominis and ~. urealyticum were isolated more 
often from women attending the STD clinic (70,6% and 64,7% 
respectively) and CC clinic (68,0% and 60,0% respectively) than the 
other two groups. Anaerobic bacteria were present in 32,6% of women 
overa 11 • 
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TABLE XXI CLINICAL SIGNS OF ALL WOMEN STUDIED 
STD CC ANC FPC Total 
pa t ients patients patients patients patients 
n=51 n=50 n=52 n=55 n=208 
No % No % No % No % No % 
Presence of 






mild 19 37,3 34 72,3 28 57,1 41 80,4 122 61,6 
moderate 25 49,0 10 21,3 12 24,5 9 17,6 56 28,3 
profuse 7 13,7 3 6,4 9 18,4 1 2,0 20 10,1 

















34 66,6 34 68,0 
24 47,0 14 28,0 
13 25,5 20 40,0 
36 70,6 34 68,0 
33 64,7 30 60,0 




































The endo-cervi ca 1 mi cro-organi sms detected were N. gonorrhoeae, f. 
trachomatis, Herpes simplex virus, ~. hominis and g. urealyticum 
(Table XXIII). ~. gonorrhoeae was isolated from 31,4% patients in the 
STO group followed by ANC (5,8%), FPC (5,5%) and CC (2,0%) groups. 
Overall the prevalence of C. trachomatis was higher than that of~. 
gonorrhoeae, being present in 37,3% of women in the STO group followed 
by CC (20,0%), ANC (19,2%) and FPC (12,7%) groups. Herpes simplex virus 
was isolated only from 2 (3,9%) women in the STO group. These women had 
no vesicular or ulcerative lesions in the genital area on clinical 
examination. Overall M. hominis and U. urealyticum were detected in the 
endocervices of 47,1% and 43,3% women respectively. Cervical 
Papanicolaou stained smears revealed human papilloma virus (HPV) 
infections predominatly in CC patients (26/50; 52%), with only one 
patient each from the STO and ANC groups being infected. 
4.4 PREVALENCE OF BACTERIAL VAGINOSIS 
The women studied were classified into those with and without bacterial 
vaginosis. This classification was based on the presence of any three 
of the criteria proposed by Amsel et al (1983) namely: i) an abnormal --
vaginal discharge, ii) a raised vaginal pH, iii) the presence of amines 
and iv) the presence of "clue" cells on vaginal wet smear microscopy. 
Using these criteria 73 (35,1%) of the women were diagnosed as having 
clinical bacterial vaginosis. The other 135 (64,9%) did not fulfil 
these diagnostic criteria for bacterial vaginosis (Table XXIV). 
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TABLE XXIV PREVALENCE OF BACTERIAL VAGINOSIS 
Bacterial Bacterial 
vaginosis vaginosis 
present not present 
No % No % 
Sexua 11y 





clinic (CC) 18 36,0 32 64,0 
n=50 
Ante-natal 





20 36,4 35 63,6 
n=55 
Total 73 35,1 135 64,9 
n=208 
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4.5 ASSOCIATION OF RECOGNISED GENITAL PATHOGENS WITH BACTERIAL 
VAGINOSIS 
Of the 208 women studied, vaginal infections alone were present in 104 
(50,0%), endo-cervical infections alone in 18 (8,7%) and coexisting 
vaginal and endo-cervical infections in 41 (19,7%). No vaginal or 
endo-cervical infections were detected in 45 (21,6%) women (Fig 2). 
Figure 3 represents all vaginal infections which occurred in a total of 
145 (69,7%) women. In 6 (4,2%) patients all three infections occurred 
(bacterial vaginosis, I. vaginalis and f. albicans) concurrently. Forty 
nine patients had dual infections comprising either bacterial vaginosis 
with I. vaginalis (16,6%); bacterial vaginosis with f. albicans (7,6%) 
and I. vaginal i s with f. albicans (9,7%). 
The micro-organisms found in association with and without bacterial 
vaginosis in the four clinic groups are detailed in Tables XXV (5TO), 
XXVI (CC), XXVII (ANC) and XXVIII (FPC). 
4.5.1 Vaginal infections 
In women with bacterial vaginosis (n=73), !. vag;nalis was 
present in association with bacterial vaginosis in 24 (33,9%). C. 
albicans was associated less frequently occurring alone in 11 (15,1%) 
women and T. vaginalis together with f. albicans was present in 6 
(8,2%) women. Of all the infections, I. vaginalis was found most 








Number without infections = 45 




T. vag inalis c. albicans 
FIGURE 3 : 
Diagram to shown the prevalence of single and 
mixed vaginal infections 
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TABLE XXV VAGINAL AND ENDO-CERVICAL INFECTIONS IN 
-WOMEN ATTENDING THE SEXUALLY TRANSMITTED 
DISEASE CLINIC 
Vaginal infections : 
T. vaginalis 
C. albicans 
T. vaginalis and 
c. albicans 
T. vaginalis and 
c. alb;cans negative 
* Endo-cervical infections 
N. gonorrhoeae 
C. trachomatis 
N. gonorrhoeae and 
c. trachoma ti s 
~. gonorrhoeae and 
Herpes simplex virus 
N. gonorrhoeae, 
c. trachomatis and 
Herpes simplex virus 





















































Alone or in combination with vaginal infections 
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TABLE XXVI VAGINAL AND ENDO-CERVICAL INFECTIONS IN 
WOMEN ATTENDING THE COLPOSCOPY CLINIC 
Bacterial Bacterial 
vaginosis vaginosis 
present not present 
n=18 n=32 
No % No % 
Vaginal infections: 
T. vaginalis 9 50,0 4 12,5 
c. albicans 2 11,1 7 21,9 
T. vaginalis and 
c. albicans 0 0 1 3,1 
T. vaginalis and 
c. albicans negative 7 38,9 4 12,5 
* Endo-cervical infections 
N. gonorrhoeae 0 0 0 0 
c. trachomatis 3 16,7 6 18,8 
N. gonorrhoeae and c. trachomatis 0 0 1 3,1 
No vaginal or endo-
cervical pathogens 16 50,0 
* Alone or in combination with vaginal infections 
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TABLE XXVII VAGINAL AND ENDO-CERVICAL INFECTIONS IN 
~OMEN ATTENDING THE ANTE-NATAL CLINIC 
Bacterial Bacterial 
vaginosis vaginosis 
present not present 
n=13 n=39 
No % No % 
Vaginal infections: 
T. vaginalis 3 23,1 13 33,3 
C. albicans 3 23,1 6 15,4 
T. vaginalis and 
c. albicans 3 23,1 8 20,5 
T. vaginalis and 
c. albicans negative 4 30,7 3 7,7 -
* Endo-cervical infections 
N. gonorrhoeae 0 0 2 5,1 
C. trachomatis 1 7,7 8 20,5 
N. gonorrhoeae and 
c. trachomatis 0 0 1 2,6 
No vaginal or endo-
cervical pathogens 9 23,1 
* Alone or in combination with vaginal infections 
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TABLE XXVIII : VAGINAL AND ENDO-CERVICAL INFECTIONS IN 
WOMEN ATTENDING THE FAMILY PLANNING CLINIC 
Bacterial Bacterial 
vaginosis vaginosis 
present not present 
n=20 n=35 
No % No % 
Vaginal infections: 
T. vaginalis 2 10,0 7 20,0 
c. albicans 3 15,0 4 11 ,4 
T. vaginalis and 
c. albicans 2 10,0 3 8,6 
T. vaginalis and 
Co albicans negative 13 65 _,0 5 14,3 
* Endo-cervical infections 
N. gonorrhoeae 3 15,0 0 0 
c. trachomatis 1 5,0 6 17,1 
N. gonorrhoeae and c. trachoma ti s 0 0 0 0 
No vaginal or endo-
cervical pathogens 16 45,7 
* Alone or in combination with vaginal infections 
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STO and CC clinics. Bacterial vaginosis was diagnosed in the absence of 
T. vaginalis and C. albicans in 32 (43,8%) women. 
In women without bacterial vaginosis (n=135), I. vaginalis alone was 
identified in 35 (25,9%) women and C. albicans alone in 23 (17,0%) 
women. Mixed infections with I. vaginalis and f. albicans occurred in 
14 (10,3%). Of the vaginal infections, I. vaginalis was again the most 
frequent pathogen from women in the STO and ANC clinics. No vaginal 
infections were detected in 18 (13,3%) women. 
4.5.2 Endo-cervical infections 
Of the 41 mixed vaginal and endo-cervical infections (Fig 2), 21 
(51,2%) endo-cervical infections were associated with bacterial 
vaginosis. ~. gonorrhoeae and C. trachomatis were associated with 
bacterial vaginosis in 7 (9,6%) and 9 (12,3%) women respectively. 
Concurrent ~. gonorrhoeae and f. trachomatis infections occurred in 4 
women. In 2 women (Table XXV) bacterial vaginosis was associated with 
Herpes simplex virus and ~. gonorrhoeae and/or f. trachomatis. 
In women without bacterial vaginosis, ~. gonorrhoeae alone was detected 
;n 6 (4,4%) women whereas C. trachomatis alone was detected in 28 
(20,7%) women. 
In a total of 45 women no vaginal or endo-cervical pathogens were 
detected. 
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4.6 ASSOCIATION OF BACTERIAL VAGINOSIS WITH OTHER VAGINAL 
MICRO-ORGANISMS 
The association of §. vaginalis, and other vaginal flora such as !:!. 
hominis, anaerobic bacteria, anaerobic Gram-negative curved rods and 
lactobacilli in women with and without bacterial vaginosis is shown in 
Table XXIX. Although §. vaginalis, !:!. hominis, anaerobic bacteria and 
Gram-negative curved rods were present in women without bacterial 
vaginosis; they were present significantly more often in women with 
bacterial vaginosis (p< 0,05). The absence of lactobacilli on Gram 
stain was significantly associated with bacterial vaginosis (p < 0,05). 
Although lactobacilli were present in vaginal smears of 2 (2,7%) women, 
the density of the organisms was less than that seen when bacterial 
vaginosis was diagnosed (p < 0,05). 
4.7 RELATIONSHIP OF "CLUE" CELLS, POSITIVE AMINE TEST AND RAISED 
VAGINAL pH IN WOMEN WITH BACTERIAL VAGINOSIS AND IN WOMEN WITH 
RECOGNIZED GENITAL INFECTIONS WITHOUT BACTERIAL VAGINOSIS 
These data are presented in Tables XXX and XXXl. "Clue" cells were 
observed in vaginal wet smear preparations in 67/73 (91,8%) women with 
bacterial vaginosis. They were found less often in women without 
bacterial vaginosis (19/135; 14,1%). Amine release was detected in the 
vaginal secretions of 56/73 (76,7%) women with bacterial vaginosis. 







* Presence of 
Gram-negative 
curved rods 
* Presence of 
1 actobaci 11 i 
* 
VAGINAL MICRO-ORGANISMS OF WOMEN WITH 
AND WITHOUT BACTERIAL VAGINOSIS 
Bacterial Bacterial 
vaginosis vaginosis 
present not present 
n=73 n=135 
No % No % p value 
66 90,4 76 56,3 < 0,05 
63 86,3 61 45,2 < 0,05 
46 63,0 22 16,3 < 0,05 
26 35,6 15 11,1 < 0,05 
2 2,7 54 40,0 < 0,05 
Detected on Gram stained smears of vaginal secretions 
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TABLE XXX CORRELATION OF IICLUE II CELLS, POSITIVE AMINE TEST, 
RAISED VAGINAL pH AND PRESENCE OF LACTOBACILLI ON 




. +ve amine 
test 
Vaginal 






Pos iti ve Negative 
No % No % 
67 91,8 6 8,2 
56 76,7 17 23,3 
69 94,5 4 5,5 
2 2,7 71 97,3 
Bacterial vaginosis 
not present n=135 
Positive Negative 
No % No % 
19 14,1 116 85,9 
6 4,4 129 95,6 
47 34,8 88 65,2 








TABLE XXXI VALUE OF LABORATORY CRITERIA FOR THE DIAGNOSIS 
OF BACTERIAL VAGINOSIS (expressed as percentages) 
Sensitivity 
Speci fi c ity 
Predictive value 
of +ve test 
Predictive value 
of -ve test 
IIClue ll cells Positive 




















An increased vaginal pH of ~4,5 was found in 69/73 (94,5%) women with 
bacterial vaginosis, however 47/135; (34,8%) women without bacterial 
vaginosis were also found to have a raised vaginal pH. 
The presence of "clue" cells, positive amine test, vaginal pH of ~4,5 
and the absence of lactobacilli on Gram stain were found to be statis-
tically significant in women with bacterial vaginosis in comparison to 
those without bacterial vaginosis (Table XXX). The sensitivity, 
specificity, predictive value of positive and negative tests of these 
laboratory criteria for the diagnosis of bacterial vaginosis are shown 
in Table XXXI. The detection of clue cells on wet smear microscopy 
showed good sensitivity and specificity overall. Culture for G. 
vaginalis and raised vaginal pH whilst being very sensitive showed poor 
specificity. The positive amine test showed good specificity with low 
sensitivity. 
The above laboratory criteria were also assessed in women with specific 
genital infections (Table XXXII). "Clue" cells, positive amine test and 
vaginal pH ~ 4,5 were found less often in specific genital infections 
caused by yeasts, I. vaginalis and in mixed infections of yeasts and I. 
vaginalis. Q. vaginalis was cultured from vaginal secretions of 31/32 
(96,9%) women with bacterial vaginosis, and significantly less often in 
women with other genital infections (p<O,05). 
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TABLE XXXII CORRELATION OF "CLUE" CELLS, POSITIVE AMINE TEST, 
RAISED VAGINAL pH AND PRESENCE OF LACTOBACILLI ON 
GRAM STAIN IN WOMEN WITH SPECIFIC GENITAL INFECTIONS 
+ve +ve Vaginal §. vaginalis Lacto-
"clue" amine pH~4,5 culture +ve bacilli 
cells test on Gram 
stain 
No % No % No % No % No % 
Bacterial 












Od 1h 3*1 23,0 7t I. vaginalis 0 7,7 8P 61,5 53,8 
infections 
n=13 
* The other 10 women had a vaginal pH of 4,0 
a vs. b p < 0,05 i vs. j P < 0,05 q vs. rp<0,05 
a vs. c p < 0,05 i vs. k P <0,05 q vs. s P <0,05 
a vs. d p < 0,05 i vs. 1 p <0,05 q vs. tp<O,05 
e vs. f p < 0,05 m vs. n p < 0,05 
e vs. g p < 0,05 m vs. 0 p < 0,05 
e vs. h p < 0,05 m vs. p p < 0,05 
• 
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4.8 CULTURE OF GARDNERELLA VAGINALIS 
Vaginal secretions inoculated directly onto human blood (HB) and horse 
blood (BA) agar were examined after 48 hours incubation at 37°C. The 
use of selective and non-selective media enabled the assessment of G. 
vaginalis in relation to the total aerobic genital flora and the 
characteristic diffuse beta-haemolysis exhibited on HB agar aided in 
the rapid presumptive identification of this organism. 
The density of the .§.. vaginalis of HB agar was graded from 1+ to 3+ 
(Table XXXIII) . .§.. vaginalis was isolated from direct culture from 
136/208 (65,4%) women. In comparison the organism was isolated from 
subcultures from modified Cary-Blair transport media (CB) in 121/208 
(58,2%) women and from subcultures from modified Stuart transport media 
(ST) in 107/208 (51,4%) women. 
A density grade of 3+ was recorded more often from the direct culture 
method (115/136; 84,5%) and from CB media (89/121; 73,6%) compared to 
ST media which yielded a 3+ density in only 54/107 (50,5%). A density 
of 1+ growth of §. vaginalis was found more often in subcultures of ST 
media and the aerobic vaginal flora frequently overgrew that of the .§.. 
vaginal is. If a selective medium had not been used this overgrowth 
would have masked the.§.. vaginalis organisms resulting in a further 
reducti on in recovery. Thi s problem of overgrowth was not seen with 
subcultures from CB transport media, the aerobic growth and G. 
vaginalis growth corresponded more closely to that of directly plated 
TABLE XXXIII COMPARISON OF DIRECT PLATING METHOD VERSUS 
TRANSPORT MEDIA FOR THE RECOVERY OF 
GARDNERELLA VAGINALIS FROM VAGINAL SPECIMENS 
Density of Growth Direct Cary-Blair Stuart 
r 
*1+ 7 12 38 
* 2+ 14 20 15 
* 3+ 115 89 54 
Total +ve culture 136a 121b 107c 
Negative culture 72 87 101 
* 1+ Growth along the initial inoculum only 
* 2+ Growth along the initial inoculum and 
along the first line of plate out 
* 3+ Growth along the initial inoculum and 
through to the third line of plate out 
a vs. b p = 0,16 
b vs. c p = 0,20 
a vs. c p<0,05 
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media. The recovery of §.. vaginalis was significantly lower from ST 
media than .from the direct plating method (p < 0,05). 
4.9 DISTRIBUTION AND FREQUENCY OF BIOTYPES OF GARDNERELLA VAGINALIS 
The biochemical tests used in the biotyping scheme were those described 
by Piot et ~ (1984). 
The distribution of the eight biotypes among §.. vaginalis isolates is 
shown in Table XXXIV. The most common biotypes encountered we~e types 
1, 2 and 5. Biotype 1 was encountered most frequently (42,2% overall) 
from vaginal, urethral and urine isolates, followed by type 5 (22,2%) 
and type 2 (11,4%). Biotypes 3, 4, 7 and 8 accounted for 5,4%, 7,0%, 
9,6% and 2,2% of the strains respectively. Biotype 6 was not encoun-
tered amongst strains from the vagina, urethra and urine. From the 
urine isolates biotype 2 was not encountered. 
The distribution of the biotypes of vaginal isolates from women with 
and without bacterial vaginosis was similar. (Table XXXV). Biotype 1 
was predominant in both groups followed by type 5 and type 2. Biotypes 
1 and 5 were present significantly more often in women with bacterial 
vaginosis than in those without (p< 0,05). The slight differences in 
the distribution of the other biotypes between the two groups were not 
statistically significant. 
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TABLE XXXIV B·IOTYPES OF GARDNERELLA VAGINALIS 
S i t e 
Biotype Vagina Urethra Urine Total 
No % No % No % No % 
1 43 43 ,0 29 40,3 6 46,2 78 42,2 
2 11 11 ,0 10 13.,9 0 0 21 11,4 
3 6 6,0 2 2,8 2 15,4 10 5,4 
4 7 7,0 4 5,6 2 15,4 13 7,0 
5 22 22,0 18 25,0 1 7,6 41 22,2 
6 0 0 0 0 0 0 0 0 
7 10 10,0 6 8,2 2 15,4 18 9,6 
8 1 1,0 3 4,2 0 0 4 2,2 

















PREVALENCE OF BIOTYPES OF GARDNERELLA 
VAGINALIS OF VAGINAL ORIGIN IN WOMEN 
WITH AND WITHOUT BACTERIAL VAGINOSIS 
Bacterial Bacterial Total 
vaginosis vaginosis 
present not present 
n=73 n=135 n=208 
No % No % No 
24 32,9a 19 14,lb 43 
2 2,7 9 6,6 11 
1 1,3 5 3,7 6 
5 6,8 2 1,5 7 
12 16,4c 10 7,4d 22 
0 0 0 0 0 
6 8,2 4 2,9 10 
1 1,3 0 0 1 
51 69,9 49 35,3 100 
15 20,5 27 20,0 42 
7 9,6 59 43,7 66 
73 100 135 100 208 
a vs b p < 0,05 
















4.10 DISTRIBUTION AND FREQUENCY OF SEROTYPES OF GARDNERELLA VAGINALIS 
The serotyping scheme used, identified a total of 27 serotypes. Tables 
XXXVI and XXXVII show the distribution of serotypes from vaginal and 
urethral isolates of ~. vaginalis. Serotypes 125 and 25 were seen more 
frequently in both vaginal and urethral strains. A wide range of other 
serotypes - each in small numbers were identified. Only 7% of strains 
overall could not be typed with available antisera. The distribution of 
serotypes of ~. vaginalis isolated from women with and without 
bacterial vaginosis were similar. The analysis of 50 strains in each 
group is shown i n Table XXXVIII. 
4.11 ANTIMICROB IAL SUSCEPTIBILITY OF GARDNERELLA VAGINALIS 
The MICs, MIC ranges, MIC50s and MIC90s of the 93 vaginal strains of ~. 
vaginalis tested are shown in Table XXXIX. The cumulative percentages 
of strains inhibited at each concentration for the various 
antimicrobial agents tested are shown in Figures 4 to 9. 
All strains were susceptible to penicillin (MIC90:0,5mg/L), ampicillin 
(MIC90:0,5mg/L), erythromycin (MIC90:0,06mg/L), clindamycin 
(MIC90:0,03mg/L), vancomycin UlIC90:0,5mg/L) and chloramphenicol 
(MIC90:2,Omg/L). 
LY 146032, a cyclic lipopeptide antibiotic, which has excellent activ-
ity against Gram-positive organisms showed limited activity against 
these strains (MIC90:8,Omg/L). 
TABLE XXXVI DISTRIBUTION OF SEROTYPES OF 































































TABLE XXXVII : DISTRIBUTION OF SEROTYPES OF 

























































TABLE XXXVII I :" DISTRIBUTION OF SEROTYPES OF 
GARDNERELLA VAGINALIS AMONG 




Present Not present 
Serotype Frequency Frequency 
Non-typab le 3 4 
1 2 3 
12 3 0 
123 1 0 
1235 3 2 
1235C 0 3 
123C 0 1 
125 7 4 
125C 4 2 
13 1 0 
135 1 3 
135C 3 5 
13C 1 1 
15C 0 1 
lC 1 3 
2 3 0 
235 2 0 
235C 0 a 
23C 1 a 
25 5 6 
25C 3 1 
2C a 1 
3 1 3 
35 2 a 
35C 0 2 
3C 1 0 
5 1 0 
C 1 3 

































TABLE XXXIX IN VITRO SUSCEPTIBILITY OF 93 STRAINS OF GARDNERELLA VAGINALIS TO 25 ANTIMICROBIAL AGENTS 
Number of isolates with MIC's (mg/L) of : 
Antimicrobial agents 0,007 0,015 \ 0,03 \ 0,06 0, 12 0,25 0,5 1 , ° 2,0 4,0 8,0 16,0 32,0 64,0 128,0 \ MIC50 MIC90 
(mg/L) (mg/L) 
Metronidazole 4 36 34 14 3 1 8,0 16,0 
2-Hydroxymetabolite* 14 16 33 19 2 3 5 1 1 , ° 4,0 
Tinidazole 3 11 32 36 10 ° ° 1 8,0 8,0 Penicillin G 2 25 13 12 24 17 0,12 0,5 
Ampi ci 11 in 5 18 8 14 43 5 0,5 0,5 
Cefamandole 2 18 6 28 39 1 , ° 2,0 
Cefox it in 2 7 ". 7 16 21 30 10 1 , ° 4,0 
Cefuroxime 2 9 7 22 15 25 13 1 , ° 4,0 
.' Cefotaxime 12 20 9 45 7 2,0 2,0 
Ceftriaxone 8 10 9 25 28 12 1 0,5 2,0 
Aztreonam 3 9 9 72 32,0 32,0 
Imipenem 8 10 35 10 30 0,25 1 , ° 
Tetracycline 34 5 I 45 9 64,0 64,0 
Mi nocyc 1 i ne 2 13 18 17 8 33 2,0 16,0 
Erythromyci n 16 28 33 16 0,03 0,06 
Clindamycin 21 42 29 0,01 0,03 
Vancomycin 8 42 43 0,25 0,5 
LY 146032 3 19 32 22 17 4,0 8,0 
Chloramphenicol 7 71 15 1 , ° 2,0 
Amikacin 3 7 11 43 20 12 32,0 128,0 
Rifampicin 14 42 37 1 , ° 2,0 
Ciprofloxacin 72 17 3 1 , ° 2,0 
Sulphamethoxazole 93 128,0 128,0 
Trimethoprim 6 21 55 11 2,0 4,0 
Co-trimoxazole** 2 8 I 11 71 64,0 64,0 
* 2-Hydroxymetabolite of metronidazole ([1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole]) 
** Sulphamethoxazole/trimethoprim in 19:1 ratio 
MIC50 - minimal inhibitory concentration at which 50% of isolates were inhibited 
MIC90 - minimal inhibitory concentration at which 90% of isolates were inhibited 
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FIGURE 4 : 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vaginalis to erythromycin, clindamycin, 
vancomycin, rifampicin and LV 146032 
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FIGURE 5 : 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vaginalis to penicillin G, ampicillin, 
tetracycline and minocycline 
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MIC (mg/I) 
-- Metronlda.,le -+- Tlnldazole 
--- 2- Hydroxymetaboll te 
FIGURE 6 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vaginalis to metronidazole, tinidazole 
and 2-hydroxymetabolite of metronidazole 
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FIGURE 7 : 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vaginalis to cefamandole, cefuroxime and 
cefoxitin 
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FIGURE 8 : 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vaginalis to cefotaxime, ceftriaxone , 
ciprofl oxacin , imipenem and aztreonam 
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• Sulphamethoxal.Ole 
FIGURE 9 : 
Cumulative % minimum inhibitory concentrations for 
Gardnerella vag i nalis to trimethoprim, sulphamethoxa-
zole, cotrimoxazole, amikacin and chloramphenicol 
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Tetracycline MICs were bimodal in distribution with many strains having 
an MIC of 2,0 to 4,Omg/L, whilst the majority of the strains had MICs 
of 64mg/L or more. More strains were sensitive to minocycline, although 
there was some resistance to minocycline with 33 (35,5%) of the iso-
1 ates havi ng an MIC of 16,Omg/L. The MICs for metronidazol e were 
variable and paralleled those for tinidazole. The hydroxymetabolite of 
metronidazole was more active than both the parent compound and tini-
dazole, with MICs being at least two dilutions less than those for 
metronidazole (Fig 7). One strain which showed marked resistance to 
metronidazole (MIC = 128,Omg/L) was also resistant to tinidazole 
(MIC = 128,Omg/L) and the hydroxymetabolite (MIC = 128,Omg/L). 
All strains were susceptible to the cephalosporins tested. No indivi-
dual cephalosporin was found to be superior (Fig 8). For cefoxitin and 
cefuroxime the MIC90s were 4,Omg/L, whereas for cefamandole, cefotaxime 
and ceftriaxione these were 2,Omg/L. 
Ciprofloxacin had an MIC90 of 2,Omg/L and imipenem an MIC90 of 1,Omg/L 
(Fig 9). All strains were susceptible to trimethoprim and resistant to 
sulphamethoxazole, and the combination of these two did not demonstrate 
any synergistic activity on the strains tested. Resistance to aztreonam 
and amikacin was marked with MIC90s of 32,Omg/L and 128,Omg/L 
respectively. 
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4.12 VAGINAL YEASTS 
Vaginal yeasts were cultured from 77/208 (37%) women (Table XL). Of 
these, f. albicans was the commonest isolate (55/77 ; 70,1%)). Four of 
these were present together with f. lipolytica, f. krusei and/or I. 
glabrata. I. glabrata alone was present in 12 (15,8%) women. Other 
strains were also encountered infrequently 
4.13 VAGINAL TR ICHOMONIASIS 
I. vaginalis was deteCted in 79 (37,9%) vaginal specimens, either by 
wet smear microscopy or by culture in modified Diamond's medium. Wet 
smears and cultures were positive in 60 and 77 women respectively. 
Motile trichomonads were detected in wet smears of 2 women in whom 
cultures were negative. In an additional 19 women the organism was 
detected by culture only (Table XLI). 
4.14 ASSOCIATION OF SEXUALLY TRANSMITTED PATHOGENS IN WOMEN WITH 
CERVICAL INTRA-EPITHELIAL NEOPLASIA (CIN) 
The prevalence of the human papilloma virus (HPV) and cervical 
intra-epithelial neoplasia (CIN) in women attending the different 
clinics is shown in Table XLII. In the ec group, HPV was detected in 26 
(52%) and eIN in 28 (56%) women by colposcopic examination and 
histology of biopsied specimens. 
TABLE XL 
* 
YEASTS ISOLATED FROM THE VAGINA 
Yeast No % 
* c. albicans 54 70,1 -
T. glabrata 12 15,6 
S. cerevisiae 5 6,5 
T. maris 1 1,3 -
c. lipolytica 1 1,3 
c. tropicalis 1 1,3 
c. gui 11 i ermondi i 1 1,3 -
c. paratropicalis 1 1,3 
c. parapsilosis 1 1,3 
TOTAL 77 100 
4 cultures were mixed with either 
f. lipolytica, f. krusei or 
I. glabrata 
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TABLE XLI WET SMEAR MICROSCOPY AND CULTURE FOR THE DIAGNOSIS 
OF TRICHOMONAS VAGINALISINFECTION IN ALL WOMEN 
(n=208) 
Total number of patients 
positive by either wet smear 
microscopy and/or culture · 
Positive wet smear microscopy 
and culture 
Positive wet smear microscopy 
only 
Positive culture only 
Total number of patients 
negative by either wet smear 
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The distribution of various sexually transmitted pathogens in women 
with and .without eIN attending ee clinic is shown in Table XLIII. 
Bacterial vaginosis was found significantly more often in women with 
CIN than in those without CIN (p=O,04). With regard to other agents, 
prevalences were similar for both groups. 
4.15 . SEROLOGICAL RESULTS 
The results of the serological tests performed on patients' sera are 
shown in Table XLIV. In a total of 47 (22,6%) women, there was evidence 
of reactive syphilis serology which was confirmed by specific 
treponemal tes t s; the Treponema pallidum haemagglutination test (TPHA) 
and fluorescen t treponemal antibody absorption test (FTA-Abs). In an 
additional 35 (16,8%) women, either the TPHA and/or FTA-Abs tests were 
positive, suggesting past exposure to syphilis. 
Hepatitis B surface antigen (HBsAg) was detected in 16 (7,7%) women 
with the majority (9/52; 17,3%) in pregnant women. 
Antibody to human immunodeficiency virus (HIV) was detected in 4 women 
attending the ec clinic, and not in any of the women from the other 
clinics. However, these 4 women were known HIV antibody positive, 
detected on routine screening of blood donors by the Natal Blood 
Transfus i on Service and were referred to the ee cl ini c for 
colposcopic examination. 
TABLE XLIII ASSOCIATION OF SEXUALLY TRANSMITTED 
PATHOGENS/INFECTIONS IN WOMEN WITH 
AND WITHOUT CERVICAL lNTRA-EPITHELIAL 
NEOPLASIA (CIN) 
CIN NON CIN 
n=28 n=22 
No % No % 
N. gonorrhoeae 1 3,6 1* 4,5 
C. trachomatis 6 21,4 5 22,7 
Human papilloma virus 13 46,4 13 59,1 
G. vaginalis 20 71 ,4 14 63,6 
T. vaginalis - lla 39,3 3
b 13,6 
C. al bicans 7 25,0 9 40,9 
M. hominis 18 64,3 16 72,7 
U. ureal,lticum 15 53,6 15 68,2 
Bacterial vaginosis 14c 50,0 4d 18,2 
* Rectal isolate only 
a vs. b p = 0,09 
c vs. d P = 0,04 
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RPR 15 29,4 
Tota 1 number of 
women with 27 52,9 
specific tests* 
positive 
HBsAg 1 1,9 
positive 
HIV antibody 0 0 
positive 
CC ANC 
patients . patients 
n=50 n=52 
No % No % 
6 12,0 14 26,9 
15 30,0 22 42,3 
2 4,0 9 17,3 
4 8,0 o 0 


















* Treponema pallidum haemagglutination (TPHA) test and/or 
Fluorescent treponemal antibody absorption test (FTA-Abs) 
HBsAg Hepatitis B surface antigen 
HIV Human immunodeficiency virus 
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5.0 DISCUSSION 
Vaginal discharge is a common clinical condition and is one of the most 
frequent problems encountered in clinical practice. The aetiology of 
vaginal infections in sexually active women is attributed to 
trichomoniasis, candidiasis and the recently recognised syndrome of 
bacterial vaginosis. The pathogenesis of bacterial vaginosis in 
particular, has received considerable attention and G. vaginalis has 
been implicated as an important aetiological agent. 
Studies conducted in developed communities have shown the increasing' 
-
importance of bacterial vaginosis (Fleury 1981). However, local studies 
in developing communities have been few (Fehler et ~, 1984; Pochee et 
I 
~, 1986) and not much information on the incriminating organism is 
available. 
In this study, the age distribution of all women recruited at the four 
clinics was similar, however, women attending the colposcopy (CC) 
clinic were slightly older (mean age of 31,2 years). The prevalence of 
sexually transmitted pathogens was high (Tables XXII and XXIII). These 
findings were probably due to the fact that all women were sexually 
active and unmarried with multiple lifetime sexual partners. 
Pelvic inflammatory disease and vaginal discharge have been associated 
with the use of intra-uterine contraceptive devices (IUD ,). Bacterial 
vaginosis specifically, has been associated with the use of IUD I s 
(Amsel et ~, 1983) and oral contraception (McCormack, 1977). In this 
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study only 4 and 27 women used an IU D or oral contraceptive 
respectively. As the preferred method of contraception was parenteral 
progesterone, IU~ I S and oral contraception could not be evaluated as 
possible predisposing factors. The paucity of use of barrier methods of 
contraception may have played a role in the common occurrence of 
vaginal infections. 
The maj~rity of the women in this study did not attend with a 
presenting complaint of vaginal discharge; however, on direct enquiry 
54,8% of women admitted to the presence of a discharge. Many considered 
it to be part of their "normal" status; in particular, women attending 
the ante-natal clinic (ANC) considered the increased discharge to be 
normal for pregnancy, thus failing to seek medical advice. The colour 
and odour of the discharge was difficult to assess. On clinical 
examination vaginal discharge was present in 95,1% of women. 
Of the 208 women examined, a vaginal and/or endo-cervical infection was 
diagnosed in 163 (78,4%). A total of 104 (50%) women had vaginal 
infection only, 18 (8,6%) had an endo-cervical infection only, with 41 
(19,7%) having concurrent vaginal and endo-cervical infections. In only 
45 (21,6%) women, no recognised genital pathogens were detected. These 
figures are somewhat disturbing as the majority of women did not attend 
with a presenting complaint of vaginal discharge. Furthermore, the 
impact of this high prevalence of lower genital tract infections on the 
outcome of pregnancy and future fertility is not known. In view of 
this, it would be important that future studies be directed to 
determine the long-term consequences of these infections. 
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The endo-cerv i ca 1 pathogens detec ted were N. gonorrhoeae, C. 
trachomatis, Herpes simplex virus and the human papilloma virs (HPV). 
~. gonorrhoeae was cultured from 11,1% of women overall. The prevalence 
of 31,4% among the STD patients is higher than the 26,0% recorded in 
Nairobi by Mirza et ~ (1983) and much higher than the 14% and 18% 
recorded by Fehler et ~ (1984) and Petersen et ~ (1986) respectively, 
in southern Africa. ~. gonorrhoeae isolation among ANC and FPC patients 
was lower, being cultured from 5,5% and 5,8% respectively. This 
prevalence in pregnant women is similar to that shown by O'Farrell et 
~ (1989) who reported 5,7% in women attending a rural ante-natal 
clinic but lower than that reported by Hoosen et ~ (1981) who found a 
prevalence of 9% in pregnant women with a vaginal discharge and 10% in 
randomly selected pregnant women attending an urban ante-natal clinic. 
The overall prevalence of f. trachomatis (22,1%) was higher than that 
of N. gonorrhoeae. The highest prevalence being recorded in the STD 
group (37,3%). A prevalence of only 7% was found among STD cl inic 
attenders in Nairobi (Mirza et ~, 1983). South African studies have 
shown prevalences of 14% and 18% (Feh 1 er et ~, 1984; Pochee et ~, 
1986). The prevalence of chlamydial infections in the ANC and FPC 
groups was 19,2% and 12,7% respectively. It appears that both C. 
trachomatis and N. gonorrhoeae are important pathogens locally. 
N. gonorrhoeae , however, appears to be the dominant aetiological agent 
in symptomatic patients. In the asymptomatic patients, ie those 
attending the ANC, FPC and CC clinics, f. trachomatis was found more 
frequently than ~. gonorrhoeae, suggesting a role for this organism in 
subacute and/or latent infections. 
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The isolation of the Herpes simplex virus from the endo-cervices of two 
STD clinic .patients who had no vesicular or ulcerative lesions of the 
genitalia confirms the asymptomatic shedding of the virus in high risk 
patients (Miller, 1985). 
Vaginal trichomoniasis diagnosed in 37,9% of women in this study is 
much higher than that shown in asymptomatic (Willcox, 1960) and 
symptomatic (Fleury, 1981) women in developed communities. It was 
present in 51,9% of ANC, 47,0% of STD, 28,0% of CC and 25,5% of FPC 
patients. South African studies have shown 25% of urban · black women 
• I 
(Fehler et ~, 1984) and 49% of unselected ante-natal clinic attenders 
(Hoosenet ~, 1981; O'Farrell et ~, 1989) to harbour the organism. A 
preva 1 ence of 51,9% among pregnant women is much hi gher than that of 
the studies mentioned above. This finding confirms the high incidence 
of this pathogen in pregnant African patients. Although vaginal 
trichomoniasis has not been associated with adverse perinatal outcome, 
it has been linked to low birth weight (Ross, 1982). 
As regards the laboratory diagnosis of trichomoniasis, microscopic 
observation of the motile protozoa in vaginal secretions mixed with 
saline is widely used. This method requires minimal equipment and is 
specific for the diagnos~s of trichomoniasis. However, since the 
protozoa are sensitive to cold and tend to lose their distinctive 
motility rapidly on cooling, facilities for microscopy and experienced 
personnel should be readily available to perform microscopic 
examinations without delay on site in the clinic settings. As the 
sensitivity of the wet smear examination is considered to be relatively 
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low by some (Krieger et !l, 1988), culture is also advocated and is 
considered .by some workers, to be the standard for the diagnosis of T. 
vaginalis (Diamond, 1957). 
In this study modified Diamond's medium was used for the culture of T. 
vaginal is. In view of relatively high prevalence of 
gentamicin-resistance in Gram-negative bacteria at KEH, the Diamond's 
medium was modified by replacing streptomycin and penicillin with 
amikacin, ampicillin and amphotericin B. These antimicrobial agents 
suppress the growth of vaginal Gram-negative and positive bacteria, and 
yeasts without inhibiting the growth and motility of I. vaginal is. 
Using the culture as a standard for diagnosis, I. vaginalis infections 
were diagnosed in 77 women, of these 58 were also diagnosed on wet 
smear microscopy. The sensitivity of the culture method was 97% and 
that of the wet smear microscopy 75%. No individual test detected all 
positive patients, however when both tests were used in combination, 
this substantially improved the accuracy of the diagnosis of patients 
infected with T. vaginalis (79/208; 37,9%). 
Although culture improved the diagnosis, there are limitations in that 
culture requires at least 1 to 7 days incubation. In one woman the 
culture was positive on day 3 and in three women culture was positive 
on day 7. If patients are asymptomatic, negative on wet smear 
microscopy and positive on culture only, it would take at least one 
repeat visit to the clinic for appropriate treatment. During this 
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period, they may remain sexually active and may not return for 
trea tment a.t all .. 
The prevalence of genital yeasts was 37,0% overall, with 55,8% in ANC, 
40,0% in CC, 27,2% in FPC and 25,5% in the patients attending the STD 
cl inic. The results of the STD and FPC patients are similar to those 
obtained by Mirza et ~ (1983) and Fehler et ~ (1984). However, the 
prevalence 55,8% for the ANC patients is higher than the 23% and 27% 
reported by Hoosen et a 1 (1981) and 0 I Farre 11 et a 1 (1989) 
respectively. As expected the prevalence of yeast in these pregnant 
women was much higher than the prevalence in other clinics. The 
commonest yeast isolated in all four groups was f. albicans {70,1%), 
followed by I. glabrata (15,6%). Yeasts other than C. albicans and T. 
glabrata were present in 14,3% of women. 
The genital mycoplasmas, especially t!. hominis, have been associated 
with vaginal infections. ~. urealyticum was present in 48,1% and 43,3% 
and ~. hominis in 59,6% and 47,1% of vaginal and endo-cervical 
specimens respectively. Factors which may contribute to the high 
colonisation rates of M. hominis in this study, may be related to 
sexual experience with multiple lifetime partners and the use of no or 
non-barrier methods of contraception (McCormack et~, 1986). 
With the use of sensitive culture media, §. vaginalis has been isolated 
from women with and without vaginal infections. In this study it was 
cultured from vaginal specimens of a total of 136/208 (65,4%) women. It 
was most commonly found in the FPC patients (72,6%), whilst in the STD 
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patients it was present in 66,6%. Similarly, Fehler et !! (1984) in 
Johannesburg i so 1 a ted ~. vagi na 1 is from 55% and 47% of FPC and STD 
patients respectively. 
With regard to the association of G. vaginalis with bacterial 
vaginosis, in this study it was cultured from 66/73 (90,4%) women with 
bacterial vagi nosis. In another South African study in symptomatic 
Black women at t ending a general practice, Pochee et !! (198~ made a 
diagnosis of bacterial vaginosis in 61%. However, they did not culture 
for the organism. 
The criteria for diagnosing bacterial vaginosis as proposed by Amsel et 
!! (1983) are well accepted. These criteria do not exclude other 
infections and there is no clear distinction between bacterial 
vaginosis based on the accepted criteria and a clinical diagnosis of 
bacterial vagi nosis which excludes recognised pathogens such as T. 
vaginal is, f. albicans, ~. gonorrhoeae and C. trachomatis. Many 
researchers have diagnosed bacterial vaginosis in the absence of these 
recognised pathogens (Spiegel et !!, 1980; Krohn et !!, 1989), whereas 
others have reported the occurrence of these pathogens in the presence 
of bacterial vaginosis. Hallen et ~ (1987) found bacterial vaginosis 
in association with C. albicans (8%), f. trachomatis (57%), I. 
vaginalis (71%) and ~. gonorrhoeae (78%). In this study bacterial 
vaginosis was associated wit T. vaginalis (75,0%), f. albicans 
( . ~ 
(34,4%), f. trachomatis (17,8%) and ~. gonorrhoeae (16,4%). It is 
important that Amsel's criteria be assessed not only in respect of 
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bacterial vaginosis alone, but also in the context of concurrent 
infections. 
With regard to vaginal infections in developed corrmunities bacterial 
vaginosis is reported as occurring more commonly than I. vaginalis and 
C. albicans (Fleury, 1981), whereas in this study I. vaginalis was 
found more frequently than bacterial vaginosis or C. albicans. In this 
respect I. vaginalis appears to be the most important cause of vaginal 
discharge locally. 
Cervical intra-epithelial neoplasia (CIN) has been considered to behave 
as a sexually transmitted disease. Single or multiple microbial 
aetiologies have been implicated in the initiation of CIN. These are 
usually acquired through coitus at an early age or through multiple 
sexual partners (Guijon et ~, 1985). This study also looked at 
infections in women who presented to the CC cl inic for follow-up of 
abnormal cervical cytology (Table XLIII). Of the various 
micro-organisms detected in this group of patients, there were no 
significant differences between those isolated from women with and 
without CIN. However, as regards the syndrome of bacterial vaginosis, 
this was associated more often in women with CIN than in those without 
CIN. No correlations were made of the colposcopic patterns of the 
uterine cervix with any specific type of microbial pathogen which may 
have been present. 
§. vaginalis together with ~. hominis, anaerobic bacteria and anaerobic 
Gram-negative curved rods (Mobiluncus species) have been implicated in 
173 
the pathogenesis of bacterial vaginosi's. However, these organisms may 
also be present as normal flora in women without bacterial vaginosis 
(McCormack et ~, 1977; Levison et ~, 1978; Ison et ~, 1982). It has 
been suggested by Osborne et ~ (1982) that a combination of host and 
microbial factors could initiate the development of signs and symptoms 
of bacterial vaginosis or the presence of these organisms may be 
transient. The results of this study also confirm the close association 
of these micro-organisms with bacterial vaginosis. §.. vaginalis was 
present significantly more often with bacterial vaginosis than without 
(90,4% vs 56,3%; p< O,Og\. Likewise ~. hominis (86,3% vs 45,2%; 
p < 0,05), anaerobic bacteria (63,0% vs 16,3%; p < 0,05) and anaerobic 
Gram-negative curved rods (Mobiluncus species) (35,6% vs 11,1%; 
p < 0,051 were also present significantly more often in women with 
bacterial vaginosis. Similar findings have been reported by Pheifer et 
~ (1978); Spiegel et ~ (1980) and Amsel et ~ (1983). 
The application, at the bedside, of simple laboratory techniques such 
as estimation of vaginal pH, the detection of amines and the 
microscopic examination of vaginal wet smears can be used for the 
diagnosis of vaginal infections. 
In this study, a vaginal pH of ~ 4,5 was found in 80,0% of women with 
bacterial vaginosis, howeve~ a raised pH was also found in women with 
trichomoniasis (62,9%). The vaginal pH, whilst having the highest 
sensitivity, had a low specificity for the diagnosis of bacterial 
vaginosis. The predictive value for a positive diagnosis was only 
59,4%, but the predictive value for a negative test was 95,7%. 
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Furthermore, in only 3 of the 13 women with concurrent trichomonas and 
candida vag.initis the pH was > 4,5; in the remaining 10 women the pH 
was 4,0, thus decreasing the reliability of the pH in women with mixed 
infections. If only vaginal pH were to be used as an aid to rapid 
diagnosis, these infections would not have been recognised since they 
were within normal vaginal pH values. 
The amine test was positive in 76,7% of women, and showed a high 
specificity of 95,5%. These data support the findings of Pheifer et ~ 
(1978) and Chen et ~ (1979) as to the usefulness of this test in 
predicting the clinical diagnosis of bacterial vaginosis. This test 
serves as a useful adjunct to microscopy in making a bedside diagnosis 
of bacterial vaginosis. 
Using the vaginal wet smear preparation, "clue" cells were observed in 
91,8% of women with bacterial vaginosis. "Clue" cells were found 
significantly less often in yeast infections (25,7%) and trichomoniasis 
(2,9%). The presence of "clue" cells in women with bacterial vaginosis 
had a sensitivity of 91,7% and a specificity of 85,9%. The predictive 
value for a positive test was 77 ,9% and that of a negative test was 
95,1%. Of all the rapid tests the presence of "clue" cells was most 
closely associated with the diagnosis of bacterial vaginosis. 
Blackwell and Barlow (1984) suggest that .the presence of "clue" cells 
should be confirmed by microscopic examination of Gram stained smears 
of vaginal secretions. In this study, the Gram stain assisted in 
interpreting changes in vaginal flora, (ie from lactobacilli to mixed 
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type, the presence of gardnerellae and the presence of curved 
Gram-negative rods). However, the Gram stain was found to be unreliable 
for the detection of "clue" cells. "Clue" cells were easily seen on 
Gram stained smears only when the technique of using a Pasteur pipette 
to place a drop of saline suspension of vaginal secretions on a glass 
slide was employed. When smears were prepared using a swab, "clue" 
cells were not seen at all. It is suggested that when applying such 
swab specimens, may result in distortion and damage of cells. 
Dunkelberg (1967) and Spiegel et ~ (1983) and more recently Eschenbach 
et ~ (1988) have suggested, the use of the Gram stain for the detection 
of changed/altered vaginal flora, rather than for the confirmation of 
the presence of "clue" cells. 
Mobiluncus spp are fastidious anaerobic bacteria and are difficult to 
culture from vaginal secretions. These organisms appear as curved 
Gram-negative rods on Gram stained smears and their presence was 
assessed on smears only. These were observed in vaginal smears of 35,6% 
of women with and 11,1% of women without bacterial vaginosis 
(p < 0,05). Although several reports have appeared on the presence of 
Gram-negative curved rods in vaginal secretions implicated in bacterial 
vaginosis (Hjelm et ~, 1981; Sprott et ~, 1982; Phillips and Taylor, 
1982; Skarin and Mardh, 1982; Thomason et ~, 1984), the pathogenic 
role of these organisms is uncertain. It has been suggested that they 
may be present in a symbiotic relationship with §. vaginal is, anaerobic 
bacteria and ~. hominis to produce symptoms of bacterial vaginosis. 
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Another technique used for the rapid diagnosis of bacterial vaginosis 
has been gas liquid chromatography (GLC). The GLC has been suggested to 
be a reliable indicator of infection as it detects short chain fatty 
acids, which result from biochemical changes occurring in bacterial 
vaginosis. 
It is relevant to note that Spiegel et ~ (1980) first reported on the 
use of GLC for direct analysis of vaginal secretions for bacterial 
vaginosis. Since then, Ison et ~ (1983) and Hill et ~ (1985) have 
confirmed GLC to be a reliable indicator of bacterial vaginosis. 
However, Ison et ~ (1983) also found it to be significantly positive 
in women with gonorrhoea (82%) and trichomoniasis (69%), thus reducing 
its reliability. Krohn et ~ (1989) found that approximately 30% of 
specimens analysed were not interpretable and concluded that a positive 
test by this method had a poor predictive value (48%). 
GLC was performed initially on vaginal secretions of women attending 
the STO clinic. The succinate lactate (S/L) ratio was increased in 
77,0% of women with bacterial vaginosis and in 48,2% without bacterial 
vaginosis. The limitations of this technique are that equipment is 
available only at large central laboratories and requires skilled 
personnel. As this pilot study revealed no advantage with this 
technique in distinguishing between bacterial vaginosis and 
non-bacterial vaginosis groups, and in view of the restricted 
availability of GLC as a routine diagnostic technique, the test was not 
pursued further in this study. 
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The laboratory media for the culture of §. vaginalis used in most 
studies have i ncluded either human blood agar without antibiotics 
(Greenwood and Pickett, 1977) or human blood bilayer medium containing 
colistin, nali dixic acid and amphotericin B (Totten et~, 1982). In 
this study excellent results were obtained using human blood agar in a 
single layer with gentamicin and colistin. The colonies of G. vaginalis 
were easily recognisable since they produced diffused beta-haemolysis 
on human blood agar which was absent on horse blood agar. 
Furthermore, with regard to the identification of G. vaginalis, all 
strains were Gram-variable with negative catalase and oxidase 
reactions. The criteria used for confirmation such as the 
alpha-glucosidase activity and zones of inhibition around trimethoprim 
and metronidazole with no zone of inhibition around the sulphathiazole 
disc were found to be rapid, reliable and reproducible with no 
discrepancies. 
A variety of media have been util ized as transport media for the 
recovery of §. vaginalis and these have included difco proteose peptone 
(Dunkelberg et ~, 1970), Stuart transport media (Akerlund and Mardh, 
1974; Jolly, 1983), heart infusion broth (Bailey et~, 1979) and Amies 
medium (Josey et ~, 1976; Ison et ~, 1982). Furthermore, using heart 
infusion broth supplemented with proteose peptone as transport media, 
Bailey et ~ (1979) showed no significant differences in isolation 
rates after a time delay of up to 6 hours when compared with the direct 
plating method. 
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The need to assess different transport media is important especially in 
large busy ~ospitals, where time delay in the transport of specimens is 
inevitable. However, data comparing different transport media are 
scarce. King Edward VIII Hospital is a large teaching hospital using 
Stuart (ST) transport media routinely, whilst another regional hospital 
for the area (Addington Hospital) uses Cary-Blair (CB) transport media. 
The direct plating method was considered as gold standard and both CB 
and ST transport media were compared to this. CB medium was shown to be 
the superior transport media because the yield of isolates as well as 
the density of growth was comparable to the direct plating method. The 
growth from ST medium was reduced compared to the CB medium, and 
significantly reduced when compared to the direct plating method 
(p« 0,05). Furthermore, the ST media allowed the overgrowth of aerobic 
Gram-negative organisms which tended to mask the growth of §. 
vaginalis. 
Since G. vaginalis has been isolated from women with and without 
bacterial vaginosis the need to differentiate strains arises. A 
biotyping scheme has been suggested by Piot et al (1984) for 
epidemiological studies. This study demonstrated that the majority of 
the strains belonged to either biotype 1, 2 or 5. Strains isolated from 
the vagina, urethra and urine were of similar biotypes. Similarly, 
biotypes 1, 2 and 5 were also predominant among strains tested from 
Antwerp, Seattle and Nairobi by Piot et ~ (1984) and in strains tested 
from the UK by Ison et ~ (1987). 
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A significant finding of this study was that among the strains tested, 
biotypes 1 and 5 were associated with bacterial vaginosis. In women 
whose urine isolates were typed the biotypes corresponded to those of 
the urethral and vaginal origin. 
The serotyping scheme used was similar to the one originally described 
by Ison et ~ (1987). This scheme made use of polyclonal antisera which 
were directed against proteins of differing molecular weights. 
Subsequently, using specific monoclonal antibodies an improved scheme 
was developed. Using Ison's monoclonal antibodies this study 
identified 27 serotypes. Of these, serotypes 125 and 25C were present 
more frequently than others. In the UK, serotype 125C has been found to 
be the predominant serotype in women with recurrent bacterial vaginosis 
(Ison, persona l communication). However, in this study women were 
investigated fo r the current episode of vaginal discharge only and were 
not subsequently followed up. There were no differences in the 
serotypes of strains of §.. vaginalis isolated from women with and 
without bacterial vaginosis. 
The choice of immunizing strains is crucial for any typing scheme. So 
far the antisera produced against §.. vaginalis have not always given 
clear differentiation among strains. Weak serological reactions have 
been obtained with a large number of strains. Negative reactions were 
obtained with 13 of the strains tested suggesting that the antigens 
selected for antisera production did not provide cover for these 
strains. These antisera may be more useful for the identification 
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rather than the typing of §. vaginalis, or there may be other as yet 
unrecognised serotypes. 
Antimicrobial agents belonging to the nitroimidazole group are 
recommended as drugs of choice for treating bacterial vaginosis. The 
MICs for both metronidazole and tinidazole against §. vaginalis ranged 
from 1mg/L to 128mg/L, with the majority of the strains having MICs 
of 16mg/L. However, the hydroxymetabolite of metronidazole was more 
active than the parent compound. The corresponding MICs of the 
hydroxymetabolite were in general at least two dilutions lower than 
that of metronidazole itself. One strain however, had an MIC of 128mg/L 
for metronidazole, tinidazole as well as the hydroxymetabolite of 
metronidazole. Similar results for these antimicrobial agents were also 
obtained by Ralph and Amatnieks (1980). 
Antimicrobial agents active against Gram-positive organisms eg peni-
cillin, ampicillin, erythromycin, clindamycin, vancomycin, rifampicin 
and chloramphenicol showed significantly higher MICs than those 
normally expected for Gram-positive organisms. These results are 
consistent with those of McCarthy et al (1979). Moreover, the 
lipopeptide, LV 146032, which is excellent for Gram-positive organisms, 
also showed markedly decreased activity against §. vaginal is. 
The activity of the cephalosporins, ciprofloxacin and imipenem was 
relatively reduced for §. vaginalis compared to those expected for most 
. gentamicin sensitive Gram-negative bacteria. The monobactam, aztreonam, 
which has activity only against Gram-negative organisms, demonstrated 
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very little activity, with MICs of 4mg/L or higher. §. vaginalis was 
found to be sensitive to trimethoprim but resistant to 
sulphamethoxazole. However, when tested in combination these agents did 
not show any synergy. 
The results of the MICs further conflict with the reports on the cell 
wall analysis of G. vaginalis. On the basis of the MICs to 
antimicrobial agents known to act at the cell wall level (ie 
penicillins and cephalosporins), the cell wall of the organism appears 
to be neither s t rictly Gram-positive or negative. It has been suggested 
that the organism is Gram-negative based on the presence of low 
mucopeptide, absence of techoic acid, the presence of 11 to 14 amino 
acids in the ' cell wall (Criswell et ~, 1971) and a 
"lipopolysaccharide-like" fraction (Greenwood and Pickett, 1980). 
However, the MICs for Gram-negative agents were high in this study. 
This is particularly the case with aztreonam which is specifically 
active against Gram-negative organisms. 
The original suggestion that §. vaginalis forms septa (Reyn et ~, 
1966) and more recent reports based on the absence of di ami nopime 1 i c 
acid (Harper and Davis, 1982) and the absence of lipopolysaccharide 
(Sadhu et ~, 1989) suggest the organism to be Gram-positive. However, 
the MICs to antimicrobial agents such as penicillin G, vancomycin and 
to LY 146032 which have activity restricted specifically to 
Gram-positives were high, suggesting that §. vaginalis is not a 
"typical" Gram-positive organism. These results emphasize the 
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uniqueness of G. vaginalis in being neither "typically" Gram-positive or 
Gram-negative .. 
For the therapy of bacterial vaginosis many antimicrobial agents have been 
used with varying success. Erythromycin although active against §. vaginalis 
and some anaerobic bacteria exhibits reduced activity in an acidic environ-
ment such as the vagina. Ampicillin which shows in vitro activity against §. 
vaginalis may be l imited in its clinical use because of the production of 
beta-lactamases by the vaginal anaerobes. 
Bacterial vaginosis and pelvic inflammatory disease (PIO) are characterised 
by a polymicrobial aetiology. The micro-organisms that are common in the 
aetiology of both these syndromes include M. hominis and anaerobic bacteria. 
It is plausible that the presence of a lower genital tract infection such as 
bacterial vaginosis may lead to the development of an upper genital tract 
infection such as PIO. Therefore adequate therapy for bacterial vaginosis 
would be recommended for preventing ascending genital tract infections. 
Sexually transmitted diseases that are diagnosed by serological tests alone 
include syphilis, hepatitis B and human immunodeficiency virus infection. 
Serological tests for these infections were performed on all patients. The 
prevalence of syphilis remains high in South Africa. Studies from different 
centres have shown a prevalence of up to 18% in asymptomatic pregnant women 
(Naicker et ~, 1983; Mahomed et ~, 1984; O'Farrell et ~, 1989). This 
study recorded a surprisingly high prevalence of 26,9% in ANC women, a 
figure close to the 29,4% recorded in the STO clinic attenders. Furthermore, 
the high background prevalence of syphilis could be gauged by the fact that 
specific treponemal tests were positive in nearly 40% of all women examined. 
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These data strongly suggest that any woman attending an outpatient clinic at 
this hospital should be routinely screened for syphilis. 
Hepatitis B is important in South Africa where horizontal transmission is 
said to be predominant. The overall finding of HBsAg in 7,7% of women, is in 
keeping with South African figures ranging between 2,1% (Botha et ~, 1984) 
and 15,8% (Bersohn et ~, 1974). As with syphilis serology there was a high 
prevalence of HBsAg (17,3%) in the ANC group. This could also suggest a role 
for vertical transmission. 
Human immunodeficiency virus infections in Africa are said to be predomi-
nantly due to heterosexual transmission. This is corroborated by the local 
figures for blood donors and STD cl inic attenders (male to female ratio 
being similar). At the time of this study, four women referred for col-
poscopy tested pos i tive for HIV antibody. In none of the other clinic 
attenders was the antibody detected. 
As most lower genital tract infections in women have been shown to be 
sexually transmitted, it would have been of interest to simultaneously 
investigate the sexual contacts of the women studied. However, past local 
experience has shown such studies to be very difficult, if not impossible to 
carry out because of poor patient and sexual partner compliance. Further-
more, patients are unaware that they have a sexually transmitted disease 







CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
This study clearly demonstrates the high prevalence of vaginal, 
endo-cervical and concurrent vaginal with endo-cervical infections 
locally. 
The prevalence of syphilis as determined by reactive syphilis 
serology was high. 
Although !!. gonorrhoeae is an important pathogen in symptomatic 
women locally, a higher prevalence of C. trachomatis infection was 
diagnosed in asymptomatic women. 
6.1.4 In developed communities, bacterial vaginosis is the most common 
vaginal infection. However, in this study trichomoniasis was more 
commonly detected than either bacterial vaginosis or candidiasis. 
6.1.5 With regard to bacterial vaginosis: 
6.1. 5.1 It frequently occurred concurrently with other recogni sed 
vaginal pathogens; 
6.1.5.2 it was significantly associated with the 
G. vaginalis, M. hominis, anaerobic bacteria 
Gram-negative curved rods and 
presence of 
and anaerobi c 
6.1.5.3 the detection of "clue" cells by vaginal wet smear microscopy 




With regard to §. vaginal is: 
6.1.6.1 Its isolation was significantly associated with the syndrome 
of bacterial vaginosis; 
6.1.6.2 the Cary-Blair medium was found to be the superior transport 
medium tested; 
6.1.6.3 biotypes 1 and 5 were significantly associated with bacterial 
vaginosis; 
6.1.6.4 the antimicrobial susceptibility pattern of isolates was not 
typical of either Gram-positive or Gram-negative bacteria and 
6.1.6.5 the MICs indicate that the majority of strains tested were 
sensitive to the nitroimidazoles. 
RECOMMENDATIONS 
6.2.1 All women with symptoms and signs of an abnormal vaginal discharge 
should be screened for lower genital tract infections (ie vaginitis and 
cervicitis) • 
6.2.2 Vaginal wet smear microscopy, being the single most reliable 
6.2.3 
6.2.4 
bedside test, should be performed on all women attending the sexually 
transmitted diseases, colposcopy, ante-natal and family planning 
clinics. 
In view of the high prevalence of syphilis, serological screening 
should be undertaken on all women attehding the various clinics at this 
hospital. 
For the transport of specimens from which G. vaginalis is to be 
cultured, the Cary-Blair medium is recommended. 
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Formulae and preparation of media used. 
1 Human Blood agar (HB) adapted from Greenwood et ~ (1977) 
Basal Medium 
44 g of Columbia blood agar (Difco) containing: 
Bacto-Pantone 109 
Bacto-Bitone 109 
Tryptic digest of beef heart 3g 
Corn starch 19 
Sodium ch loride Sg 
Bacto agar lSg 
with Proteose peptone No 3 (Difco) 109 
Human blood: expired, approximately 3 weeks after collection from the 
Natal Blood Transfusion service (NBTS) was used. It was tested for 
antibacterial activity and thereafter aliquoted in 2Smt amounts into 
sterile universal containers and stored at 4°C. 
The medium was dissolved in 9S0mt distilled water, the pH adjusted to 
7,3 and autoclaved at 121°C for 15 minutes. Thereafter it was cooled to 
48°C and SOmt sterile human blood was added aseptically and mixed. 
Approximately 20mts of medium was poured into each 9cm petri dish. 
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2 Selective human blood agar (SHBA) 
This medium was used for the primary isolation of G. vaginalis. 
Human blood agar was prepared as in (1) and stock antibiotic solutions 
added to give a final concentration of gentamicin (Scherag) 5ug/mt and 
colistin (Sigma) 10ug/mt. 
Antibiotic stocks were prepared as follows: 
100mg gentamicin + 20mt sterile distilled water; 
200mg colistin + 20mt sterile distilled water 
The stock antibiotics were distributed in 1mt amounts separately and 
stored at -20°C. One aliquot of each was added to 1 litre of agar to 
give the final required concentration. 
3 Horse blood agar (BA) 
Horse blood agar was prepared using Columbia blood agar base as in (1) 
and 5% horse blood (v/v). 
Horse Blood was otbained from the South African Institute of Medical 
Research (SAIMR), Johannesburg and used as for human blood. 
4 Wilkins-Chalgren Anaerobe Agar (WC). 
This medium was used for the primary isolation of anaerobic bacteria. 
Basal medium 
43g of Wilkens-Chalgren anaerobe agar (Oxoid) containing: 
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Tryptone 109 
Gelatine peptone 109 
Yeast extract 5g 
Dextrose 19 
Sodium chloride 5g 
L-arginine 19 




The medium was dissolved in g50mt distilled water, the pH adjusted to 
7,1 and autoclaved at 121°C for 15 minutes. Thereafter it was cooled to 
48°C and 50mt horse blood added. Approximately 20mt of medium was 
poured into each gcm petri dish. 
5 Modified Diamond's Medium 
This medium was used for the culture of T. vaginalis 
Basal Medium 
Trypticase (BBL) 20g 
Yeast extract 109 
Maltose 5g 








Sterile horse serum (SAIMR) 100mt 
Antibiotics 
Amikacin (The B-M group Pty) 






The dry ingredients were dissolved in distilled water and the pH 
adjusted to 6,0. Sterilised at 121°C for 10 minutes. Once cooled to 
48°C the supplements were added. Approximately 9mt of the medium was 
dispensed in 15mt tubes (Falcon 2099, Becton Dickinson, USA) and kept 
at 4°C. When required the medium was allowed to warm up to room 
temperature before being inoculated. 
6 Shepard's A7 Agar 
Basal med i um 
Ureaplasma basal agar medium (Gibco) consisting per litre of the 
following ingredients: 
Peptone 220 (yeast casein polypeptone) 17g 
Peptone 140 (Pancreatic digest of casein) 17g 
Peptone 110 (Papaic digest of soy protein) 3g 
Dextrose 2,5g 
Manganous sulphate (MnS04.H20) 0,2g 
Sodium chloride 5,Og 
Potassium phosphate dibasic 2,5g 
Agar 
Supplements 
Unheated normal horse serum 
CVA enrichment (Gibco) 
20% Yeast extract solution (Gibco) 
10% urea solution 
1% L-Cysteine-HCL solution 
0,5% Phenol red 
Antibiotics 
Ampicillin (Beechams) 











The basal agar medium (6,6 grams) was dissolved in 165m.e of distilled 
water, pH adjusted to 5,5 and steril i zed at 121°C for 15 mi nutes. 
Thereafter it was cooled to 48°C and sterile supplements and 
antibiotics were added to the molten agar. The complete medium was 
mixed thoroughly and poured into sterile 6cm petri dishes. The prepared 
medium was stored at 4°C and used within 2 weeks. 
7 U9 - Broth 
Basal Medium 
Tryptic digest broth (Difco) 
Sodium chloride 
Potassium acid phosphate 
Di sti 11 ed water 
Supplements 
Unheated normal horse serum 
10% urea solution 
2% L-cysteine HCl solution 










Penicillin G potassium (Novo Industries) 100,000 units/me 
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The ingredients for the basal medium were mixed thoroughly in distilled 
water and the pH adjusted to 5,5 with IN HC1. Thereafter it was 
sterlised at 121°C for 15 minutes and cooled. To 95mt of basal broth 
the supplements and antibiotic were added and the complete medium was 
aseptically dispensed in 2mt volumes into bijou bottles. The prepared 
medium was stored at -20°C and used within one week. 
8 Sabouraud dextrose agar 
Basal Medium 










The medium was dissolved in distilled water and pH adjusted to 5,6. It 
was sterilized at 121°C for 15 minutes. Approximately 20mt of medium 
was poured into each 9cm petri dish. 
9 Modified Stuart Transport Medium 
Basal Medium 
16g of Modified Stuart Transport Medium (Oxoid) consisting of 
Sodium glycerophosphate 10,Og 
Sodium thioglycollate 0,5g 
Cysteine hydrochloride 0,5g 
Calcium chloride O,lg 
Methylene blue O,OOlg 
Agar No 1 5,Og 
Di sti 11 ed water 1000mt 
The medium was suspended in distilled water and boiled to dissolve 
completely, pH adjusted to 7,4 and dispensed into screw-capped bijou 
bottl es. The bottl es were fi 11 ed to the brim, the caps ti ghtened and 
sterilized at 121°C for 15 minutes. 
10 Modified Cary-Blair Transport Media 
Basal medium consisting of 
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Sodium thioglycollate 1,5g 
Calcium chloride O,lg 
Disodium phosphate O,lg 
Sodium chloride 5,Og 
Sodium meta bisulphite O,lg 
Purified agar 10,Og 
Resazurin solution 5mt 
Di sti 11 ed water 1000mt 
L-cysteine HCL 1,0g 
The ingredients were dissolved in water and steamed for 45 minutes and 
then cooled with CO2. L-cysteine HCL was added and the pH adjusted to 
7,5. The medium was dispensed into universal bottles in 25mt amounts in 
an anaerobic chamber. These were sterilized at 121°C for 15 minutes. 
All bottles were checked for tightness after autoclaving. 
11 Modified New York City Medium 
Basal medium 
18g of Gonococcal (GC) agar base (Oxoid) consisting of per litre: 
Special peptone 15,Og 
Corn starch 1,0g 
Sodium Chloride 5,Og 
Dipotassium hydrogen phosphate 4,Og 
Potassium dihydrogen phosphate 1,0g 
Agar No 1 10,Og 
Di sti 11 ed water 425mt 
Supplement 
Sterile yeast autolysate supplement (Oxoid) consisting of 
Yeast autolysate 5,Og 
Dextrose 0,5g 
Sodium bicarbonate 0,075g 
Reconstituted with sterile distilled water, l5me 







Trimethoprim lactate 3,25mg 
Reconstituted with sterile distilled water lOme 
Defibrinated lysed horse blood 
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50mi of horse blood (SAIMR) was lysed with 0,5% (by vol) saponin 
The basal medium was dissolved in distilled water and sterilised at 
121°C for 15 minutes, thereafter cooled to 50°C. Aseptically the lysed 
defibrinated horse blood; reconstituted yeast autolysate and LCAT 
antibiotic supplement were added to the cooled GC agar base. The 
contents were mixed gently and poured into sterile petri dishes. 
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Antibiotic stock solutions were prepared as follows: 
a IOOmg gentamicin (Scherag) dissolved in 20mt distilled water 
b 2000mg amikacin (The B-M Group) dissolved in 20mt distilled water 
c 200mg colistin (Sigma) dissolved in 20mt distilled water 
d IOOmg amphotericin B (Squibb) dissolved in 2mt of dimethyl 
sulphoxide (DMSO) and the volume made up with 18mt of distilled 
water 
e 20000mg ampicillin (Beechams) dissolved in 20mt of distilled 
water. 
The stock antibiotic solutions were distributed in lmt amounts 
separately and stored at -20°C. One aliquot of each was added to I 
litre of medium where required to give the final concentration. 
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APPENDIX B 
Formulae and preparation of biochemical substrates 
1 Substrates used for the biochemical identification of G. 
vaginal is. 
The determination of alpha and beta-glucosidase activity. 
Buffer : 
Sorensons phosphate buffer pH 8,0 was prepared as follows: 
Solution A 
9,08g monopotassium phosphate (KH2 P04) (BDH 10203) 
per litre of distilled water giving a concentration of 67mmot 
Solution B 
11,88g disodium phoshate (Na2 HP04 2H20) (BDH 10249) 
per litre of distilled water giving a concentration of 67mmot 
To make up buffer 
x of solution A 
+ 
(100-x) mt of solution B 
or x mt of solution A titrated with solution B to a final pH of 8,0. 
Substrates 
4-nitrophenyl-alpha-D-glucopyranoside (Sigma N1377) 
4-nitrophenyl-beta-D-glucopyranoside (Sigma N7006) 
To make up substrates 
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0,1% (w/v) of each substrate was made up in 67mmot Sorensons phosphate 
buffer, pH 8,0. The substrates were aliquoted in 20mt portions and 
stored at -20°C until required. 
A loop of bacterial suspension from an HB agar plate incubated for 24 
hours was added to 0,5mt of both these solutions. These were incubated 
for 18 hours at 37°C in a water bath. A positive reaction was 
indicated by the formation of a yellow colouration. 
2 Substrate and media for biotyping of G. vaginalis 
a Hippurate hydrolysis 
The substrate consisted of: 
0,67 mol/L potassium dihydrogen phosphate 73,2mt (BOH 10203) 
0,67 mol/L disodium hydrogen phosphate 26,8mt (BOH 10249) 
Sodium hippurate (Sigma H9380) Ig 
The pH was adjusted to 6,4 and the substrate filter sterilised. 
This was aliquoted into 20mt amounts and stored at -20°C until 
required. Each tube containing 0,5mt of the test medium was 
inoculated with a large loopful of bacterial growth and incubated 
for 4 hours at 37°C in a waterbath. The reaction was visualised by 
the addition of 2 drops of ninhydrin (API r7049). A blue 
colouration after 5 minutes at 37°C was indicative of a positive 
reaction. 
b Beta galactosidase activity 
The buffer was prepared as follows: 
Sodium dihydrogen phosphate 6,9g 
Distilled water 40mt 
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The buffer was adjusted to pH 7,0 with NaOH and made up to a final 
volume of SOme. 
The buffer was used to make the substrate 
Buffer 2Smi 
Distilled water 7Smi 
2-nitrophenyl-beta-D-galactopyranoside (Sigma N12S2) 0,4g 
The substrate was fi lter steri 1 i sed and stored at -20°C unti 1 
required. The test organisms were inoculated into o,smt of 
substrate and incubated for 18 hours at 37°C in a water bath. A 
yellow colouration indicated a positive reaction. 
c Lipase Activity 
Basal medium consisting of 
Proteose peptone No 3 (Difco) 




5% (w/v) magnesium sulphate 
solution 
Di sti 11 ed water 
Supplement 
Egg yolk emulsion (Oxoid) 20m.e 









The basal medium was dissolved in distilled water and sterilised 
at 121°C for 15 minutes. After cooling to 50°C the egg yolk 
emulsion and horse serum were added aseptically. Approximately 
20m.e of medium was filled in 9cm petri dishes. 
Organisms to be tested were spot inoculated onto the medium and 
the plates were incubated at 37°C in an anaerobic jar (BBl) for 3 
days. Using an oblique light the growth was examined for the 
appearance of an oily irridescent sheen, indicating a positive 
reaction. 
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3 Nitrocefin (Chromogenic cephalosporin compound) (Glaxo, England) 
5mg nitrocefin was added to 0,5ml of dimethyl sulphoxide (Merck 2937). 
Once the compound dissolved well, 9,5ml of O,lM phosphate buffer pH 7,0 
was added. This was shaken well to mix. The prepared solution was 
stored in the dark at 4°C and used within 14 days. 
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APPENDIX C 
Reagents for Immune Dot Blot Assays 
1 Enzyme Linked Immunosorbent Assay (ELISA) buffer 
Sodium chloride 9,Og 
Tris (2-amino-2-(hydroxymethyl) 
propane -1,3 diol, (tris) (BDH 10315) 1,21g 
Distilled water 1000mt 
Only 800mt of distilled water was added and adjusted to pH 7,4. The 
solution was then made up to a final volume of 1000mt. 
2 Preparation of washing buffer 
30% bovine serum albumin 
ELISA buffer pH 7,4 
3,3mt 
96,7mt 
3 Preparation of blocking buffer 
30% bovine serum albumin 




4 Alkaline phosphatase substrates for Dot Blotting 
Reagents Volume 
5-bromo-4-chloro-3-indolyphosphate (Sigma B-0766) 
4mg/mt in a mixture of methanol:acetone 2:1 v/v 2,25mt 
Nitro blue tetrazolium (Sigma N6876) (1mg/mt) 15,Omt 
Magnesium chloride 1mol/L 0,6mt 
Diethanolamine-HCL (BDH-28612) buffer pH 9,6 82,15mt 
0.1 mol/L 
